sampleID,CN-Clusters-nature2012,Days-to-Date-of-Last-Contact-nature2012,Days-to-date-of-Death-nature2012,Integrated-Clusters-no-exp--nature2012,Integrated-Clusters-unsup-exp--nature2012,Integrated-Clusters-with-PAM50--nature2012,OS-Time-nature2012,OS-event-nature2012,SigClust-Intrinsic-mRNA-nature2012,SigClust-Unsupervised-mRNA-nature2012,age-at-initial-pathologic-diagnosis,days-to-birth,days-to-collection,days-to-death,days-to-last-followup,her2-neu-chromosone-17-signal-ratio-value,initial-weight,lymph-node-examined-count,methylation-Clusters-nature2012,miRNA-Clusters-nature2012,number-of-lymphnodes-positive-by-he,number-of-lymphnodes-positive-by-ihc,year-of-initial-pathologic-diagnosis,Converted-Stage-nature2012,ER-Status-nature2012,Node-Coded-nature2012,Node-nature2012,PAM50Call-RNAseq,PAM50-mRNA-nature2012,PR-Status-nature2012,Survival-Data-Form-nature2012,Tumor-T1-Coded-nature2012,Tumor-nature2012,PANCAN-CNA-PANCAN-K8,PANCAN-Cluster-Cluster-PANCAN,PANCAN-DNAMethyl-BRCA,PANCAN-DNAMethyl-PANCAN,PANCAN-RPPA-PANCAN-K8,PANCAN-UNC-RNAseq-PANCAN-K16,PANCAN-mutation-PANCAN,axillary-lymph-node-stage-method-type,breast-carcinoma-estrogen-receptor-status,breast-carcinoma-immunohistochemistry-pos-cell-score,breast-carcinoma-progesterone-receptor-status,breast-carcinoma-surgical-procedure-name,cytokeratin-immunohistochemistry-staining-method-mcrmtstss-ndctr,er-level-cell-percentage-category,her2-erbb-pos-finding-cell-percent-category,her2-immunohistochemistry-level-result,histological-type,icd-o-3-histology,immunohistochemistry-positive-cell-score,initial-pathologic-diagnosis-method,lab-proc-her2-neu-immunohistochemistry-receptor-status,lab-procedure-her2-neu-in-situ-hybrid-outcome-type,menopause-status,oct-embedded,pathologic-M,pathologic-T,postoperative-rx-tx,radiation-therapy,tissue-prospective-collection-indicator,tissue-retrospective-collection-indicator,Subtype,HER2-Final-Status-nature2012,PANCAN-miRNA-PANCAN,PANCAN-mirna-BRCA,pathologic-stage,gender,Age
TCGA-3C-AAAU-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,5.0,null,5.0,null,1.0,3.0,null,null,2.0,null,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,50-59%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,TX,NO,NO,NO,YES,LumA,null,null,null,Stage X,FEMALE,null
TCGA-3C-AALI-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,5.0,null,5.0,null,1.0,4.0,null,null,1.0,null,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,null,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,Her2,null,null,null,Stage IIB,FEMALE,null
TCGA-3C-AALJ-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,null,null,2.0,null,null,6.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Indeterminate,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,NO,NO,NO,YES,LumB,null,null,null,Stage IIB,FEMALE,null
TCGA-3C-AALK-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,2.0,null,2.0,null,1.0,1.0,null,null,1.0,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,null,True,M0,T1c,NO,NO,NO,YES,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-4H-AAAK-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,4.0,4.0,null,null,2.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,60-69%,10-19%,2+,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-5L-AAT0-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,2.0,null,2.0,null,1.0,2.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Incisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-5L-AAT1-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,2.0,null,2.0,null,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Other (specify),Positive,null,Positive,Simple Mastectomy,NO,80-89%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M1,T2,YES,NO,NO,YES,LumA,null,null,null,Stage IV,FEMALE,null
TCGA-5T-A9QA-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,3.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Positive,null,Negative,null,NO,70-79%,10-19%,2+,"Other, specify",8523/3,2+,Excisional Biopsy,Equivocal,Negative,null,True,MX,T2,YES,YES,YES,NO,LumB,null,null,null,Stage IIA,FEMALE,null
TCGA-A1-A0SB-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,null,null,1.0,null,null,1.0,10.0,4.0,1.0,null,9.0,Stage I,Positive,Negative,N0,Normal,null,Negative,enrollment,T1,T1,Kirc+,C4-BRCA/Basal,cluster 5,Low purity c2,null,BRCA basal-like c8,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,null,70-79%,null,null,"Other, specify",8200/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,null,NO,YES,Normal,Negative,miRNA cluster 7,cluster 3,Stage I,FEMALE,70.0
TCGA-A1-A0SD-01,3.0,1.0,null,null,null,null,1.0,1.0,4.0,8.0,6.0,5.0,3.0,null,1.0,null,1.0,1.0,1.0,9.0,1.0,1.0,7.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,59.0
TCGA-A1-A0SE-01,3.0,2.0,null,null,null,null,2.0,1.0,7.0,5.0,5.0,6.0,null,null,2.0,1.0,null,2.0,1.0,9.0,1.0,null,7.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,null,80-89%,null,1+,Mixed Histology (please specify),8522/3,3+,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,null,null,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage I,FEMALE,56.0
TCGA-A1-A0SF-01,6.0,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,3.0,null,2.0,null,1.0,1.0,8.0,9.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 12,cluster 6,Stage IIA,FEMALE,54.0
TCGA-A1-A0SG-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,3.0,null,1.0,null,1.0,3.0,3.0,7.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,"Other, specify",8507/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 5,Stage IIB,FEMALE,61.0
TCGA-A1-A0SH-01,10.0,3.0,null,1.0,1.0,1.0,3.0,1.0,7.0,5.0,3.0,8.0,2.0,null,2.0,1.0,2.0,1.0,3.0,6.0,1.0,null,8.0,Stage IIA,Negative,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 10,Sentinel node biopsy alone,Negative,null,Positive,Lumpectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA c1uster 9,cluster 4,Stage IIA,FEMALE,39.0
TCGA-A1-A0SI-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,2.0,null,1.0,null,1.0,6.0,10.0,10.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,null,50-59%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,True,M0,T2,null,null,NO,YES,LumB,Negative,miRNA cluster 4,cluster 7,Stage IIB,FEMALE,52.0
TCGA-A1-A0SJ-01,6.0,1.0,null,1.0,6.0,7.0,1.0,1.0,8.0,8.0,3.0,8.0,2.0,null,1.0,1.0,1.0,5.0,8.0,6.0,1.0,null,8.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,null,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,null,True,M0,T3,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,39.0
TCGA-A1-A0SK-01,1.0,1.0,2.0,3.0,3.0,4.0,2.0,10.0,1.0,6.0,5.0,6.0,2.0,2.0,null,null,1.0,1.0,10.0,7.0,1.0,null,8.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,GBM-like c6,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,null,null,null,0,"Other, specify",8013/3,null,Excisional Biopsy,Negative,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,54.0
TCGA-A1-A0SM-01,3.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,8.0,3.0,null,null,1.0,7.0,null,1.0,8.0,6.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Modified Radical Mastectomy,null,20-29%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,null,null,M0,T2,null,null,NO,YES,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIA,MALE,77.0
TCGA-A1-A0SN-01,10.0,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,2.0,null,2.0,null,1.0,3.0,6.0,6.0,2.0,null,8.0,Stage IIA,Positive,Positive,N1,LumB,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T1c,null,null,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,50.0
TCGA-A1-A0SO-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,10.0,7.0,4.0,2.0,null,2.0,1.0,1.0,3.0,10.0,7.0,1.0,null,8.0,Stage IIB,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,67.0
TCGA-A1-A0SP-01,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,null,null,1.0,null,null,1.0,null,null,1.0,null,8.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,null,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,null,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,null,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 12,null,Stage IIA,FEMALE,40.0
TCGA-A1-A0SQ-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,2.0,null,1.0,null,1.0,4.0,3.0,2.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 3,cluster 2,Stage IIB,FEMALE,45.0
TCGA-A2-A04N-01,8.0,5.0,null,6.0,6.0,7.0,5.0,1.0,7.0,8.0,7.0,4.0,4.0,null,6.0,1.0,1.0,2.0,3.0,9.0,1.0,1.0,6.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Other (specify),Positive,null,Positive,Lumpectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage IA,FEMALE,66.0
TCGA-A2-A04P-01,1.0,1.0,1.0,3.0,3.0,4.0,1.0,10.0,1.0,10.0,2.0,9.0,4.0,1.0,null,1.0,2.0,5.0,10.0,7.0,6.0,1.0,7.0,No_Conversion,Negative,Positive,N3,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIIC,FEMALE,36.0
TCGA-A2-A04Q-01,6.0,2.0,null,1.0,3.0,7.0,2.0,1.0,1.0,1.0,4.0,7.0,3.0,null,3.0,1.0,2.0,1.0,1.0,6.0,1.0,1.0,7.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T1,T1,High,C4-BRCA/Basal,cluster 1,BRCA CIMP c7,KIRC-like c1,BRCA basal-like c8,mutation c1uster 9,Other (specify),Negative,null,Negative,Simple Mastectomy,YES,<10%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,YES,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,48.0
TCGA-A2-A04R-01,10.0,4.0,null,null,null,null,4.0,1.0,3.0,8.0,2.0,9.0,3.0,null,5.0,1.0,1.0,1.0,8.0,6.0,1.0,1.0,7.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Positive,followup,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 10,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,60-69%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,36.0
TCGA-A2-A04T-01,1.0,4.0,null,null,null,null,4.0,1.0,1.0,1.0,6.0,5.0,3.0,null,3.0,1.0,1.0,1.0,10.0,7.0,1.0,1.0,7.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 14,cluster 5,Stage IIA,FEMALE,62.0
TCGA-A2-A04U-01,null,1.0,null,null,null,null,1.0,1.0,1.0,10.0,4.0,7.0,3.0,null,4.0,2.0,1.0,1.0,10.0,7.0,1.0,2.0,7.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Positive,Peri (6-12 months since last menstrual period),True,M0,T2,YES,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 5,Stage IIA,FEMALE,47.0
TCGA-A2-A04V-01,3.0,3.0,5.0,6.0,6.0,7.0,3.0,10.0,10.0,8.0,3.0,9.0,3.0,3.0,null,1.0,1.0,1.0,3.0,2.0,1.0,1.0,7.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,39.0
TCGA-A2-A04W-01,6.0,3.0,null,null,null,null,3.0,1.0,2.0,6.0,4.0,7.0,3.0,null,4.0,2.0,2.0,5.0,1.0,6.0,1.0,null,7.0,No_Conversion,Negative,Positive,N1,Her2,HER2-enriched,Negative,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,<10%,null,null,"Other, specify",8401/3,null,Core needle biopsy,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,NO,YES,Her2,Positive,miRNA c1uster 9,cluster 4,Stage IIB,FEMALE,50.0
TCGA-A2-A04X-01,6.0,3.0,null,null,null,null,3.0,1.0,9.0,6.0,2.0,9.0,2.0,null,2.0,2.0,1.0,1.0,1.0,6.0,1.0,1.0,8.0,Stage IIA,Positive,Negative,N0,Her2,HER2-enriched,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,80-89%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,34.0
TCGA-A2-A04Y-01,10.0,2.0,null,3.0,6.0,7.0,2.0,1.0,9.0,8.0,5.0,6.0,1.0,null,2.0,1.0,1.0,3.0,1.0,7.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 5,Stage IIB,FEMALE,53.0
TCGA-A2-A0CK-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,4.0,null,5.0,1.0,2.0,5.0,null,null,2.0,null,6.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Lumpectomy,NO,40-49%,null,null,Infiltrating Lobular Carcinoma,8520/3,2+,Excisional Biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,LumA,null,miRNA cluster 14,null,Stage IIIA,FEMALE,null
TCGA-A2-A0CL-01,6.0,3.0,null,1.0,1.0,1.0,3.0,1.0,9.0,6.0,2.0,9.0,null,null,4.0,1.0,null,4.0,1.0,6.0,3.0,1.0,8.0,No_Conversion,Positive,Positive,N2,Normal,HER2-enriched,Positive,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,20-29%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T3,YES,YES,NO,YES,Normal,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,37.0
TCGA-A2-A0CM-01,8.0,2.0,2.0,1.0,1.0,4.0,2.0,10.0,1.0,1.0,3.0,8.0,4.0,1.0,null,null,2.0,1.0,8.0,6.0,1.0,1.0,7.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,0,Negative,Simple Mastectomy,YES,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,0,Excisional Biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,40.0
TCGA-A2-A0CO-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,null,5.0,4.0,1.0,null,3.0,null,null,1.0,1.0,6.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,null,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,40-49%,null,null,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T3,YES,YES,NO,YES,LumA,null,miRNA cluster 3,null,Stage IIB,FEMALE,null
TCGA-A2-A0CP-01,8.0,4.0,null,1.0,8.0,7.0,4.0,1.0,7.0,5.0,6.0,5.0,4.0,null,4.0,null,1.0,1.0,1.0,6.0,1.0,1.0,7.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,60.0
TCGA-A2-A0CQ-01,3.0,4.0,null,1.0,6.0,7.0,4.0,1.0,1.0,8.0,6.0,5.0,3.0,null,4.0,1.0,1.0,1.0,8.0,2.0,1.0,1.0,7.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,62.0
TCGA-A2-A0CR-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,3.0,null,4.0,1.0,2.0,4.0,null,null,1.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,Quiet,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,60-69%,null,null,Infiltrating Lobular Carcinoma,8520/3,1+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,NO,NO,YES,LumA,null,miRNA cluster 13,null,Stage IIB,FEMALE,null
TCGA-A2-A0CS-01,3.0,4.0,null,6.0,6.0,7.0,4.0,1.0,1.0,8.0,8.0,3.0,3.0,4.0,3.0,1.0,1.0,4.0,3.0,6.0,4.0,1.0,7.0,No_Conversion,Positive,Positive,N3,LumA,Luminal A,Positive,followup,T_Other,T4,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,80-89%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M1,T4b,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IV,FEMALE,73.0
TCGA-A2-A0CT-01,10.0,4.0,null,8.0,6.0,10.0,4.0,1.0,3.0,8.0,8.0,3.0,null,null,3.0,1.0,null,1.0,6.0,2.0,1.0,1.0,7.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Negative,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,0,Negative,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,71.0
TCGA-A2-A0CU-01,10.0,1.0,1.0,6.0,6.0,7.0,1.0,10.0,10.0,8.0,8.0,3.0,3.0,1.0,null,1.0,1.0,1.0,3.0,2.0,1.0,2.0,7.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,73.0
TCGA-A2-A0CV-01,3.0,3.0,null,6.0,8.0,7.0,3.0,1.0,7.0,5.0,3.0,8.0,null,null,4.0,1.0,null,5.0,3.0,9.0,2.0,1.0,7.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 7,cluster 6,Stage IIB,FEMALE,41.0
TCGA-A2-A0CW-01,1.0,3.0,null,null,null,null,3.0,1.0,9.0,6.0,7.0,4.0,2.0,null,4.0,1.0,2.0,5.0,1.0,null,1.0,1.0,8.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,LumB,Negative,null,null,Stage IIB,FEMALE,67.0
TCGA-A2-A0CX-01,6.0,3.0,null,null,null,null,3.0,1.0,2.0,6.0,5.0,6.0,2.0,null,3.0,null,3.0,1.0,8.0,null,1.0,1.0,8.0,Stage IIA,Positive,Negative,N0,Her2,HER2-enriched,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,YES,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,Her2,Positive,null,null,Stage IIA,FEMALE,52.0
TCGA-A2-A0CY-01,1.0,3.0,null,null,null,null,3.0,1.0,10.0,8.0,6.0,5.0,2.0,null,2.0,1.0,1.0,6.0,10.0,10.0,1.0,1.0,8.0,No_Conversion,Positive,Positive,N1,null,HER2-enriched,Positive,followup,T_Other,T2,Kirc+,null,cluster 5,Cluster 5,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA c1uster 10,cluster 7,Stage IIB,FEMALE,63.0
TCGA-A2-A0CZ-01,8.0,3.0,null,6.0,8.0,7.0,3.0,1.0,7.0,5.0,4.0,7.0,2.0,null,2.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,8.0,Stage IIA,Positive,Negative,N0,Normal,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Peri (6-12 months since last menstrual period),True,M0,T2,null,NO,NO,YES,Normal,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,46.0
TCGA-A2-A0D0-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,6.0,5.0,1.0,null,3.0,1.0,3.0,2.0,10.0,7.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,0,Negative,Simple Mastectomy,NO,<10%,null,0,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,Basal,Negative,miRNA cluster 14,cluster 5,Stage IIA,FEMALE,60.0
TCGA-A2-A0D1-01,1.0,2.0,null,3.0,3.0,1.0,2.0,1.0,9.0,6.0,8.0,3.0,1.0,null,2.0,4.0,2.0,1.0,6.0,1.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Her2,HER2-enriched,Negative,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Her2,Positive,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,76.0
TCGA-A2-A0D2-01,6.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,1.0,3.0,8.0,1.0,null,2.0,1.0,2.0,2.0,10.0,6.0,1.0,6.0,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 2,Sentinel node biopsy alone,Negative,0,Negative,Simple Mastectomy,YES,<10%,null,0,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,45.0
TCGA-A2-A0D3-01,3.0,2.0,null,6.0,6.0,7.0,2.0,1.0,7.0,8.0,3.0,8.0,1.0,null,3.0,1.0,2.0,1.0,8.0,9.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IA,FEMALE,42.0
TCGA-A2-A0D4-01,10.0,2.0,null,8.0,6.0,10.0,2.0,1.0,3.0,8.0,2.0,9.0,1.0,null,1.0,1.0,1.0,6.0,6.0,7.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 5,Stage IIB,FEMALE,37.0
TCGA-A2-A0EM-01,3.0,5.0,null,null,null,null,5.0,1.0,1.0,8.0,8.0,3.0,4.0,null,4.0,1.0,1.0,1.0,3.0,2.0,1.0,1.0,6.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,73.0
TCGA-A2-A0EN-01,3.0,4.0,null,null,null,null,4.0,1.0,7.0,5.0,7.0,4.0,3.0,null,4.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,7.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Excisional Biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,70.0
TCGA-A2-A0EO-01,3.0,4.0,null,1.0,8.0,7.0,4.0,1.0,7.0,5.0,5.0,6.0,3.0,null,3.0,1.0,1.0,1.0,8.0,2.0,1.0,1.0,7.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Peri (6-12 months since last menstrual period),True,M0,T1,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,54.0
TCGA-A2-A0EP-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,5.0,1.0,null,1.0,null,null,1.0,2.0,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Negative,Simple Mastectomy,YES,80-89%,null,null,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1,YES,NO,NO,YES,LumA,null,miRNA cluster 4,null,Stage I,FEMALE,null
TCGA-A2-A0EQ-01,8.0,4.0,null,1.0,1.0,10.0,4.0,1.0,9.0,6.0,6.0,5.0,null,null,3.0,1.0,null,1.0,8.0,7.0,1.0,1.0,7.0,Stage IIA,Negative,Negative,N0,Her2,HER2-enriched,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,Other (specify),Negative,0,Negative,Lumpectomy,YES,<10%,null,3+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Positive,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,Her2,Positive,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,64.0
TCGA-A2-A0ER-01,10.0,4.0,null,null,null,null,4.0,1.0,3.0,8.0,6.0,5.0,3.0,null,3.0,1.0,2.0,4.0,3.0,2.0,1.0,1.0,7.0,No_Conversion,Positive,Positive,N1,LumA,Luminal B,Positive,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IB,FEMALE,63.0
TCGA-A2-A0ES-01,8.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,5.0,6.0,1.0,null,3.0,1.0,3.0,1.0,1.0,9.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,60-69%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,52.0
TCGA-A2-A0ET-01,6.0,2.0,null,null,null,null,2.0,1.0,3.0,8.0,6.0,5.0,1.0,null,2.0,1.0,5.0,4.0,8.0,1.0,2.0,1.0,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,58.0
TCGA-A2-A0EU-01,8.0,2.0,null,6.0,6.0,7.0,2.0,1.0,3.0,8.0,9.0,2.0,1.0,null,2.0,1.0,3.0,1.0,3.0,2.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,79.0
TCGA-A2-A0EV-01,6.0,2.0,null,6.0,8.0,7.0,2.0,1.0,10.0,7.0,9.0,2.0,1.0,null,2.0,1.0,5.0,2.0,3.0,6.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,80.0
TCGA-A2-A0EW-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,5.0,6.0,1.0,3.0,2.0,1.0,8.0,null,3.0,9.0,8.0,1.0,9.0,No_Conversion,Positive,Positive,N3,LumA,Luminal A,Positive,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,0,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1b,YES,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIIC,FEMALE,53.0
TCGA-A2-A0EX-01,8.0,1.0,null,1.0,8.0,7.0,1.0,1.0,7.0,5.0,4.0,7.0,1.0,null,1.0,1.0,3.0,1.0,8.0,6.0,1.0,2.0,9.0,Stage IIB,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T3,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,60-69%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,46.0
TCGA-A2-A0EY-01,6.0,2.0,null,1.0,1.0,10.0,2.0,1.0,9.0,6.0,6.0,5.0,1.0,null,3.0,5.0,3.0,6.0,8.0,1.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Lumpectomy,YES,60-69%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Positive,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,62.0
TCGA-A2-A0ST-01,1.0,3.0,null,3.0,3.0,4.0,3.0,1.0,1.0,1.0,6.0,5.0,4.0,null,4.0,1.0,1.0,3.0,10.0,4.0,1.0,1.0,7.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T1,T1,Kirc+,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,62.0
TCGA-A2-A0SU-01,3.0,3.0,null,6.0,6.0,7.0,3.0,1.0,10.0,10.0,7.0,4.0,2.0,null,2.0,null,2.0,2.0,3.0,2.0,1.0,2.0,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,66.0
TCGA-A2-A0SV-01,10.0,2.0,2.0,6.0,6.0,10.0,2.0,10.0,9.0,8.0,6.0,5.0,2.0,1.0,null,1.0,3.0,3.0,3.0,9.0,3.0,null,8.0,No_Conversion,Positive,Positive,N2,LumB,Luminal B,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M1,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 6,Stage IV,FEMALE,63.0
TCGA-A2-A0SW-01,8.0,2.0,3.0,1.0,1.0,10.0,2.0,10.0,9.0,6.0,9.0,2.0,null,2.0,null,1.0,null,4.0,8.0,4.0,2.0,null,8.0,No_Conversion,Positive,Positive,N2,LumB,Luminal B,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Lumpectomy,NO,40-49%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M1,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 7,cluster 3,Stage IV,FEMALE,82.0
TCGA-A2-A0SX-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,1.0,4.0,7.0,2.0,null,2.0,null,5.0,1.0,10.0,6.0,1.0,1.0,8.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,null,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,48.0
TCGA-A2-A0SY-01,3.0,2.0,null,null,null,null,2.0,1.0,7.0,5.0,6.0,5.0,2.0,null,2.0,3.0,3.0,4.0,8.0,9.0,1.0,1.0,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,80-89%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,NO,YES,LumA,Positive,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,62.0
TCGA-A2-A0T0-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,6.0,5.0,1.0,null,1.0,null,1.0,4.0,10.0,7.0,1.0,null,9.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 12,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 11,cluster 5,Stage IIB,FEMALE,59.0
TCGA-A2-A0T1-01,8.0,1.0,null,1.0,1.0,1.0,1.0,1.0,2.0,6.0,5.0,6.0,1.0,null,1.0,null,2.0,3.0,10.0,6.0,3.0,null,9.0,No_Conversion,Negative,Positive,N3,Her2,HER2-enriched,Negative,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 5,Cluster 5,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,<10%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,55.0
TCGA-A2-A0T2-01,6.0,1.0,1.0,3.0,3.0,4.0,1.0,10.0,1.0,10.0,7.0,4.0,1.0,1.0,null,null,2.0,4.0,10.0,4.0,3.0,null,9.0,No_Conversion,Negative,Positive,N3,Basal,Basal-like,Negative,followup,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,<10%,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M1,T3,null,NO,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IV,FEMALE,66.0
TCGA-A2-A0T3-01,6.0,1.0,null,8.0,10.0,10.0,1.0,1.0,10.0,8.0,2.0,9.0,null,null,2.0,1.0,null,3.0,6.0,10.0,1.0,1.0,9.0,Stage IIA,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Lumpectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 7,Stage IB,FEMALE,37.0
TCGA-A2-A0T4-01,3.0,1.0,null,1.0,8.0,7.0,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,1.0,1.0,7.0,1.0,8.0,6.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Other (specify),Positive,2+,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,62.0
TCGA-A2-A0T5-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,8.0,3.0,8.0,1.0,null,1.0,1.0,8.0,1.0,3.0,9.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,39.0
TCGA-A2-A0T6-01,3.0,1.0,null,1.0,8.0,7.0,1.0,1.0,7.0,5.0,4.0,7.0,null,null,1.0,null,null,1.0,8.0,2.0,1.0,1.0,9.0,Stage IIB,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,50.0
TCGA-A2-A0T7-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,8.0,10.0,4.0,7.0,1.0,null,1.0,null,5.0,1.0,1.0,6.0,1.0,2.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,2+,Positive,Modified Radical Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,51.0
TCGA-A2-A0YC-01,3.0,2.0,null,1.0,6.0,7.0,2.0,1.0,1.0,8.0,6.0,5.0,1.0,null,2.0,1.0,6.0,1.0,8.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Other (specify),Positive,null,Positive,Lumpectomy,YES,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,59.0
TCGA-A2-A0YD-01,3.0,2.0,null,6.0,6.0,7.0,2.0,1.0,7.0,5.0,6.0,5.0,null,null,1.0,1.0,null,1.0,1.0,6.0,1.0,2.0,9.0,Stage IIB,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T3,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,63.0
TCGA-A2-A0YE-01,6.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,4.0,7.0,1.0,null,1.0,null,2.0,5.0,10.0,null,1.0,null,9.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,null,null,Stage IIB,FEMALE,48.0
TCGA-A2-A0YF-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,7.0,4.0,1.0,null,2.0,null,3.0,1.0,3.0,1.0,1.0,2.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Negative,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,0,Negative,Simple Mastectomy,YES,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1b,YES,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage I,FEMALE,67.0
TCGA-A2-A0YG-01,10.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,6.0,5.0,1.0,null,1.0,null,7.0,5.0,8.0,6.0,5.0,null,9.0,No_Conversion,Positive,Positive,N3,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 2,Axillary lymph node dissection alone,Positive,2+,Positive,Lumpectomy,NO,90-99%,null,3+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,63.0
TCGA-A2-A0YH-01,8.0,1.0,null,6.0,6.0,10.0,1.0,1.0,9.0,6.0,5.0,6.0,1.0,null,1.0,null,3.0,7.0,3.0,6.0,2.0,null,9.0,No_Conversion,Positive,Positive,N2,LumB,Luminal B,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Positive,3+,Positive,Lumpectomy,NO,80-89%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,53.0
TCGA-A2-A0YI-01,6.0,1.0,null,1.0,8.0,7.0,1.0,1.0,1.0,7.0,6.0,5.0,1.0,null,2.0,null,2.0,1.0,1.0,6.0,1.0,2.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Other (specify),Positive,2+,Positive,Lumpectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8522/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,62.0
TCGA-A2-A0YJ-01,6.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,3.0,8.0,1.0,null,1.0,null,5.0,5.0,10.0,null,2.0,null,9.0,No_Conversion,Positive,Positive,N2,Basal,Basal-like,Negative,followup,T_Other,T3,COAD-READ,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Positive,0,Negative,Modified Radical Mastectomy,NO,<10%,null,0,Infiltrating Ductal Carcinoma,8500/3,1+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,Basal,Negative,null,null,Stage IIIA,FEMALE,39.0
TCGA-A2-A0YK-01,10.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,1.0,null,3.0,1.0,1.0,9.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,Normal,Normal-like,Negative,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Negative,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,Normal,Negative,miRNA cluster 14,cluster 6,Stage IIA,FEMALE,61.0
TCGA-A2-A0YL-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,4.0,7.0,1.0,null,2.0,null,4.0,7.0,1.0,9.0,2.0,1.0,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Simple Mastectomy,YES,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,YES,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,48.0
TCGA-A2-A0YM-01,6.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,1.0,7.0,4.0,1.0,null,2.0,1.0,2.0,2.0,10.0,7.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,OV-like c4,BRCA basal-like c8,mutation cluster 13,Other (specify),Negative,null,Negative,Lumpectomy,YES,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,67.0
TCGA-A2-A0YT-01,null,1.0,2.0,null,null,null,2.0,10.0,null,null,5.0,6.0,2.0,1.0,null,1.0,5.0,2.0,null,null,2.0,null,9.0,No_Conversion,Positive,Positive,N2,LumB,null,Negative,followup,T_Other,T4,High,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T4b,null,YES,NO,YES,LumB,Negative,miRNA cluster 6,null,Stage IIIB,FEMALE,56.0
TCGA-A2-A1FV-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,1.0,1.0,1.0,6.0,9.0,1.0,2.0,9.0,Stage IIB,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,YES,NO,LumA,Negative,miRNA cluster 12,cluster 6,Stage IIB,FEMALE,74.0
TCGA-A2-A1FW-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,3.0,5.0,8.0,9.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,null,Negative,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,YES,NO,LumB,Negative,miRNA cluster 4,cluster 6,Stage IIIA,FEMALE,62.0
TCGA-A2-A1FX-01,8.0,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,2.0,null,3.0,1.0,2.0,6.0,8.0,6.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,61.0
TCGA-A2-A1FZ-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,4.0,1.0,8.0,9.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,YES,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA c1uster 9,cluster 6,Stage IIA,FEMALE,63.0
TCGA-A2-A1G0-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,1.0,4.0,5.0,3.0,9.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Simple Mastectomy,NO,90-99%,null,2+,"Other, specify",8500/3,3+,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 14,cluster 6,Stage IIB,FEMALE,49.0
TCGA-A2-A1G1-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,null,1.0,10.0,2.0,3.0,10.0,9.0,1.0,null,9.0,Stage IIB,Negative,Positive,N1,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,YES,NO,Basal,Positive,miRNA cluster 14,cluster 6,Stage IIB,FEMALE,85.0
TCGA-A2-A1G4-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,4.0,4.0,8.0,7.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T3,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,NO,YES,NO,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,71.0
TCGA-A2-A1G6-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,4.0,3.0,10.0,9.0,2.0,null,9.0,Stage IIIA,Negative,Positive,N2,Normal,null,Negative,enrollment,T_Other,T2,Quiet,C5-KIRC,cluster 5,Low purity c2,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,YES,NO,Normal,Negative,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,50.0
TCGA-A2-A259-01,8.0,2.0,null,null,null,null,2.0,1.0,null,null,7.0,4.0,2.0,null,2.0,1.0,2.0,1.0,1.0,null,1.0,1.0,8.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,null,Stage I,FEMALE,70.0
TCGA-A2-A25A-01,3.0,5.0,null,null,null,null,5.0,1.0,null,null,3.0,8.0,4.0,null,4.0,1.0,1.0,4.0,8.0,null,1.0,1.0,7.0,Stage IIA,Positive,Negative,N0,Normal,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Simple Mastectomy,YES,<10%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,Normal,Negative,miRNA cluster 5,null,Stage IIA,FEMALE,44.0
TCGA-A2-A25B-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,1.0,4.0,2.0,8.0,7.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA cluster 2,cluster 5,Stage IIB,FEMALE,39.0
TCGA-A2-A25C-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,null,null,1.0,null,null,4.0,8.0,7.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Simple Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,YES,YES,NO,LumB,Negative,miRNA cluster 2,cluster 5,Stage IIB,FEMALE,50.0
TCGA-A2-A25D-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,null,1.0,1.0,2.0,6.0,8.0,null,7.0,null,9.0,Stage IIIC,Positive,Positive,N3,LumA,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Negative,Lumpectomy,NO,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 13,null,Stage IIIC,FEMALE,90.0
TCGA-A2-A25E-01,10.0,4.0,null,null,null,null,4.0,1.0,null,null,2.0,9.0,4.0,null,4.0,2.0,1.0,3.0,8.0,7.0,2.0,null,7.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,80-89%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Equivocal,Equivocal,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumB,Equivocal,miRNA cluster 2,cluster 5,Stage IIIA,FEMALE,34.0
TCGA-A2-A25F-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,1.0,1.0,null,1.0,1.0,10.0,Stage IIA,Negative,Negative,N0,Basal,null,Positive,enrollment,T_Other,T2,Kirc+,C4-BRCA/Basal,cluster 1,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Sentinel node biopsy alone,Negative,null,Positive,Lumpectomy,YES,null,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,YES,NO,Basal,Negative,null,null,Stage IIA,FEMALE,66.0
TCGA-A2-A3KC-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,2.0,1.0,4.0,5.0,null,null,1.0,1.0,10.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Simple Mastectomy,NO,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-A2-A3KD-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,1.0,4.0,5.0,null,null,1.0,2.0,9.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,YES,90-99%,null,1+,Mucinous Carcinoma,8480/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,YES,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-A2-A3XS-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,5.0,2.0,null,1.0,1.0,5.0,null,null,3.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,NO,NO,YES,Basal,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-A2-A3XT-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,3.0,null,4.0,1.0,2.0,3.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA basal-like c6,null,null,Other (specify),Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Basal,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-A2-A3XU-01,null,null,null,null,null,null,null,null,null,null,2.0,9.0,3.0,2.0,null,1.0,2.0,3.0,null,null,1.0,1.0,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA basal-like c6,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,Basal,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-A2-A3XV-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,2.0,2.0,null,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA basal-like c6,null,null,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,YES,<10%,null,2+,Infiltrating Ductal Carcinoma,8500/3,1+,Core needle biopsy,Equivocal,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,YES,NO,Her2,null,null,null,Stage IIA,FEMALE,null
TCGA-A2-A3XW-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,null,null,3.0,1.0,null,5.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIB,FEMALE,null
TCGA-A2-A3XX-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,2.0,2.0,2.0,1.0,4.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,KIRC-like c1,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A2-A3XY-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,2.0,1.0,1.0,5.0,4.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-A2-A3XZ-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,2.0,null,2.0,null,6.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA basal-like c6,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,NO,NO,YES,Her2,null,null,null,Stage I,FEMALE,null
TCGA-A2-A3Y0-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,2.0,null,2.0,null,4.0,9.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-A2-A4RW-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,1.0,null,null,7.0,null,null,8.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,80-89%,null,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,null,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-A2-A4RX-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,null,null,1.0,null,null,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,2+,Positive,Simple Mastectomy,YES,<10%,null,1+,Metaplastic Carcinoma,8575/3,1+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,null,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A2-A4RY-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,6.0,7.0,null,null,6.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,YES,YES,YES,NO,Normal,null,null,null,Stage IIIC,FEMALE,null
TCGA-A2-A4S0-01,null,null,null,null,null,null,null,null,null,null,8.0,2.0,1.0,null,1.0,null,5.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,2+,Positive,Simple Mastectomy,YES,90-99%,null,1+,Mucinous Carcinoma,8480/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-A2-A4S1-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,YES,<10%,null,null,Metaplastic Carcinoma,8575/3,1+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,YES,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A2-A4S2-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,7.0,3.0,null,null,2.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Lobular Carcinoma,8524/3,2+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-A2-A4S3-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,7.0,4.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,YES,NO,LumB,null,null,null,Stage IIB,FEMALE,null
TCGA-A7-A0CD-01,6.0,1.0,null,8.0,6.0,7.0,1.0,1.0,3.0,8.0,7.0,4.0,1.0,null,2.0,1.0,2.0,1.0,6.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Indeterminate (neither Pre or Postmenopausal),False,M0,T1,YES,YES,YES,NO,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,66.0
TCGA-A7-A0CE-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,5.0,6.0,1.0,null,2.0,1.0,2.0,1.0,10.0,7.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,<10%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Indeterminate (neither Pre or Postmenopausal),False,M0,T2,YES,YES,YES,NO,Basal,Negative,miRNA cluster 4,cluster 5,Stage IIA,FEMALE,57.0
TCGA-A7-A0CE-11,null,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,2.0,1.0,2.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,followup,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,<10%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Indeterminate (neither Pre or Postmenopausal),False,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,57.0
TCGA-A7-A0CG-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,9.0,2.0,1.0,null,2.0,null,1.0,2.0,1.0,10.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Negative,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Lumpectomy,YES,90-99%,null,1+,Mixed Histology (please specify),8522/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,YES,YES,NO,LumA,Negative,miRNA cluster 7,cluster 7,Stage IIA,FEMALE,78.0
TCGA-A7-A0CH-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,9.0,2.0,1.0,null,2.0,null,2.0,1.0,3.0,2.0,1.0,1.0,9.0,Stage IIA,null,Negative,N0,LumA,Luminal A,null,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,null,null,null,Simple Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,79.0
TCGA-A7-A0CH-11,null,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,2.0,null,2.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,null,null,null,Simple Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,79.0
TCGA-A7-A0CJ-01,1.0,1.0,null,8.0,6.0,10.0,1.0,1.0,6.0,8.0,5.0,6.0,1.0,null,2.0,null,2.0,1.0,6.0,2.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,YES,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,57.0
TCGA-A7-A0D9-01,8.0,1.0,null,6.0,6.0,7.0,1.0,1.0,8.0,8.0,2.0,9.0,1.0,null,2.0,null,9.0,1.0,3.0,7.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Negative,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Negative,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,37.0
TCGA-A7-A0D9-11,null,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,2.0,null,9.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Negative,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,37.0
TCGA-A7-A0DA-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,6.0,5.0,1.0,null,2.0,null,2.0,1.0,10.0,6.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 13,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Basal,Negative,miRNA c1uster 9,cluster 4,Stage IIA,FEMALE,62.0
TCGA-A7-A0DB-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,7.0,5.0,5.0,6.0,1.0,null,2.0,null,2.0,1.0,1.0,6.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,Negative,miRNA cluster 12,cluster 4,Stage IIA,FEMALE,56.0
TCGA-A7-A0DB-11,null,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,2.0,null,2.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,56.0
TCGA-A7-A0DC-01,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,1.0,1.0,null,null,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,null,Negative,followup,T1,T1,null,null,null,null,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,YES,NO,LumA,Negative,null,null,Stage IA,FEMALE,63.0
TCGA-A7-A0DC-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,3.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,YES,NO,Normal,null,null,null,Stage IA,FEMALE,63.0
TCGA-A7-A13D-01,6.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,4.0,7.0,1.0,null,2.0,1.0,2.0,1.0,10.0,7.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Positive,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 2,Sentinel node biopsy alone,Negative,null,Positive,Lumpectomy,NO,<10%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,46.0
TCGA-A7-A13E-01,1.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,6.0,5.0,1.0,1.0,1.0,1.0,4.0,3.0,8.0,7.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Lumpectomy,NO,20-29%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,NO,YES,NO,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,62.0
TCGA-A7-A13E-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,1.0,1.0,1.0,4.0,3.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C4-BRCA/Basal,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Lumpectomy,NO,20-29%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,NO,YES,NO,Normal,null,null,null,Stage IIB,FEMALE,62.0
TCGA-A7-A13F-01,6.0,1.0,null,1.0,6.0,10.0,1.0,1.0,10.0,8.0,3.0,8.0,null,null,1.0,1.0,null,3.0,8.0,6.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T3,YES,YES,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,44.0
TCGA-A7-A13F-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,1.0,5.0,3.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T3,YES,YES,YES,NO,Normal,null,null,null,Stage IIIA,FEMALE,44.0
TCGA-A7-A13G-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,null,null,1.0,null,null,1.0,3.0,4.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,followup,T_Other,T2,Iq,null,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 14,cluster 3,Stage IIA,FEMALE,79.0
TCGA-A7-A13G-11,null,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,4.0,1.0,null,null,1.0,null,9.0,null,null,null,null,LumA,null,null,followup,null,null,null,null,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,79.0
TCGA-A7-A13H-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,2.0,2.0,1.0,3.0,null,null,1.0,3.0,9.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,80-89%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,NO,NO,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-A7-A26E-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,2.0,null,2.0,4.0,8.0,10.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N1,LumA,null,Positive,followup,T_Other,T3,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 1,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,71.0
TCGA-A7-A26F-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,1.0,1.0,1.0,8.0,7.0,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,null,Negative,enrollment,T1,T1,BRCA-LUAD+,C4-BRCA/Basal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 3,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,2+,"Other, specify",8575/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1,YES,YES,YES,NO,Basal,Negative,miRNA cluster 4,cluster 5,Stage IA,FEMALE,55.0
TCGA-A7-A26G-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,2.0,1.0,10.0,6.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,COAD-READ,C4-BRCA/Basal,cluster 5,Low purity c2,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Other,NO,null,null,null,"Other, specify",8575/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,50.0
TCGA-A7-A26H-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,2.0,2.0,2.0,8.0,null,1.0,2.0,10.0,Stage IIA,Positive,Positive,N1,LumA,null,Negative,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1,YES,NO,YES,NO,LumA,Positive,miRNA cluster 4,null,Stage IIA,FEMALE,72.0
TCGA-A7-A26I-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,1.0,1.0,1.0,10.0,null,1.0,null,10.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Basal,Negative,miRNA cluster 4,null,Stage IIA,FEMALE,65.0
TCGA-A7-A26J-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,null,null,1.0,null,null,1.0,8.0,9.0,1.0,null,10.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,49.0
TCGA-A7-A2KD-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,2.0,3.0,null,null,3.0,1.0,10.0,null,null,null,null,LumB,null,null,null,null,null,Squamous,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,null,No axillary staging,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,null,3+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,YES,YES,NO,LumB,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-A7-A3IY-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,null,null,1.0,null,null,1.0,null,null,1.0,null,10.0,null,null,null,null,LumA,null,null,null,null,null,Kirc+,null,null,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,null,Mucinous Carcinoma,8480/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage I,FEMALE,null
TCGA-A7-A3IZ-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,2.0,1.0,null,null,null,2.0,10.0,null,null,null,null,LumA,null,null,null,null,null,Kirc+,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Lumpectomy,YES,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,miRNA cluster 14,null,Stage IIA,FEMALE,null
TCGA-A7-A3J0-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,LumA,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,1+,Mucinous Carcinoma,8480/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,miRNA cluster 6,null,Stage IIA,FEMALE,null
TCGA-A7-A3J1-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage IA,FEMALE,null
TCGA-A7-A3RF-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,Quiet,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,null,Mucinous Carcinoma,8480/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,miRNA c1uster 10,null,Stage IIA,FEMALE,null
TCGA-A7-A425-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,1.0,2.0,5.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Modified Radical Mastectomy,YES,90-99%,30-39%,3+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Indeterminate,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-A7-A426-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,5.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Simple Mastectomy,YES,70-79%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-A7-A4SA-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,1.0,null,1.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,YES,80-89%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-A7-A4SA-11,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,1.0,null,7.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,YES,80-89%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,YES,NO,null,null,null,null,Stage IIB,FEMALE,null
TCGA-A7-A4SB-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,70-79%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-A7-A4SC-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Negative,Simple Mastectomy,YES,90-99%,null,3+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-A7-A4SC-11,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,3.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Negative,Simple Mastectomy,YES,90-99%,null,3+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,null,null,null,null,Stage IIB,FEMALE,null
TCGA-A7-A4SD-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,1.0,2.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A4SD-11,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,1.0,5.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,null,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A4SE-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A4SE-11,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,3.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,null,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A4SF-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,1.0,null,null,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,YES,90-99%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,YES,NO,Her2,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A56D-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,null,1.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Lumpectomy,YES,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A5ZV-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,null,null,1.0,1.0,null,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,2+,Infiltrating Carcinoma NOS,8010/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A5ZW-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),False,M0,T1c,YES,YES,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A5ZX-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,1.0,null,null,6.0,null,null,7.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-A7-A6VV-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,6.0,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),False,M0,T2,YES,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A6VW-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,1.0,null,null,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A6VX-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumB,null,null,null,Stage IIA,FEMALE,null
TCGA-A7-A6VY-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-A8-A06N-01,6.0,1.0,null,1.0,6.0,10.0,1.0,1.0,3.0,8.0,7.0,4.0,1.0,null,1.0,null,3.0,null,8.0,2.0,null,null,9.0,Stage IIIB,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T_Other,T4,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Other,null,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,null,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage IIIB,FEMALE,66.0
TCGA-A8-A06O-01,10.0,1.0,null,null,null,null,1.0,1.0,9.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,null,8.0,6.0,null,null,9.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,60.0
TCGA-A8-A06P-01,8.0,1.0,null,6.0,6.0,7.0,1.0,1.0,7.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,null,3.0,6.0,null,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,63.0
TCGA-A8-A06Q-01,6.0,1.0,null,null,null,null,1.0,1.0,9.0,8.0,6.0,5.0,2.0,null,1.0,null,1.0,null,8.0,10.0,null,null,8.0,No_Conversion,Positive,Positive,N2,LumB,Luminal B,Positive,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,null,NO,YES,LumB,Negative,miRNA cluster 7,cluster 7,Stage IIIA,FEMALE,63.0
TCGA-A8-A06R-01,null,1.0,null,null,null,null,1.0,1.0,9.0,6.0,7.0,4.0,2.0,null,1.0,null,1.0,null,8.0,6.0,null,null,8.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Negative,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumB,Equivocal,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,69.0
TCGA-A8-A06T-01,8.0,2.0,null,null,null,null,2.0,1.0,3.0,8.0,8.0,3.0,null,null,2.0,null,null,null,8.0,2.0,null,null,8.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 14,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T3,YES,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIIA,FEMALE,75.0
TCGA-A8-A06U-01,null,2.0,2.0,null,null,null,2.0,10.0,9.0,6.0,9.0,2.0,1.0,2.0,null,null,2.0,null,8.0,6.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,NO,YES,LumA,Equivocal,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,80.0
TCGA-A8-A06X-01,1.0,2.0,2.0,null,null,null,2.0,10.0,9.0,6.0,8.0,2.0,2.0,2.0,null,null,4.0,null,6.0,null,null,null,8.0,Stage IIB,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 10,null,Positive,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,YES,NO,YES,LumB,Positive,null,null,Stage IIB,FEMALE,77.0
TCGA-A8-A06Y-01,8.0,2.0,null,1.0,6.0,7.0,2.0,1.0,10.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,null,8.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,66.0
TCGA-A8-A06Z-01,10.0,1.0,null,1.0,6.0,10.0,1.0,1.0,3.0,8.0,10.0,1.0,2.0,null,1.0,null,2.0,null,10.0,1.0,null,null,8.0,Stage IIB,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,null,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,84.0
TCGA-A8-A075-01,3.0,1.0,null,10.0,3.0,1.0,1.0,1.0,9.0,6.0,3.0,8.0,1.0,null,1.0,null,1.0,null,10.0,1.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumB,HER2-enriched,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,42.0
TCGA-A8-A076-01,8.0,3.0,null,1.0,1.0,1.0,3.0,1.0,9.0,6.0,7.0,4.0,2.0,null,2.0,null,1.0,null,6.0,6.0,null,null,8.0,Stage IIA,Positive,Negative,N0,LumB,HER2-enriched,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumB,Positive,miRNA cluster 6,cluster 4,Stage IIA,FEMALE,66.0
TCGA-A8-A079-01,10.0,1.0,null,8.0,6.0,10.0,1.0,1.0,6.0,8.0,7.0,4.0,2.0,null,1.0,null,2.0,null,6.0,7.0,null,null,8.0,Stage IIIC,Positive,Positive,N3,LumB,Luminal B,Positive,enrollment,T_Other,T4,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 5,Stage IIIB,FEMALE,69.0
TCGA-A8-A07B-01,10.0,2.0,null,null,null,null,2.0,1.0,10.0,8.0,7.0,4.0,2.0,null,2.0,null,1.0,null,6.0,2.0,null,null,8.0,Stage IIA,Positive,Negative,N0,LumA,HER2-enriched,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 2,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumA,Positive,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,69.0
TCGA-A8-A07C-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,5.0,6.0,1.0,null,2.0,null,1.0,null,10.0,7.0,null,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 14,null,Negative,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 5,Stage IIA,FEMALE,57.0
TCGA-A8-A07E-01,3.0,1.0,null,1.0,6.0,7.0,1.0,1.0,7.0,8.0,9.0,2.0,1.0,null,1.0,null,2.0,null,8.0,1.0,null,null,9.0,Stage IIIC,Positive,Positive,N3,LumA,Luminal A,Positive,enrollment,T_Other,T4,Squamous,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T4b,YES,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage X,FEMALE,81.0
TCGA-A8-A07F-01,3.0,1.0,null,1.0,8.0,7.0,1.0,1.0,10.0,10.0,7.0,4.0,1.0,null,1.0,null,1.0,null,8.0,6.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 4,Stage IIB,FEMALE,65.0
TCGA-A8-A07G-01,6.0,1.0,null,null,null,null,1.0,1.0,7.0,5.0,7.0,4.0,null,null,1.0,null,null,null,1.0,6.0,null,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,65.0
TCGA-A8-A07I-01,6.0,1.0,null,1.0,1.0,1.0,1.0,1.0,9.0,6.0,7.0,4.0,1.0,null,1.0,null,1.0,null,6.0,6.0,null,null,9.0,Stage IIIA,Positive,Positive,N2,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,69.0
TCGA-A8-A07J-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,5.0,2.0,9.0,null,null,1.0,null,null,null,1.0,6.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,35.0
TCGA-A8-A07L-01,8.0,1.0,null,null,null,null,1.0,1.0,3.0,8.0,6.0,5.0,1.0,null,2.0,null,1.0,null,8.0,7.0,null,null,9.0,Stage IIIA,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 12,null,Positive,null,Positive,Other,null,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 5,Stage IIIA,FEMALE,58.0
TCGA-A8-A07O-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,4.0,7.0,1.0,null,1.0,null,1.0,null,10.0,6.0,null,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,51.0
TCGA-A8-A07P-01,8.0,1.0,null,8.0,6.0,7.0,1.0,1.0,3.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,null,6.0,2.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Positive,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,68.0
TCGA-A8-A07R-01,6.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,9.0,2.0,null,null,1.0,null,null,null,10.0,6.0,null,null,9.0,Stage IIIC,Negative,Positive,N3,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,null,null,null,M0,T2,null,null,NO,YES,Basal,Equivocal,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,80.0
TCGA-A8-A07S-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,8.0,3.0,1.0,null,1.0,null,1.0,null,3.0,10.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,null,Positive,null,Negative,Other,null,null,null,null,Mixed Histology (please specify),8522/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA c1uster 10,cluster 7,Stage IIA,FEMALE,73.0
TCGA-A8-A07U-01,6.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,7.0,4.0,1.0,null,1.0,null,1.0,null,10.0,6.0,null,null,9.0,Stage IIIA,Negative,Positive,N2,Basal,Basal-like,Positive,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 4,Stage IIIA,FEMALE,66.0
TCGA-A8-A07W-01,6.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,8.0,3.0,1.0,null,1.0,null,1.0,null,8.0,6.0,null,null,9.0,Stage IV,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M1,T2,YES,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IV,FEMALE,76.0
TCGA-A8-A07Z-01,6.0,2.0,null,6.0,6.0,10.0,2.0,1.0,1.0,8.0,10.0,1.0,null,null,2.0,null,null,null,3.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,null,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,85.0
TCGA-A8-A081-01,10.0,1.0,null,1.0,1.0,1.0,1.0,1.0,9.0,6.0,9.0,2.0,1.0,null,1.0,null,1.0,null,8.0,4.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,HER2-enriched,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,LumB,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,80.0
TCGA-A8-A082-01,8.0,1.0,null,1.0,6.0,10.0,1.0,1.0,4.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,null,8.0,7.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 5,Stage IIB,FEMALE,58.0
TCGA-A8-A083-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,7.0,4.0,1.0,null,1.0,null,2.0,null,3.0,2.0,null,null,9.0,Stage IIB,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,67.0
TCGA-A8-A084-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,10.0,6.0,9.0,2.0,2.0,null,1.0,null,2.0,null,6.0,4.0,null,null,8.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,YES,NO,YES,LumB,Negative,miRNA cluster 7,cluster 3,Stage IIB,FEMALE,81.0
TCGA-A8-A085-01,10.0,2.0,null,1.0,6.0,10.0,2.0,1.0,3.0,8.0,3.0,8.0,1.0,null,2.0,null,1.0,null,8.0,2.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,null,False,M0,T2,YES,NO,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage IIB,MALE,44.0
TCGA-A8-A086-01,10.0,1.0,null,3.0,6.0,7.0,1.0,1.0,4.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,null,3.0,7.0,null,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 5,Stage IIA,FEMALE,59.0
TCGA-A8-A08A-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,10.0,1.0,2.0,null,1.0,null,1.0,null,3.0,2.0,null,null,8.0,Stage I,Positive,Negative,N0,null,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,89.0
TCGA-A8-A08B-01,6.0,1.0,null,null,null,null,1.0,1.0,10.0,6.0,5.0,6.0,1.0,null,2.0,null,1.0,null,1.0,10.0,null,null,9.0,Stage IIA,Positive,Negative,N0,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,Her2,Positive,miRNA cluster 14,cluster 7,Stage IIA,FEMALE,52.0
TCGA-A8-A08C-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,7.0,4.0,1.0,null,2.0,null,1.0,null,3.0,null,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,null,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,null,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,null,null,Stage IIA,FEMALE,65.0
TCGA-A8-A08F-01,8.0,1.0,null,null,null,null,1.0,1.0,9.0,8.0,6.0,5.0,1.0,null,2.0,null,1.0,null,3.0,null,null,null,9.0,Stage IIIC,Positive,Positive,N3,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumB,Negative,null,null,Stage IIIC,FEMALE,59.0
TCGA-A8-A08G-01,6.0,1.0,null,6.0,6.0,10.0,1.0,1.0,3.0,8.0,3.0,8.0,1.0,null,1.0,null,1.0,null,3.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,41.0
TCGA-A8-A08H-01,1.0,1.0,null,1.0,8.0,7.0,1.0,1.0,7.0,4.0,7.0,4.0,2.0,null,1.0,null,2.0,null,1.0,6.0,null,null,8.0,Stage IIA,Positive,Negative,N0,Normal,Basal-like,Positive,enrollment,T_Other,T2,Quiet,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,Normal,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,66.0
TCGA-A8-A08I-01,8.0,1.0,null,null,null,null,1.0,1.0,9.0,6.0,5.0,6.0,1.0,null,1.0,null,1.0,null,3.0,4.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,53.0
TCGA-A8-A08J-01,10.0,2.0,3.0,1.0,1.0,1.0,2.0,10.0,9.0,6.0,5.0,6.0,3.0,2.0,null,null,3.0,null,8.0,6.0,null,null,7.0,Stage IV,Positive,Positive,N3,Her2,HER2-enriched,Negative,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 12,null,Positive,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8541/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M1,T4b,null,NO,NO,YES,Her2,Negative,miRNA cluster 4,cluster 4,Stage IV,FEMALE,52.0
TCGA-A8-A08L-01,1.0,1.0,1.0,10.0,3.0,1.0,1.0,10.0,9.0,6.0,10.0,1.0,1.0,1.0,null,null,1.0,null,8.0,1.0,null,null,9.0,Stage IIIA,Positive,Positive,N2,Her2,HER2-enriched,Negative,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 1,null,Positive,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,YES,NO,YES,Her2,Negative,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,89.0
TCGA-A8-A08O-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,3.0,7.0,null,null,2.0,null,null,null,3.0,9.0,null,null,9.0,Stage IV,Positive,Positive,N3,LumA,Luminal A,Positive,enrollment,T_Other,T2,COAD-READ,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M1,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 3,cluster 6,Stage IV,FEMALE,45.0
TCGA-A8-A08P-01,6.0,2.0,null,null,null,null,2.0,1.0,9.0,6.0,7.0,4.0,2.0,null,2.0,null,1.0,null,8.0,null,null,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumB,Positive,null,null,Stage IIIA,FEMALE,70.0
TCGA-A8-A08R-01,8.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,5.0,6.0,1.0,null,1.0,null,1.0,null,10.0,6.0,null,null,9.0,Stage IIB,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 3,null,Negative,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,52.0
TCGA-A8-A08S-01,null,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,2.0,null,1.0,null,null,null,null,null,9.0,Stage IIA,Positive,Positive,N1,LumB,null,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,null,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumB,Positive,miRNA cluster 4,null,Stage IIA,FEMALE,71.0
TCGA-A8-A08T-01,8.0,4.0,null,1.0,6.0,7.0,4.0,1.0,7.0,8.0,6.0,5.0,4.0,5.0,4.0,null,1.0,null,8.0,2.0,null,null,6.0,Stage IV,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M1,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IV,FEMALE,64.0
TCGA-A8-A08X-01,6.0,2.0,null,3.0,3.0,1.0,2.0,1.0,1.0,2.0,3.0,8.0,2.0,null,2.0,null,1.0,null,1.0,4.0,null,null,8.0,Stage IIIC,Negative,Positive,N3,Her2,HER2-enriched,Negative,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T4d,YES,YES,NO,YES,Her2,Positive,miRNA cluster 7,cluster 3,Stage IIIC,FEMALE,43.0
TCGA-A8-A08Z-01,3.0,2.0,null,6.0,6.0,7.0,2.0,1.0,7.0,8.0,8.0,3.0,3.0,null,2.0,null,2.0,null,3.0,6.0,null,null,7.0,Stage IIIC,Positive,Positive,N3,LumA,Luminal A,Positive,enrollment,T_Other,T4,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,[Discrepancy],FEMALE,76.0
TCGA-A8-A090-01,8.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,8.0,3.0,1.0,null,1.0,null,1.0,null,8.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,COAD-READ,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,74.0
TCGA-A8-A091-01,8.0,1.0,null,1.0,6.0,7.0,1.0,1.0,3.0,8.0,6.0,5.0,1.0,null,2.0,null,1.0,null,8.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Negative,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,61.0
TCGA-A8-A092-01,3.0,1.0,null,null,null,null,1.0,1.0,9.0,8.0,4.0,7.0,1.0,null,2.0,null,1.0,null,3.0,6.0,null,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,HER2-enriched,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,48.0
TCGA-A8-A093-01,6.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,null,8.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 2,Stage IIA,FEMALE,61.0
TCGA-A8-A094-01,1.0,1.0,null,3.0,3.0,1.0,1.0,1.0,2.0,6.0,8.0,3.0,1.0,null,1.0,null,2.0,null,1.0,4.0,null,null,9.0,Stage IIA,Positive,Negative,N0,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 6,null,Positive,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,Her2,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,75.0
TCGA-A8-A095-01,6.0,2.0,null,null,null,null,2.0,1.0,5.0,8.0,3.0,7.0,2.0,null,2.0,null,1.0,null,8.0,6.0,null,null,8.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,45.0
TCGA-A8-A096-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,7.0,8.0,3.0,1.0,null,1.0,null,1.0,null,8.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,73.0
TCGA-A8-A097-01,10.0,1.0,null,null,null,null,1.0,1.0,10.0,9.0,7.0,4.0,1.0,null,1.0,null,1.0,null,3.0,6.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,65.0
TCGA-A8-A099-01,3.0,1.0,null,8.0,6.0,7.0,1.0,1.0,1.0,8.0,8.0,3.0,1.0,null,1.0,null,1.0,null,6.0,1.0,null,null,9.0,Stage IIIC,Positive,Positive,N3,LumA,Luminal A,Positive,enrollment,T_Other,T4,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T4b,YES,YES,NO,YES,LumA,Positive,miRNA cluster 6,cluster 1,Stage X,FEMALE,76.0
TCGA-A8-A09A-01,8.0,1.0,null,1.0,6.0,7.0,1.0,1.0,8.0,8.0,3.0,8.0,1.0,null,1.0,null,1.0,null,8.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 10,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 4,Stage X,FEMALE,40.0
TCGA-A8-A09B-01,8.0,1.0,null,1.0,6.0,7.0,1.0,1.0,10.0,8.0,6.0,5.0,null,null,1.0,null,null,null,8.0,6.0,null,null,9.0,Stage IIIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T4,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T4b,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIB,FEMALE,58.0
TCGA-A8-A09C-01,8.0,1.0,null,6.0,6.0,10.0,1.0,1.0,10.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,null,3.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,null,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage X,FEMALE,69.0
TCGA-A8-A09D-01,10.0,1.0,null,null,null,null,1.0,1.0,8.0,8.0,4.0,7.0,null,null,2.0,null,null,null,1.0,1.0,null,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal B,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,47.0
TCGA-A8-A09E-01,null,2.0,null,null,null,null,2.0,1.0,null,null,8.0,3.0,2.0,null,2.0,null,1.0,null,null,null,null,null,9.0,Stage IIIB,Positive,Positive,N1,null,null,Positive,enrollment,T_Other,T4,High,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,YES,YES,NO,YES,LumB,Equivocal,miRNA cluster 14,null,Stage IIIB,FEMALE,73.0
TCGA-A8-A09G-01,3.0,1.0,null,6.0,3.0,1.0,1.0,1.0,2.0,6.0,9.0,2.0,1.0,null,1.0,null,2.0,null,1.0,4.0,null,null,9.0,Stage IIIC,Positive,Positive,N3,Her2,HER2-enriched,Negative,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,null,NO,YES,Her2,Positive,miRNA cluster 7,cluster 3,Stage IIIC,FEMALE,79.0
TCGA-A8-A09I-01,10.0,2.0,null,1.0,1.0,10.0,2.0,1.0,9.0,6.0,10.0,1.0,1.0,null,2.0,null,2.0,null,6.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,84.0
TCGA-A8-A09K-01,null,2.0,null,null,null,null,2.0,1.0,null,null,7.0,4.0,1.0,null,2.0,null,2.0,null,null,null,null,null,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,NO,NO,NO,YES,LumA,Negative,miRNA cluster 6,null,Stage IIA,FEMALE,68.0
TCGA-A8-A09M-01,10.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,8.0,3.0,1.0,null,2.0,null,1.0,null,8.0,7.0,null,null,9.0,Stage IIIC,Positive,Positive,N3,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 10,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 14,cluster 5,Stage IIIC,FEMALE,75.0
TCGA-A8-A09N-01,1.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,5.0,6.0,2.0,null,1.0,null,1.0,null,8.0,10.0,null,null,8.0,Stage IIIC,Positive,Positive,N3,LumB,Luminal B,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,LumB,Positive,miRNA cluster 4,cluster 7,Stage IIIC,FEMALE,57.0
TCGA-A8-A09Q-01,3.0,2.0,null,null,null,null,2.0,1.0,9.0,6.0,9.0,2.0,1.0,null,1.0,null,1.0,null,6.0,6.0,null,null,9.0,Stage IIIB,Positive,Positive,N2,LumB,Luminal B,Positive,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,YES,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIB,FEMALE,83.0
TCGA-A8-A09R-01,10.0,1.0,null,1.0,1.0,10.0,1.0,1.0,10.0,8.0,9.0,2.0,1.0,null,1.0,null,1.0,null,8.0,6.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,82.0
TCGA-A8-A09T-01,8.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,7.0,4.0,null,null,1.0,null,null,null,3.0,2.0,null,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage X,FEMALE,68.0
TCGA-A8-A09V-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,4.0,7.0,1.0,null,1.0,null,1.0,null,3.0,null,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,0,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumA,Negative,null,null,Stage IIA,FEMALE,51.0
TCGA-A8-A09W-01,3.0,1.0,null,null,null,null,1.0,1.0,9.0,6.0,7.0,4.0,2.0,null,1.0,null,1.0,null,8.0,null,null,null,8.0,Stage IIIC,Positive,Positive,N3,LumB,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,0,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,LumB,Negative,null,null,Stage IIIB,FEMALE,70.0
TCGA-A8-A09X-01,6.0,1.0,1.0,3.0,1.0,1.0,1.0,10.0,2.0,6.0,6.0,5.0,1.0,1.0,null,null,1.0,null,8.0,4.0,null,null,9.0,Stage IIIC,Negative,Positive,N3,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,Her2,Negative,miRNA cluster 7,cluster 3,Stage IIIC,FEMALE,62.0
TCGA-A8-A09Z-01,3.0,1.0,null,null,null,null,1.0,1.0,10.0,6.0,9.0,1.0,1.0,null,1.0,null,2.0,null,8.0,2.0,null,null,9.0,Stage IIB,Positive,Negative,N0,null,Luminal B,Negative,enrollment,T_Other,T3,Iq,null,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,null,null,null,Positive,null,Negative,Other,null,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,null,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,83.0
TCGA-A8-A0A1-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,5.0,10.0,1.0,1.0,null,1.0,null,1.0,null,8.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 4,Stage IIA,FEMALE,84.0
TCGA-A8-A0A2-01,3.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,null,6.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,0,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,66.0
TCGA-A8-A0A4-01,3.0,1.0,null,1.0,6.0,7.0,1.0,1.0,7.0,5.0,8.0,3.0,1.0,null,1.0,null,1.0,null,8.0,4.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,73.0
TCGA-A8-A0A6-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,7.0,6.0,5.0,1.0,null,1.0,null,1.0,null,8.0,1.0,null,null,9.0,Stage IIIC,Positive,Positive,N3,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,null,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,null,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIC,FEMALE,64.0
TCGA-A8-A0A7-01,6.0,1.0,null,1.0,1.0,1.0,1.0,1.0,9.0,6.0,5.0,6.0,null,null,1.0,null,null,null,1.0,6.0,null,null,9.0,Stage IIB,Negative,Positive,N1,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 4,null,Negative,null,Negative,Other,null,null,null,3+,Infiltrating Lobular Carcinoma,8520/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,null,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,57.0
TCGA-A8-A0A9-01,6.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,9.0,2.0,1.0,null,1.0,null,1.0,null,6.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,80.0
TCGA-A8-A0AB-01,3.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,5.0,6.0,1.0,null,1.0,null,1.0,null,8.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,null,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,54.0
TCGA-A8-A0AD-01,3.0,2.0,null,null,null,null,2.0,1.0,1.0,8.0,9.0,2.0,null,null,2.0,null,null,null,3.0,2.0,null,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Mixed Histology (please specify),8522/3,null,null,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 3,cluster 2,Stage I,FEMALE,83.0
TCGA-AC-A23C-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,8.0,10.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,NO,YES,LumA,Positive,miRNA cluster 7,cluster 7,Stage IIB,FEMALE,62.0
TCGA-AC-A23E-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,1.0,1.0,3.0,null,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,null,30-39%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,False,MX,T2,YES,YES,null,null,LumA,Negative,miRNA cluster 13,null,Stage IIB,FEMALE,50.0
TCGA-AC-A23G-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,3.0,null,3.0,null,1.0,2.0,null,null,1.0,null,8.0,null,null,null,null,LumA,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,null,null,Positive,null,Positive,Other,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,NO,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-AC-A23H-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,1.0,1.0,null,1.0,null,6.0,null,null,null,9.0,Stage IIA,Positive,Negative,N0,Her2,null,Negative,enrollment,T_Other,T2,High,null,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,null,null,Positive,null,Negative,Simple Mastectomy,null,10-19%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,Her2,Positive,miRNA cluster 4,null,Stage IIA,FEMALE,90.0
TCGA-AC-A23H-11,null,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,1.0,1.0,null,1.0,null,null,null,null,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,null,null,null,null,null,null,null,Positive,null,Negative,Simple Mastectomy,null,10-19%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,90.0
TCGA-AC-A2B8-01,3.0,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,null,1.0,1.0,1.0,null,1.0,1.0,10.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Simple Mastectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,YES,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AC-A2BK-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,3.0,null,3.0,null,1.0,6.0,null,null,2.0,null,8.0,null,null,null,null,Basal,null,null,null,null,null,High,C4-BRCA/Basal,null,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,YES,NO,YES,Basal,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-AC-A2BM-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,3.0,null,4.0,null,1.0,3.0,null,null,1.0,2.0,7.0,null,null,null,null,LumB,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,60-69%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,Negative,null,False,MX,T2,NO,NO,NO,YES,LumB,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AC-A2FB-01,6.0,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,2.0,null,1.0,1.0,1.0,null,1.0,null,9.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,NO,90-99%,10-19%,3+,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Positive,null,null,False,MX,T2,YES,NO,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-AC-A2FB-11,null,null,null,null,null,null,null,null,null,null,7.0,4.0,null,null,2.0,null,null,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,null,null,null,null,C3-BRCA/Luminal,null,null,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,NO,90-99%,10-19%,3+,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Positive,null,null,null,MX,T2,YES,NO,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,null
TCGA-AC-A2FE-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,3.0,4.0,1.0,null,1.0,5.0,null,null,6.0,null,7.0,null,null,null,null,null,null,null,null,null,null,BRCA-LUAD+,null,null,BRCA CIMP c7,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,60-69%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIIC,FEMALE,null
TCGA-AC-A2FF-01,1.0,null,null,null,null,null,null,null,null,null,3.0,null,3.0,null,4.0,1.0,1.0,2.0,1.0,null,1.0,1.0,8.0,null,null,null,null,LumA,null,null,null,null,null,Quiet,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,YES,30-39%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,null,False,MX,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AC-A2FF-11,null,null,null,null,null,null,null,null,null,null,3.0,null,3.0,null,4.0,1.0,1.0,2.0,null,null,1.0,1.0,8.0,null,null,null,null,Normal,null,null,null,null,null,null,C3-BRCA/Luminal,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,YES,30-39%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,null,False,MX,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A2FG-01,3.0,null,null,null,null,null,null,null,null,null,9.0,2.0,2.0,null,3.0,null,1.0,3.0,1.0,null,1.0,2.0,8.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Modified Radical Mastectomy,YES,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,NO,YES,LumA,null,miRNA c1uster 10,null,Stage IIB,FEMALE,null
TCGA-AC-A2FG-11,null,null,null,null,null,null,null,null,null,null,9.0,2.0,2.0,null,3.0,null,1.0,3.0,null,null,1.0,2.0,8.0,null,null,null,null,null,null,null,null,null,null,null,C3-BRCA/Luminal,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Modified Radical Mastectomy,YES,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,NO,YES,null,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A2FK-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,3.0,null,4.0,null,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,null,null,null,Quiet,null,null,Low purity c2,null,BRCA nonbasal-like c7,null,null,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,null,False,M0,T2,YES,YES,NO,YES,Normal,null,miRNA cluster 5,null,Stage IIIC,FEMALE,null
TCGA-AC-A2FM-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,4.0,1.0,null,null,1.0,1.0,null,null,1.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,High,null,null,BRCA CIMP c7,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,null,null,null,Modified Radical Mastectomy,YES,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIB,FEMALE,null
TCGA-AC-A2FM-11,null,null,null,null,null,null,null,null,null,null,10.0,1.0,4.0,1.0,null,null,1.0,1.0,null,null,1.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,null,null,null,Modified Radical Mastectomy,YES,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A2FO-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,null,null,3.0,null,null,3.0,null,null,1.0,null,7.0,null,null,null,null,LumA,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,null,Other (specify),Positive,null,Negative,Simple Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Indeterminate,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T2,YES,NO,NO,YES,LumA,null,miRNA cluster 14,null,Stage IIB,FEMALE,null
TCGA-AC-A2QH-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,null,null,2.0,null,null,6.0,null,null,1.0,1.0,10.0,null,null,null,null,Basal,null,null,null,null,null,Squamous,null,null,Cluster 5,null,GBM-like c6,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,YES,null,null,null,Metaplastic Carcinoma,8575/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T3,YES,YES,YES,NO,Basal,null,miRNA cluster 13,null,Stage IIB,FEMALE,null
TCGA-AC-A2QI-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,BRCA-LUAD+,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Negative,Other,null,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,LumA,null,miRNA cluster 3,null,Stage IIIA,FEMALE,null
TCGA-AC-A2QJ-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,1.0,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,BRCA-LUAD+,null,null,BRCA non-CIMP c9,KIRC-like c1,null,null,Other (specify),Negative,null,Negative,Other,NO,null,null,null,Metaplastic Carcinoma,8575/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),False,M0,T4b,YES,YES,YES,NO,Basal,null,miRNA cluster 5,null,Stage IIIB,FEMALE,null
TCGA-AC-A3BB-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,null,1.0,4.0,null,null,2.0,null,10.0,null,null,null,null,null,null,null,null,null,null,BRCA-LUAD+,null,null,BRCA non-CIMP c9,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,null,False,MX,T3,YES,YES,YES,NO,LumA,null,miRNA cluster 5,null,Stage IIIA,FEMALE,null
TCGA-AC-A3EH-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,1.0,1.0,null,1.0,3.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,BRCA-LUAD+,null,null,BRCA CIMP c7,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8022/3,null,Excisional Biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,YES,NO,YES,NO,LumA,null,miRNA c1uster 9,null,Stage IIIC,FEMALE,null
TCGA-AC-A3HN-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,1+,Positive,Simple Mastectomy,YES,90-99%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AC-A3OD-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,LumA,null,null,null,null,null,High,null,null,BRCA CIMP c7,null,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,NO,YES,YES,NO,LumA,null,miRNA cluster 14,null,Stage IIB,FEMALE,null
TCGA-AC-A3QP-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,null,1.0,1.0,1.0,1.0,null,null,1.0,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,null,70-79%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,YES,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AC-A3QQ-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,1.0,null,null,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Other,YES,90-99%,null,3+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Positive,null,Peri (6-12 months since last menstrual period),null,MX,T1c,NO,NO,YES,NO,LumA,null,miRNA c1uster 10,null,Stage IA,FEMALE,null
TCGA-AC-A3TM-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,1.0,1.0,1.0,null,null,1.0,3.0,10.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA CIMP c7,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Equivocal,Peri (6-12 months since last menstrual period),False,M0,T3,YES,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-AC-A3TN-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA CIMP c7,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,"Other method, specify:",Positive,Indeterminate,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AC-A3W5-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,High,null,null,BRCA CIMP c7,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,50-59%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Positive,null,False,MX,T2,YES,YES,YES,NO,Her2,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-AC-A3W6-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,4.0,10.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,1+,Positive,Modified Radical Mastectomy,YES,90-99%,null,3+,Infiltrating Lobular Carcinoma,8520/3,1+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,NO,NO,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-AC-A3W7-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Negative,Simple Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AC-A3YI-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,3.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,YES,YES,NO,Normal,null,null,null,Stage IIIC,FEMALE,null
TCGA-AC-A3YJ-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA nonbasal-like c8,null,null,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,YES,null,null,null,"Other, specify",8050/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-AC-A4ZE-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,2.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,NO,NO,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A5EH-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,null,null,1.0,null,null,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,20-29%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,null,MX,T2,NO,YES,YES,NO,Her2,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A5EI-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,null,null,1.0,null,null,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,null,"Other, specify",9020/3,null,Tumor resection,Negative,null,null,null,MX,T1c,NO,NO,YES,NO,null,null,null,null,Stage IB,FEMALE,null
TCGA-AC-A5XS-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,null,False,MX,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-AC-A5XU-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,null,null,1.0,null,null,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,null,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A62V-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,1.0,1.0,null,1.0,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,False,M1,T2,YES,YES,YES,NO,LumB,null,null,null,Stage IV,MALE,null
TCGA-AC-A62X-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,NO,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-AC-A62Y-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A6IV-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,YES,90-99%,null,2+,Infiltrating Lobular Carcinoma,8524/3,null,Core needle biopsy,Equivocal,null,null,False,MX,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A6IW-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,NO,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-AC-A6IX-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,5.0,null,null,6.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,null,Peri (6-12 months since last menstrual period),False,MX,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-AC-A6IX-06,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,5.0,null,null,6.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,null,Peri (6-12 months since last menstrual period),False,MX,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-AC-A6NO-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,1.0,null,1.0,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,False,MX,T2,null,null,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A7VB-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,1.0,null,null,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Modified Radical Mastectomy,NO,80-89%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,null,MX,T1c,YES,YES,YES,NO,LumB,null,null,null,Stage IIA,FEMALE,null
TCGA-AC-A7VC-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,1.0,null,null,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,null,null,Metaplastic Carcinoma,8575/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T3,null,null,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A8OP-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,2.0,null,1.0,null,1.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Indeterminate,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,NO,YES,NO,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-AC-A8OQ-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Indeterminate,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,null,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-AC-A8OR-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,<10%,null,Mucinous Carcinoma,8480/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,null,null,YES,NO,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-AC-A8OS-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,null,null,1.0,null,null,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,10-19%,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T2,null,null,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-AN-A03X-01,8.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,8.0,3.0,null,null,1.0,null,null,5.0,6.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,No axillary staging,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,74.0
TCGA-AN-A03Y-01,6.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,3.0,8.0,7.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,No axillary staging,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumB,Negative,miRNA cluster 14,cluster 5,Stage IIA,FEMALE,66.0
TCGA-AN-A041-01,10.0,1.0,null,1.0,6.0,10.0,1.0,1.0,9.0,8.0,1.0,10.0,null,null,1.0,null,null,5.0,8.0,6.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal B,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,null,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,NO,NO,NO,YES,LumA,Equivocal,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,29.0
TCGA-AN-A046-01,3.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,5.0,8.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,null,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,null,No axillary staging,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 12,cluster 4,Stage IIA,FEMALE,68.0
TCGA-AN-A049-01,10.0,1.0,null,1.0,6.0,10.0,1.0,1.0,10.0,8.0,6.0,5.0,1.0,null,1.0,null,2.0,3.0,8.0,4.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal B,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,No axillary staging,Positive,2+,Positive,Simple Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,62.0
TCGA-AN-A04A-01,10.0,1.0,null,6.0,6.0,7.0,1.0,1.0,7.0,8.0,2.0,9.0,1.0,null,1.0,null,2.0,2.0,3.0,6.0,2.0,1.0,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,1+,Positive,Simple Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,2+,Tumor resection,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,36.0
TCGA-AN-A04C-01,6.0,1.0,null,null,null,null,1.0,1.0,2.0,3.0,4.0,7.0,null,null,1.0,null,null,4.0,8.0,7.0,1.0,1.0,9.0,No_Conversion,Negative,Positive,N1,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,0,Negative,Simple Mastectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,0,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,null,NO,YES,Her2,Positive,miRNA cluster 6,cluster 5,Stage IIB,FEMALE,51.0
TCGA-AN-A04D-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,6.0,5.0,null,null,1.0,null,null,4.0,10.0,7.0,1.0,1.0,9.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,No axillary staging,Negative,0,Negative,Simple Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,0,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,58.0
TCGA-AN-A0AJ-01,10.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,9.0,2.0,1.0,null,1.0,null,2.0,3.0,6.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 2,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,80-89%,90-99%,3+,Infiltrating Ductal Carcinoma,8522/3,3+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,NO,NO,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,79.0
TCGA-AN-A0AK-01,1.0,1.0,null,null,null,null,1.0,1.0,3.0,6.0,8.0,3.0,1.0,null,1.0,null,2.0,3.0,8.0,1.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,0,Negative,Modified Radical Mastectomy,NO,80-89%,70-79%,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,76.0
TCGA-AN-A0AL-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,3.0,8.0,1.0,null,1.0,null,2.0,2.0,10.0,4.0,1.0,1.0,9.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T4,Squamous,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,0,Negative,Modified Radical Mastectomy,NO,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,0,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T4,NO,NO,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIIB,FEMALE,41.0
TCGA-AN-A0AM-01,6.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,5.0,6.0,1.0,null,1.0,null,2.0,5.0,8.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,56.0
TCGA-AN-A0AR-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,5.0,6.0,1.0,null,1.0,null,1.0,4.0,10.0,7.0,1.0,1.0,9.0,No_Conversion,Negative,Negative,N0,null,Basal-like,Negative,enrollment,T_Other,T2,Squamous,C8-BLCA,cluster 5,Cluster 5,BRCA basal-like c6,null,mutation cluster 5,No axillary staging,Negative,0,Negative,Modified Radical Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,0,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,NO,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,55.0
TCGA-AN-A0AS-01,6.0,1.0,null,6.0,6.0,10.0,1.0,1.0,10.0,8.0,7.0,4.0,1.0,null,1.0,null,2.0,3.0,3.0,2.0,2.0,1.0,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal B,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,No axillary staging,Positive,0,Negative,Modified Radical Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIIA,FEMALE,70.0
TCGA-AN-A0AT-01,1.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,6.0,5.0,null,null,1.0,null,null,3.0,10.0,null,1.0,1.0,9.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,No axillary staging,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,NO,NO,NO,YES,Basal,Negative,null,null,Stage IIA,FEMALE,62.0
TCGA-AN-A0FD-01,1.0,1.0,null,6.0,6.0,7.0,1.0,1.0,4.0,8.0,8.0,3.0,1.0,null,1.0,null,2.0,4.0,3.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,1+,Positive,Modified Radical Mastectomy,NO,80-89%,60-69%,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Tumor resection,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,71.0
TCGA-AN-A0FE-01,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,False,null,null,null,null,null,null,null,null,null,null,null,null,null
TCGA-AN-A0FF-01,6.0,1.0,null,1.0,6.0,10.0,1.0,1.0,10.0,8.0,1.0,10.0,1.0,null,1.0,null,2.0,4.0,8.0,1.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1b,NO,NO,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IA,FEMALE,32.0
TCGA-AN-A0FG-01,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,2.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,False,null,null,null,null,null,null,null,null,null,null,null,null,null
TCGA-AN-A0FJ-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,6.0,5.0,null,null,1.0,null,null,4.0,10.0,7.0,3.0,1.0,9.0,No_Conversion,Positive,Positive,N2,Basal,Basal-like,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Positive,0,Negative,Modified Radical Mastectomy,NO,10-19%,40-49%,1+,Infiltrating Ductal Carcinoma,8500/3,1+,Tumor resection,Positive,null,Peri (6-12 months since last menstrual period),null,M1,T2,NO,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IV,FEMALE,59.0
TCGA-AN-A0FK-01,3.0,1.0,null,6.0,6.0,10.0,1.0,1.0,1.0,8.0,10.0,1.0,1.0,null,1.0,null,2.0,2.0,3.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal B,Positive,enrollment,T_Other,T4,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,20-29%,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIB,FEMALE,88.0
TCGA-AN-A0FL-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,6.0,5.0,1.0,null,1.0,null,2.0,2.0,10.0,7.0,1.0,1.0,9.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,1+,Negative,Modified Radical Mastectomy,NO,<10%,20-29%,1+,Infiltrating Ductal Carcinoma,8500/3,1+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,62.0
TCGA-AN-A0FN-01,1.0,1.0,null,null,null,null,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,1.0,null,1.0,3.0,1.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,1+,Positive,Modified Radical Mastectomy,NO,90-99%,20-29%,1+,Infiltrating Lobular Carcinoma,8500/3,3+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,61.0
TCGA-AN-A0FS-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,5.0,6.0,1.0,null,1.0,null,1.0,4.0,3.0,2.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Negative,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,0,Negative,Modified Radical Mastectomy,NO,90-99%,20-29%,1+,Infiltrating Lobular Carcinoma,8500/3,3+,Tumor resection,Positive,null,Peri (6-12 months since last menstrual period),False,M0,T1c,NO,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,55.0
TCGA-AN-A0FT-01,6.0,1.0,null,8.0,10.0,7.0,1.0,1.0,9.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,2.0,6.0,7.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumA,Positive,miRNA cluster 6,cluster 5,Stage IIB,FEMALE,63.0
TCGA-AN-A0FV-01,1.0,1.0,null,1.0,1.0,1.0,1.0,1.0,2.0,6.0,6.0,5.0,1.0,null,1.0,null,1.0,3.0,3.0,6.0,1.0,1.0,9.0,No_Conversion,Negative,Negative,N0,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,No axillary staging,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,Her2,Positive,miRNA cluster 6,cluster 4,Stage IIA,FEMALE,58.0
TCGA-AN-A0FW-01,6.0,1.0,null,8.0,6.0,7.0,1.0,1.0,7.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,4.0,6.0,1.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Indeterminate,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,null,Indeterminate,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,67.0
TCGA-AN-A0FX-01,1.0,1.0,null,1.0,1.0,4.0,1.0,1.0,1.0,1.0,5.0,6.0,1.0,null,1.0,null,2.0,3.0,8.0,6.0,1.0,1.0,9.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,No axillary staging,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,52.0
TCGA-AN-A0FY-01,6.0,1.0,null,6.0,6.0,10.0,1.0,1.0,9.0,8.0,5.0,6.0,1.0,null,1.0,null,1.0,3.0,3.0,7.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 2,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,No axillary staging,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,NO,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 5,Stage IA,FEMALE,55.0
TCGA-AN-A0FZ-01,6.0,1.0,null,6.0,6.0,7.0,1.0,1.0,8.0,8.0,3.0,8.0,1.0,null,1.0,null,2.0,4.0,3.0,6.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,null,Negative,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,NO,NO,NO,YES,LumA,Equivocal,miRNA cluster 12,cluster 4,Stage IIIA,FEMALE,45.0
TCGA-AN-A0G0-01,null,1.0,null,null,null,null,1.0,1.0,1.0,10.0,5.0,6.0,1.0,null,1.0,null,1.0,6.0,10.0,4.0,1.0,1.0,9.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,null,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,No axillary staging,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,56.0
TCGA-AN-A0XL-01,10.0,1.0,null,null,null,null,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,1.0,null,1.0,4.0,3.0,9.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 14,null,Positive,null,Positive,null,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,61.0
TCGA-AN-A0XN-01,8.0,1.0,null,1.0,6.0,7.0,1.0,1.0,7.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,4.0,6.0,6.0,1.0,null,9.0,Stage IIIA,Negative,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 2,null,Negative,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,68.0
TCGA-AN-A0XO-01,3.0,1.0,null,1.0,6.0,7.0,1.0,1.0,5.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,3.0,8.0,6.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Negative,null,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,59.0
TCGA-AN-A0XP-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,5.0,3.0,6.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,null,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,69.0
TCGA-AN-A0XR-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,5.0,6.0,1.0,null,1.0,null,1.0,4.0,6.0,6.0,3.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,Luminal B,Negative,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Negative,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,55.0
TCGA-AN-A0XS-01,8.0,1.0,null,6.0,6.0,7.0,1.0,1.0,7.0,7.0,6.0,5.0,1.0,null,1.0,null,1.0,3.0,3.0,6.0,1.0,null,9.0,Stage IIIA,Negative,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 14,null,Negative,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,63.0
TCGA-AN-A0XT-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,10.0,8.0,5.0,6.0,1.0,null,1.0,null,1.0,4.0,10.0,10.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Negative,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 12,cluster 7,Stage IIIA,FEMALE,54.0
TCGA-AN-A0XU-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,5.0,6.0,1.0,null,1.0,null,1.0,4.0,10.0,6.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,54.0
TCGA-AN-A0XV-01,8.0,1.0,null,null,null,null,1.0,1.0,10.0,10.0,7.0,4.0,1.0,null,1.0,null,1.0,4.0,8.0,2.0,3.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,1+,Positive,null,NO,90-99%,60-69%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIIA,FEMALE,67.0
TCGA-AN-A0XW-01,10.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,7.0,2.0,9.0,1.0,null,1.0,null,2.0,4.0,3.0,6.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,null,NO,90-99%,60-69%,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Tumor resection,Positive,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,36.0
TCGA-AO-A03L-01,10.0,4.0,null,1.0,6.0,1.0,4.0,1.0,9.0,7.0,2.0,9.0,4.0,null,3.0,1.0,4.0,4.0,8.0,1.0,2.0,null,7.0,No_Conversion,Positive,Positive,N2,LumA,HER2-enriched,Positive,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Modified Radical Mastectomy,NO,70-79%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Positive,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,34.0
TCGA-AO-A03M-01,1.0,3.0,null,null,null,null,3.0,1.0,9.0,6.0,1.0,10.0,null,null,3.0,1.0,null,1.0,1.0,10.0,1.0,1.0,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,YES,70-79%,30-39%,2+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 7,Stage I,FEMALE,29.0
TCGA-AO-A03N-01,6.0,3.0,null,6.0,6.0,10.0,3.0,1.0,9.0,8.0,6.0,5.0,3.0,null,3.0,null,2.0,5.0,3.0,9.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumB,HER2-enriched,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 2,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Modified Radical Mastectomy,NO,70-79%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 12,cluster 6,Stage IIB,FEMALE,59.0
TCGA-AO-A03O-01,6.0,2.0,6.0,1.0,1.0,10.0,4.0,10.0,9.0,6.0,7.0,4.0,4.0,4.0,null,1.0,4.0,4.0,8.0,1.0,1.0,1.0,6.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 8,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,69.0
TCGA-AO-A03P-01,6.0,4.0,null,null,null,null,4.0,1.0,3.0,6.0,5.0,6.0,4.0,4.0,4.0,null,2.0,6.0,3.0,null,1.0,3.0,7.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Lumpectomy,YES,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Negative,null,null,Stage IIB,FEMALE,54.0
TCGA-AO-A03R-01,8.0,3.0,null,null,null,null,3.0,1.0,10.0,10.0,5.0,6.0,3.0,null,3.0,1.0,1.0,6.0,3.0,2.0,1.0,1.0,7.0,No_Conversion,Positive,Positive,N1,Normal,Normal-like,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Normal,Negative,miRNA cluster 3,cluster 2,Stage IIB,FEMALE,57.0
TCGA-AO-A03T-01,10.0,2.0,null,null,null,null,2.0,1.0,9.0,8.0,3.0,8.0,2.0,null,3.0,null,1.0,3.0,3.0,6.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,Normal,Normal-like,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 12,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,NO,YES,Normal,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,42.0
TCGA-AO-A03U-01,1.0,3.0,4.0,3.0,3.0,4.0,3.0,10.0,7.0,10.0,1.0,10.0,5.0,3.0,null,null,1.0,2.0,10.0,6.0,1.0,1.0,6.0,Stage I,Negative,Negative,N0,Normal,Normal-like,Negative,followup,T1,T1,Kirc+,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,<10%,0,"Other, specify",8502/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,null,NO,NO,YES,Normal,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,31.0
TCGA-AO-A03V-01,1.0,2.0,null,null,null,null,2.0,1.0,10.0,8.0,3.0,8.0,1.0,null,2.0,null,1.0,1.0,3.0,10.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,COAD-READ,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Positive,2+,Positive,Simple Mastectomy,YES,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage I,FEMALE,41.0
TCGA-AO-A0J2-01,6.0,1.0,null,3.0,3.0,4.0,1.0,1.0,2.0,3.0,3.0,8.0,1.0,null,2.0,1.0,2.0,2.0,10.0,6.0,1.0,1.0,9.0,Stage I,Negative,Negative,N0,Her2,HER2-enriched,Negative,followup,T1,T1,High,C3-BRCA/Luminal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,30-39%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,null,NO,NO,YES,Her2,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,41.0
TCGA-AO-A0J3-01,10.0,1.0,null,8.0,6.0,10.0,1.0,1.0,3.0,8.0,7.0,4.0,1.0,null,1.0,1.0,6.0,9.0,6.0,1.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,4+,Positive,Modified Radical Mastectomy,YES,<10%,10-19%,2+,"Other, specify",8523/3,4+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 12,cluster 1,Stage IIB,FEMALE,67.0
TCGA-AO-A0J4-01,1.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,3.0,8.0,1.0,null,2.0,null,1.0,1.0,10.0,6.0,1.0,1.0,9.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,null,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,41.0
TCGA-AO-A0J5-01,null,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,1.0,1.0,1.0,3.0,1.0,null,null,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,null,Negative,followup,T_Other,T4,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,90-99%,10-19%,2+,"Other, specify",8523/3,4+,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M1,T4,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,null,Stage IV,FEMALE,48.0
TCGA-AO-A0J6-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,1.0,6.0,5.0,1.0,null,2.0,null,2.0,1.0,10.0,2.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,61.0
TCGA-AO-A0J7-01,3.0,1.0,null,1.0,6.0,10.0,1.0,1.0,10.0,8.0,8.0,3.0,1.0,null,1.0,null,2.0,3.0,8.0,2.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,1+,"Other, specify",8523/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,71.0
TCGA-AO-A0J8-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,1.0,8.0,6.0,5.0,1.0,null,1.0,null,4.0,1.0,1.0,2.0,1.0,2.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,1+,Infiltrating Lobular Carcinoma,8520/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,61.0
TCGA-AO-A0J9-01,3.0,2.0,null,1.0,8.0,7.0,2.0,1.0,9.0,8.0,6.0,5.0,2.0,null,2.0,1.0,2.0,8.0,8.0,2.0,5.0,1.0,8.0,No_Conversion,Positive,Positive,N3,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,4+,Positive,Lumpectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,4+,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIIC,FEMALE,61.0
TCGA-AO-A0JA-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,7.0,2.0,9.0,null,null,1.0,null,null,3.0,8.0,1.0,4.0,null,9.0,No_Conversion,Positive,Positive,N3,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIC,FEMALE,36.0
TCGA-AO-A0JB-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,9.0,8.0,4.0,7.0,null,null,2.0,null,null,4.0,10.0,2.0,1.0,1.0,8.0,No_Conversion,Positive,Positive,N1,null,Normal-like,Positive,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,mutation cluster 5,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T3,null,YES,NO,YES,Normal,Negative,miRNA cluster 14,cluster 2,Stage IIIA,FEMALE,50.0
TCGA-AO-A0JC-01,1.0,3.0,null,3.0,3.0,4.0,3.0,1.0,9.0,6.0,6.0,5.0,2.0,null,2.0,null,3.0,3.0,10.0,2.0,1.0,1.0,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,followup,T_Other,T2,Quiet,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,YES,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,64.0
TCGA-AO-A0JD-01,3.0,3.0,null,6.0,6.0,10.0,3.0,1.0,9.0,9.0,6.0,5.0,3.0,null,3.0,1.0,2.0,7.0,3.0,7.0,1.0,1.0,7.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T3,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 8,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,NO,YES,LumB,Negative,miRNA c1uster 10,cluster 5,Stage IIIA,FEMALE,59.0
TCGA-AO-A0JE-01,10.0,3.0,null,1.0,1.0,1.0,3.0,1.0,2.0,6.0,5.0,6.0,null,null,3.0,3.0,null,7.0,8.0,6.0,3.0,1.0,7.0,No_Conversion,Negative,Positive,N2,Her2,HER2-enriched,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,<10%,50-59%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,Her2,Positive,miRNA cluster 7,cluster 4,Stage IIIA,FEMALE,53.0
TCGA-AO-A0JF-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,7.0,4.0,1.0,null,3.0,null,2.0,4.0,3.0,10.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Lumpectomy,NO,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 7,Stage IIA,FEMALE,68.0
TCGA-AO-A0JG-01,10.0,1.0,null,1.0,6.0,7.0,1.0,1.0,7.0,5.0,4.0,7.0,1.0,null,1.0,null,2.0,5.0,8.0,1.0,2.0,1.0,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,1+,"Other, specify",8523/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,49.0
TCGA-AO-A0JI-01,8.0,2.0,null,8.0,6.0,10.0,2.0,1.0,3.0,8.0,5.0,6.0,null,null,2.0,null,null,3.0,6.0,2.0,1.0,2.0,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal B,Negative,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Modified Radical Mastectomy,YES,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,56.0
TCGA-AO-A0JJ-01,3.0,3.0,null,6.0,8.0,7.0,3.0,1.0,7.0,5.0,5.0,6.0,null,null,3.0,null,null,10.0,1.0,10.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,0,Infiltrating Lobular Carcinoma,8520/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 3,cluster 7,Stage IIB,FEMALE,54.0
TCGA-AO-A0JL-01,6.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,10.0,6.0,5.0,2.0,null,2.0,2.0,2.0,6.0,10.0,7.0,3.0,null,8.0,No_Conversion,Negative,Positive,N2,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,<10%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,59.0
TCGA-AO-A0JM-01,6.0,3.0,null,8.0,10.0,10.0,3.0,1.0,9.0,6.0,3.0,8.0,3.0,null,3.0,3.0,4.0,6.0,6.0,7.0,1.0,null,7.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Modified Radical Mastectomy,NO,90-99%,70-79%,3+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumB,Positive,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,40.0
TCGA-AO-A124-01,6.0,5.0,null,null,null,null,5.0,1.0,1.0,1.0,2.0,9.0,5.0,null,5.0,null,4.0,5.0,10.0,4.0,1.0,1.0,6.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Modified Radical Mastectomy,YES,<10%,<10%,0,"Other, specify",8523/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,38.0
TCGA-AO-A125-01,3.0,5.0,null,null,null,null,5.0,1.0,1.0,8.0,8.0,3.0,5.0,null,5.0,1.0,1.0,2.0,8.0,4.0,1.0,1.0,6.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,4+,Positive,Simple Mastectomy,YES,50-59%,<10%,0,"Other, specify",8050/3,3+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,72.0
TCGA-AO-A126-01,10.0,5.0,null,1.0,6.0,7.0,5.0,1.0,10.0,8.0,3.0,9.0,4.0,null,4.0,1.0,3.0,2.0,8.0,9.0,1.0,1.0,6.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 14,Sentinel node biopsy alone,Positive,2+,Positive,Simple Mastectomy,YES,20-29%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,39.0
TCGA-AO-A128-01,6.0,5.0,null,null,null,null,5.0,1.0,1.0,10.0,6.0,5.0,4.0,null,4.0,1.0,3.0,4.0,10.0,9.0,1.0,1.0,6.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,BRCA-LUAD+,C4-BRCA/Basal,cluster 5,Cluster 5,BRCA basal-like c6,BRCA basal-like c8,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 14,cluster 6,Stage IIA,FEMALE,61.0
TCGA-AO-A129-01,1.0,5.0,null,3.0,3.0,4.0,5.0,1.0,1.0,1.0,1.0,10.0,4.0,null,4.0,1.0,2.0,5.0,10.0,4.0,1.0,null,6.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 3,Stage IIB,FEMALE,29.0
TCGA-AO-A12A-01,3.0,4.0,null,6.0,8.0,7.0,4.0,1.0,7.0,5.0,4.0,7.0,4.0,null,4.0,1.0,1.0,7.0,3.0,9.0,1.0,2.0,7.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,4+,Positive,Modified Radical Mastectomy,YES,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage IIA,FEMALE,47.0
TCGA-AO-A12B-01,6.0,4.0,null,6.0,6.0,10.0,4.0,1.0,1.0,8.0,6.0,5.0,4.0,null,4.0,null,3.0,1.0,3.0,4.0,1.0,1.0,7.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,4+,Positive,Simple Mastectomy,YES,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,63.0
TCGA-AO-A12C-01,3.0,3.0,null,null,null,null,3.0,1.0,7.0,5.0,3.0,8.0,3.0,null,3.0,1.0,2.0,8.0,8.0,9.0,1.0,null,7.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Lumpectomy,NO,90-99%,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Positive,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumA,Positive,miRNA cluster 13,cluster 6,Stage IIB,FEMALE,42.0
TCGA-AO-A12D-01,6.0,3.0,null,3.0,3.0,1.0,3.0,1.0,2.0,2.0,3.0,8.0,3.0,null,3.0,4.0,4.0,4.0,10.0,4.0,1.0,1.0,7.0,No_Conversion,Negative,Positive,N1,Her2,HER2-enriched,Negative,followup,T1,T1,High,C3-BRCA/Luminal,cluster 5,Cluster 5,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Modified Radical Mastectomy,YES,<10%,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,YES,NO,YES,Her2,Positive,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,43.0
TCGA-AO-A12E-01,6.0,3.0,null,8.0,6.0,7.0,3.0,1.0,7.0,5.0,4.0,7.0,3.0,null,3.0,null,3.0,3.0,6.0,1.0,1.0,2.0,7.0,Stage IIB,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,YES,80-89%,<10%,0,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,51.0
TCGA-AO-A12F-01,1.0,3.0,null,3.0,3.0,4.0,3.0,1.0,1.0,10.0,2.0,9.0,3.0,null,3.0,null,3.0,4.0,10.0,7.0,1.0,1.0,8.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,36.0
TCGA-AO-A12G-01,3.0,2.0,null,1.0,6.0,7.0,2.0,1.0,10.0,10.0,8.0,3.0,2.0,null,2.0,1.0,2.0,1.0,8.0,2.0,1.0,2.0,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 8,Sentinel node biopsy alone,Positive,2+,Positive,Simple Mastectomy,YES,90-99%,null,2+,"Other, specify",8022/3,4+,Core needle biopsy,Positive,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,75.0
TCGA-AO-A12H-01,1.0,2.0,null,6.0,6.0,7.0,2.0,1.0,1.0,8.0,7.0,4.0,2.0,null,2.0,null,2.0,3.0,3.0,2.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Quiet,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,2+,Positive,Simple Mastectomy,YES,90-99%,<10%,0,"Other, specify",8523/3,4+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 2,Stage IIA,FEMALE,69.0
TCGA-AO-A1KO-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,2.0,null,1.0,null,3.0,5.0,10.0,9.0,1.0,2.0,9.0,Stage IIB,Positive,Negative,N0,Normal,null,Positive,followup,T_Other,T3,Quiet,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,4+,Positive,Simple Mastectomy,YES,90-99%,<10%,1+,Infiltrating Lobular Carcinoma,8520/3,4+,Excisional Biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,NO,NO,YES,Normal,Negative,miRNA cluster 7,cluster 6,Stage IIB,FEMALE,46.0
TCGA-AO-A1KP-01,3.0,4.0,null,null,null,null,4.0,1.0,null,null,8.0,2.0,4.0,null,4.0,1.0,2.0,3.0,8.0,9.0,1.0,2.0,7.0,Stage IIA,Positive,Positive,N1,LumB,null,Positive,followup,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,4+,Positive,Simple Mastectomy,YES,80-89%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,NO,NO,YES,LumB,Negative,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,77.0
TCGA-AO-A1KQ-01,8.0,3.0,null,null,null,null,3.0,1.0,null,null,10.0,1.0,2.0,null,3.0,null,3.0,3.0,3.0,6.0,1.0,1.0,8.0,Stage IIIB,Positive,Positive,N1,LumB,null,Positive,followup,T_Other,T4,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,null,True,M0,T4,null,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIB,MALE,84.0
TCGA-AO-A1KR-01,1.0,4.0,null,null,null,null,4.0,1.0,null,null,4.0,7.0,3.0,null,3.0,null,1.0,1.0,10.0,4.0,1.0,1.0,7.0,null,Negative,null,null,Basal,null,Negative,enrollment,null,null,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 4,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,Basal,null,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,51.0
TCGA-AO-A1KS-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,1.0,2.0,2.0,8.0,7.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,2+,Positive,Lumpectomy,YES,90-99%,10-19%,2+,Infiltrating Lobular Carcinoma,8520/3,4+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,69.0
TCGA-AO-A1KT-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,1.0,1.0,2.0,6.0,6.0,1.0,2.0,9.0,Stage IIA,Positive,Positive,N1,LumB,null,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,4+,Positive,Lumpectomy,YES,90-99%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,78.0
TCGA-AQ-A04H-01,10.0,1.0,null,null,null,null,1.0,1.0,3.0,8.0,6.0,5.0,null,null,1.0,2.0,null,4.0,6.0,10.0,2.0,null,9.0,No_Conversion,Positive,Positive,N2,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Indeterminate,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T2,YES,YES,NO,YES,LumB,Positive,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,61.0
TCGA-AQ-A04J-01,1.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,3.0,8.0,1.0,null,1.0,null,1.0,5.0,10.0,6.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,0,Negative,Simple Mastectomy,NO,<10%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,45.0
TCGA-AQ-A04L-01,1.0,5.0,null,3.0,3.0,4.0,5.0,1.0,10.0,6.0,4.0,7.0,5.0,null,5.0,null,1.0,1.0,6.0,4.0,1.0,null,6.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 13,Sentinel node biopsy alone,Positive,null,Negative,Modified Radical Mastectomy,NO,60-69%,null,3+,Infiltrating Ductal Carcinoma,8500/3,2+,Fine needle aspiration biopsy,Positive,null,Peri (6-12 months since last menstrual period),False,MX,T2,YES,NO,NO,YES,LumA,Positive,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,48.0
TCGA-AQ-A0Y5-01,6.0,null,1.0,null,null,null,1.0,10.0,null,null,7.0,4.0,1.0,1.0,null,3.0,1.0,4.0,8.0,6.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,NO,YES,NO,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,70.0
TCGA-AQ-A1H2-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,null,1.0,2.0,1.0,5.0,3.0,1.0,4.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Indeterminate,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,YES,YES,NO,LumA,Positive,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,84.0
TCGA-AQ-A1H3-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,2.0,6.0,8.0,9.0,5.0,null,9.0,Stage IIIC,Positive,Positive,N3,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,MX,T2,YES,YES,YES,NO,LumA,Negative,miRNA cluster 5,cluster 6,Stage IIIC,FEMALE,49.0
TCGA-AQ-A54N-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,1.0,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-AQ-A54O-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,null,2.0,4.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,False,M0,T2,YES,NO,YES,NO,LumB,null,null,null,Stage IIA,MALE,null
TCGA-AQ-A7U7-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,1.0,1.0,null,null,4.0,null,null,2.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,80-89%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-AR-A0TP-01,1.0,4.0,null,3.0,3.0,4.0,4.0,1.0,1.0,1.0,3.0,8.0,null,null,5.0,null,null,2.0,10.0,4.0,1.0,1.0,7.0,No_Conversion,Positive,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Other,YES,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,43.0
TCGA-AR-A0TQ-01,6.0,3.0,null,1.0,1.0,10.0,3.0,1.0,9.0,6.0,1.0,10.0,2.0,null,4.0,null,4.0,4.0,8.0,6.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Negative,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Negative,Simple Mastectomy,NO,10-19%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,YES,YES,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,27.0
TCGA-AR-A0TR-01,1.0,1.0,1.0,6.0,6.0,7.0,1.0,10.0,1.0,8.0,7.0,4.0,2.0,1.0,null,null,3.0,7.0,3.0,10.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 13,cluster 7,Stage IIB,FEMALE,68.0
TCGA-AR-A0TS-01,8.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,1.0,4.0,7.0,2.0,null,3.0,null,2.0,4.0,10.0,7.0,1.0,null,8.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,0,Negative,Lumpectomy,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA c1uster 9,cluster 5,Stage IIB,FEMALE,46.0
TCGA-AR-A0TT-01,6.0,3.0,null,1.0,1.0,10.0,3.0,1.0,9.0,6.0,5.0,6.0,2.0,null,4.0,null,2.0,5.0,1.0,6.0,2.0,null,8.0,No_Conversion,Positive,Positive,N2,LumB,Luminal B,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,0,Negative,Other,null,10-19%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,53.0
TCGA-AR-A0TU-01,8.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,2.0,9.0,3.0,null,1.0,null,4.0,1.0,10.0,null,1.0,null,8.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Negative,0,Negative,Simple Mastectomy,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,NO,YES,Basal,Negative,null,null,Stage IIA,FEMALE,35.0
TCGA-AR-A0TV-01,1.0,2.0,null,1.0,1.0,10.0,2.0,1.0,3.0,6.0,7.0,4.0,3.0,null,3.0,null,3.0,1.0,8.0,2.0,1.0,null,7.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 8,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,66.0
TCGA-AR-A0TW-01,8.0,2.0,null,null,null,null,2.0,1.0,9.0,6.0,4.0,7.0,null,null,4.0,null,null,7.0,8.0,null,1.0,null,7.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T3,YES,NO,NO,YES,LumA,Negative,null,null,Stage IIIA,FEMALE,50.0
TCGA-AR-A0TX-01,1.0,1.0,null,3.0,3.0,1.0,1.0,1.0,2.0,6.0,6.0,4.0,3.0,null,3.0,null,3.0,6.0,1.0,1.0,1.0,null,7.0,No_Conversion,Positive,Positive,N1,Her2,HER2-enriched,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,<10%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,YES,NO,YES,Her2,Positive,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,64.0
TCGA-AR-A0TY-01,1.0,1.0,4.0,1.0,1.0,10.0,3.0,10.0,9.0,6.0,5.0,6.0,3.0,3.0,null,null,2.0,4.0,8.0,6.0,1.0,null,7.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 12,Sentinel lymph node biopsy plus axillary dissection,Positive,0,Negative,Simple Mastectomy,YES,10-19%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,54.0
TCGA-AR-A0TZ-01,10.0,2.0,null,8.0,6.0,10.0,2.0,1.0,3.0,8.0,3.0,8.0,3.0,5.0,3.0,null,2.0,7.0,6.0,2.0,2.0,null,7.0,No_Conversion,Positive,Positive,N2,LumA,Luminal B,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M1,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIIA,FEMALE,43.0
TCGA-AR-A0U0-01,1.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,8.0,3.0,3.0,null,3.0,null,2.0,1.0,1.0,null,1.0,3.0,7.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Negative,0,Negative,Simple Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,null,null,Stage IIB,FEMALE,73.0
TCGA-AR-A0U1-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,2.0,9.0,3.0,null,5.0,null,2.0,8.0,10.0,9.0,1.0,null,7.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,null,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,0,Negative,Other,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 13,cluster 6,Stage IIB,FEMALE,36.0
TCGA-AR-A0U2-01,10.0,3.0,6.0,null,null,null,4.0,10.0,3.0,6.0,4.0,7.0,4.0,4.0,null,null,1.0,4.0,3.0,7.0,2.0,1.0,7.0,No_Conversion,Positive,Positive,N2,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,squamous c3,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,10-19%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,47.0
TCGA-AR-A0U3-01,8.0,4.0,null,8.0,6.0,10.0,4.0,1.0,10.0,8.0,6.0,5.0,null,null,5.0,null,null,1.0,6.0,10.0,1.0,null,7.0,No_Conversion,Positive,Positive,N1,LumA,Luminal B,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,NO,10-19%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 7,Stage IIB,FEMALE,59.0
TCGA-AR-A0U4-01,1.0,3.0,null,3.0,3.0,4.0,3.0,1.0,1.0,1.0,5.0,6.0,null,null,4.0,null,null,3.0,10.0,7.0,1.0,null,8.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,mutation cluster 11,Sentinel lymph node biopsy plus axillary dissection,Negative,0,Negative,Simple Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,54.0
TCGA-AR-A1AH-01,1.0,4.0,null,3.0,3.0,4.0,4.0,1.0,1.0,10.0,4.0,6.0,4.0,null,5.0,null,1.0,3.0,10.0,7.0,1.0,null,7.0,Stage IIB,Positive,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Negative,Other,null,10-19%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,51.0
TCGA-AR-A1AI-01,1.0,3.0,null,3.0,3.0,4.0,3.0,1.0,1.0,1.0,4.0,7.0,3.0,null,4.0,null,5.0,2.0,10.0,4.0,1.0,null,7.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Simple Mastectomy,YES,null,null,2+,Medullary Carcinoma,8510/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,47.0
TCGA-AR-A1AJ-01,6.0,3.0,null,1.0,3.0,4.0,3.0,1.0,1.0,1.0,9.0,2.0,3.0,null,4.0,null,2.0,2.0,10.0,6.0,1.0,null,7.0,Stage I,Positive,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Other,YES,10-19%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,NO,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,83.0
TCGA-AR-A1AK-01,6.0,3.0,null,1.0,8.0,7.0,3.0,1.0,7.0,10.0,7.0,4.0,null,null,4.0,null,null,2.0,1.0,6.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,10-19%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,70.0
TCGA-AR-A1AL-01,3.0,3.0,null,6.0,8.0,7.0,3.0,1.0,7.0,10.0,6.0,5.0,2.0,null,4.0,null,3.0,4.0,3.0,9.0,1.0,null,8.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 1,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage IIIA,FEMALE,60.0
TCGA-AR-A1AM-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,4.0,null,null,3.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,null,Positive,null,Positive,Simple Mastectomy,null,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T3,YES,NO,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-AR-A1AN-01,1.0,2.0,null,null,null,null,2.0,1.0,7.0,5.0,4.0,7.0,2.0,null,4.0,null,1.0,2.0,10.0,9.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 7,cluster 6,Stage IIA,FEMALE,46.0
TCGA-AR-A1AO-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,7.0,4.0,4.0,7.0,2.0,null,4.0,null,1.0,9.0,10.0,6.0,1.0,null,8.0,Stage IIA,Positive,Positive,N1,Normal,Normal-like,Negative,enrollment,T1,T1,Quiet,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Other,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1,YES,YES,NO,YES,Normal,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,47.0
TCGA-AR-A1AP-01,3.0,2.0,null,1.0,6.0,7.0,2.0,1.0,10.0,10.0,9.0,2.0,2.0,null,4.0,null,2.0,1.0,8.0,6.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,80.0
TCGA-AR-A1AQ-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,1.0,4.0,7.0,2.0,null,4.0,null,1.0,2.0,10.0,4.0,1.0,null,8.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Other,YES,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,49.0
TCGA-AR-A1AR-01,1.0,null,1.0,null,null,null,1.0,10.0,1.0,10.0,4.0,7.0,2.0,1.0,null,null,2.0,4.0,10.0,7.0,2.0,null,8.0,Stage IIIA,Negative,Positive,N2,Basal,Basal-like,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,50.0
TCGA-AR-A1AS-01,6.0,2.0,null,6.0,6.0,7.0,2.0,1.0,5.0,8.0,5.0,6.0,2.0,null,2.0,null,2.0,4.0,3.0,6.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 2,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,70-79%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,54.0
TCGA-AR-A1AT-01,null,null,3.0,null,null,null,2.0,10.0,2.0,6.0,6.0,5.0,2.0,2.0,null,null,2.0,1.0,1.0,6.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,null,HER2-enriched,Positive,enrollment,T_Other,T2,null,null,cluster 1,BRCA CIMP c7,BRCA basal-like c6,null,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,<10%,null,3+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,62.0
TCGA-AR-A1AU-01,8.0,2.0,null,6.0,8.0,7.0,2.0,1.0,8.0,5.0,3.0,8.0,2.0,null,4.0,null,2.0,9.0,3.0,9.0,2.0,null,8.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIIA,FEMALE,39.0
TCGA-AR-A1AV-01,6.0,2.0,null,8.0,10.0,10.0,2.0,1.0,9.0,6.0,7.0,4.0,2.0,null,3.0,null,2.0,6.0,6.0,10.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumA,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,70-79%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIB,MALE,68.0
TCGA-AR-A1AW-01,6.0,2.0,null,3.0,3.0,7.0,2.0,1.0,1.0,8.0,7.0,4.0,2.0,null,4.0,null,4.0,1.0,1.0,4.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumB,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,YES,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,65.0
TCGA-AR-A1AX-01,8.0,2.0,null,6.0,1.0,7.0,2.0,1.0,10.0,6.0,6.0,5.0,2.0,null,4.0,null,2.0,2.0,10.0,9.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Squamous,C5-KIRC,cluster 5,Low purity c2,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,YES,YES,NO,YES,LumA,Positive,miRNA cluster 4,cluster 6,Stage I,FEMALE,64.0
TCGA-AR-A1AY-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,7.0,4.0,2.0,null,2.0,null,1.0,1.0,10.0,7.0,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Other,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,YES,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage I,FEMALE,65.0
TCGA-AR-A24H-01,3.0,5.0,null,null,null,null,5.0,1.0,null,null,7.0,4.0,null,null,6.0,null,null,1.0,6.0,null,1.0,null,6.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 13,null,Stage IIA,FEMALE,65.0
TCGA-AR-A24K-01,6.0,3.0,null,null,null,null,3.0,1.0,null,null,4.0,7.0,3.0,null,2.0,null,1.0,1.0,8.0,null,1.0,null,7.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,10-19%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 13,null,Stage IIA,FEMALE,46.0
TCGA-AR-A24L-01,10.0,4.0,null,null,null,null,4.0,1.0,null,null,1.0,10.0,null,4.0,3.0,null,null,3.0,3.0,6.0,1.0,null,7.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,10-19%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,26.0
TCGA-AR-A24M-01,6.0,3.0,null,null,null,null,3.0,1.0,null,null,2.0,9.0,3.0,null,5.0,null,2.0,7.0,8.0,10.0,2.0,null,7.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,10-19%,null,1+,Mixed Histology (please specify),8522/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,38.0
TCGA-AR-A24N-01,3.0,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,3.0,null,4.0,null,2.0,1.0,6.0,4.0,1.0,null,7.0,Stage I,Positive,Negative,N0,LumB,null,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,10-19%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Peri (6-12 months since last menstrual period),True,M0,T1,NO,NO,NO,YES,LumB,Negative,miRNA cluster 12,cluster 3,Stage I,FEMALE,54.0
TCGA-AR-A24O-01,3.0,3.0,null,null,null,null,3.0,1.0,null,null,3.0,8.0,3.0,null,5.0,null,4.0,5.0,1.0,10.0,3.0,null,7.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T_Other,T3,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Mixed Histology (please specify),8522/3,null,Incisional Biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,43.0
TCGA-AR-A24P-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,3.0,null,1.0,null,1.0,1.0,8.0,2.0,1.0,null,7.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,10-19%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,47.0
TCGA-AR-A24Q-01,1.0,3.0,null,null,null,null,3.0,1.0,null,null,4.0,7.0,3.0,null,4.0,null,3.0,1.0,10.0,9.0,1.0,null,8.0,Stage IIB,Positive,Negative,N0,Basal,null,Negative,enrollment,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation cluster 2,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,null,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,Basal,Negative,miRNA c1uster 9,cluster 6,Stage IIB,FEMALE,49.0
TCGA-AR-A24R-01,10.0,3.0,null,null,null,null,3.0,1.0,null,null,3.0,8.0,3.0,null,5.0,null,2.0,7.0,6.0,7.0,2.0,null,8.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,10-19%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1,YES,YES,NO,YES,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,45.0
TCGA-AR-A24S-01,1.0,3.0,null,null,null,null,3.0,1.0,null,null,6.0,5.0,3.0,null,4.0,null,3.0,1.0,3.0,6.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumB,null,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 2,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,61.0
TCGA-AR-A24T-01,3.0,3.0,null,null,null,null,3.0,1.0,null,null,4.0,7.0,3.0,null,4.0,null,3.0,4.0,8.0,2.0,5.0,null,8.0,Stage IIIC,Positive,Positive,N3,LumA,null,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,null,10-19%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIIC,FEMALE,46.0
TCGA-AR-A24U-01,8.0,3.0,null,null,null,null,3.0,1.0,null,null,4.0,7.0,3.0,null,4.0,null,2.0,6.0,1.0,10.0,1.0,null,8.0,Stage IIA,Negative,Positive,N1,Her2,null,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Simple Mastectomy,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1,YES,YES,NO,YES,Her2,Positive,miRNA cluster 7,cluster 7,Stage IIA,FEMALE,47.0
TCGA-AR-A24V-01,10.0,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,3.0,null,4.0,null,2.0,1.0,8.0,6.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,80-89%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,52.0
TCGA-AR-A24W-01,6.0,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,2.0,null,null,6.0,1.0,9.0,1.0,null,8.0,null,null,null,null,LumA,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,NO,NO,YES,LumA,null,miRNA cluster 14,cluster 6,Stage IIB,FEMALE,null
TCGA-AR-A24X-01,3.0,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,3.0,null,4.0,null,1.0,2.0,8.0,2.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,80-89%,null,2+,Mixed Histology (please specify),8522/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,52.0
TCGA-AR-A24Z-01,6.0,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,3.0,null,4.0,null,1.0,2.0,8.0,null,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,LumB,Negative,miRNA cluster 6,null,Stage IIA,FEMALE,57.0
TCGA-AR-A250-01,6.0,3.0,null,null,null,null,3.0,1.0,null,null,6.0,5.0,3.0,null,4.0,null,2.0,1.0,6.0,6.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumB,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Other,null,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,58.0
TCGA-AR-A251-01,1.0,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,3.0,null,4.0,null,3.0,2.0,10.0,null,2.0,null,8.0,Stage IIIA,Positive,Positive,N2,Basal,null,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 7,null,Stage IIIA,FEMALE,51.0
TCGA-AR-A252-01,6.0,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,2.0,null,4.0,null,3.0,1.0,1.0,1.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1,YES,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage I,FEMALE,50.0
TCGA-AR-A254-01,6.0,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,2.0,null,4.0,null,5.0,7.0,8.0,null,3.0,null,8.0,Stage IIIA,Positive,Positive,N2,Her2,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Her2,Positive,miRNA cluster 4,null,Stage IIIA,FEMALE,50.0
TCGA-AR-A255-01,10.0,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,2.0,null,3.0,null,2.0,1.0,6.0,null,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,YES,YES,NO,YES,LumA,Positive,miRNA cluster 13,null,Stage I,FEMALE,62.0
TCGA-AR-A256-01,1.0,5.0,7.0,null,null,null,5.0,10.0,null,null,3.0,8.0,5.0,4.0,null,null,1.0,2.0,10.0,null,1.0,null,6.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Other,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,Basal,Negative,miRNA cluster 12,null,Stage IIA,FEMALE,45.0
TCGA-AR-A2LE-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,5.0,null,6.0,null,2.0,1.0,null,null,1.0,null,6.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Negative,Other,YES,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,YES,YES,NO,YES,LumA,null,miRNA c1uster 10,null,Stage I,FEMALE,null
TCGA-AR-A2LH-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,3.0,1.0,null,null,6.0,9.0,null,null,9.0,null,8.0,null,null,null,null,Normal,null,null,null,null,null,Quiet,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,Normal,null,miRNA cluster 5,null,Stage III,FEMALE,null
TCGA-AR-A2LJ-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,2.0,null,4.0,null,3.0,5.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,70-79%,null,3+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T3,YES,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-AR-A2LK-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,2.0,3.0,2.0,null,3.0,5.0,null,null,2.0,null,8.0,null,null,null,null,LumB,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,LumB,null,miRNA cluster 4,null,Stage III,FEMALE,null
TCGA-AR-A2LL-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,2.0,null,3.0,null,6.0,1.0,null,null,1.0,null,8.0,null,null,null,null,LumB,null,null,null,null,null,High,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,70-79%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,NO,NO,YES,LumB,null,miRNA cluster 14,null,Stage IIB,FEMALE,null
TCGA-AR-A2LM-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,2.0,null,3.0,null,3.0,1.0,null,null,1.0,null,8.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,70-79%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1,YES,NO,NO,YES,LumA,null,miRNA cluster 12,null,Stage II,FEMALE,null
TCGA-AR-A2LN-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,2.0,null,7.0,1.0,null,null,1.0,null,9.0,null,null,null,null,LumA,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIA,FEMALE,null
TCGA-AR-A2LO-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,null,8.0,4.0,null,null,1.0,null,9.0,null,null,null,null,LumA,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,null,70-79%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-AR-A2LQ-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,2.0,null,6.0,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,null,null,null,Quiet,C3-BRCA/Luminal,null,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,null,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,Normal,null,miRNA cluster 5,null,Stage IIB,FEMALE,null
TCGA-AR-A2LR-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,3.0,null,4.0,1.0,null,null,1.0,null,9.0,null,null,null,null,Basal,null,null,null,null,null,High,C4-BRCA/Basal,null,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Simple Mastectomy,null,null,null,null,Metaplastic Carcinoma,8575/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,NO,NO,NO,YES,Basal,null,miRNA cluster 5,null,Stage I,FEMALE,null
TCGA-AR-A5QM-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,2.0,null,3.0,null,2.0,3.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-AR-A5QN-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,2.0,null,3.0,5.0,null,null,3.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,3+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-AR-A5QP-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,2.0,null,2.0,10.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,null,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,null,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-AR-A5QQ-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,1.0,null,null,4.0,6.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,1+,"Other, specify",8575/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,Basal,null,null,null,Stage IIIA,FEMALE,null
TCGA-B6-A0I1-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,6.0,4.0,null,null,1.0,2.0,null,null,1.0,null,5.0,null,null,null,null,Basal,null,null,null,null,null,High,null,null,BRCA basal-like c8,null,BRCA basal-like c8,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,Basal,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-B6-A0I2-01,6.0,7.0,null,3.0,3.0,4.0,7.0,1.0,1.0,1.0,3.0,7.0,7.0,null,6.0,null,1.0,2.0,10.0,4.0,1.0,null,3.0,Stage I,null,Negative,N0,Basal,Basal-like,null,followup,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,null,null,null,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T1c,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IA,FEMALE,45.0
TCGA-B6-A0I5-01,3.0,7.0,null,null,null,null,7.0,1.0,7.0,8.0,4.0,7.0,10.0,null,10.0,null,1.0,3.0,1.0,9.0,2.0,null,1.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 12,cluster 6,Stage IIB,FEMALE,49.0
TCGA-B6-A0I6-01,null,2.0,2.0,null,null,null,2.0,10.0,1.0,10.0,4.0,7.0,10.0,2.0,null,null,1.0,8.0,10.0,6.0,2.0,null,1.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T1,T1,null,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T1c,null,NO,NO,YES,Basal,null,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,49.0
TCGA-B6-A0I8-01,null,2.0,2.0,null,null,null,2.0,10.0,10.0,8.0,4.0,7.0,null,1.0,null,null,null,1.0,3.0,6.0,null,null,2.0,No_Conversion,null,Negative,N0,LumA,Luminal A,null,followup,T1,T1,null,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,null,null,null,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),null,M0,T1,null,NO,NO,YES,LumA,null,miRNA cluster 4,cluster 4,Stage X,FEMALE,46.0
TCGA-B6-A0I9-01,10.0,1.0,1.0,1.0,1.0,1.0,1.0,10.0,9.0,6.0,6.0,5.0,9.0,1.0,null,null,1.0,null,8.0,6.0,null,null,2.0,No_Conversion,Indeterminate,Negative,N0,Her2,HER2-enriched,Positive,followup,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,No axillary staging,Indeterminate,null,Positive,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M1,T3,null,YES,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IV,FEMALE,62.0
TCGA-B6-A0IA-01,8.0,10.0,null,null,null,null,10.0,1.0,1.0,8.0,4.0,7.0,9.0,null,10.0,null,1.0,4.0,3.0,6.0,1.0,null,2.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,null,"Other, specify",8523/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 12,cluster 4,Stage IIA,FEMALE,51.0
TCGA-B6-A0IB-01,8.0,6.0,9.0,1.0,6.0,10.0,6.0,10.0,10.0,8.0,6.0,4.0,9.0,6.0,null,null,1.0,4.0,8.0,1.0,3.0,null,2.0,No_Conversion,Positive,Positive,N3,LumB,Luminal B,Positive,followup,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M1,T3,null,NO,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IV,FEMALE,64.0
TCGA-B6-A0IC-01,3.0,3.0,4.0,null,null,null,3.0,10.0,1.0,8.0,10.0,1.0,9.0,2.0,null,null,1.0,null,3.0,2.0,null,null,2.0,No_Conversion,Positive,Negative,N0,LumA,Luminal B,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,No axillary staging,Positive,null,Positive,Other,NO,null,null,null,"Other, specify",8503/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage X,FEMALE,90.0
TCGA-B6-A0IE-01,6.0,3.0,5.0,null,null,null,3.0,10.0,9.0,8.0,2.0,9.0,null,3.0,null,null,null,6.0,1.0,6.0,2.0,null,3.0,No_Conversion,Negative,Positive,N1,LumA,Normal-like,Negative,followup,null,TX,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Negative,Other,NO,null,null,null,Mixed Histology (please specify),8520/3,null,Incisional Biopsy,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,38.0
TCGA-B6-A0IG-01,null,7.0,10.0,null,null,null,7.0,10.0,9.0,10.0,4.0,7.0,8.0,6.0,null,null,1.0,4.0,8.0,10.0,2.0,null,3.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 12,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T2,null,YES,NO,YES,LumA,null,miRNA cluster 6,cluster 7,Stage IIB,FEMALE,50.0
TCGA-B6-A0IH-01,3.0,null,8.0,null,null,null,5.0,10.0,7.0,5.0,9.0,2.0,7.0,5.0,null,null,1.0,7.0,8.0,9.0,8.0,null,3.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,81.0
TCGA-B6-A0IJ-01,6.0,8.0,null,3.0,3.0,4.0,8.0,1.0,1.0,1.0,3.0,8.0,7.0,null,9.0,null,1.0,7.0,10.0,7.0,1.0,null,3.0,Stage IIB,Positive,Negative,N0,Basal,Basal-like,Positive,followup,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T3,YES,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,42.0
TCGA-B6-A0IK-01,10.0,1.0,1.0,1.0,1.0,1.0,1.0,10.0,2.0,6.0,6.0,5.0,8.0,1.0,null,null,1.0,4.0,8.0,6.0,1.0,null,3.0,No_Conversion,Negative,Positive,N1,Her2,HER2-enriched,Negative,followup,T_Other,T4,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 3,null,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T4,null,NO,NO,YES,Her2,Negative,miRNA cluster 4,cluster 4,Stage IIIB,FEMALE,63.0
TCGA-B6-A0IM-01,8.0,6.0,null,null,null,null,6.0,1.0,3.0,8.0,8.0,3.0,7.0,6.0,5.0,null,1.0,3.0,8.0,6.0,1.0,null,4.0,Stage IIB,Positive,Negative,N0,LumA,Luminal B,Positive,followup,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,"Other, specify",8523/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,75.0
TCGA-B6-A0IN-01,6.0,4.0,6.0,null,null,null,4.0,10.0,9.0,8.0,3.0,7.0,7.0,4.0,null,null,1.0,null,8.0,1.0,null,null,4.0,No_Conversion,Positive,Negative,N0,LumB,Luminal A,Negative,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,null,Negative,Other,NO,null,null,null,"Other, specify",8523/3,null,Fine needle aspiration biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,MX,T1c,null,NO,NO,YES,LumB,null,miRNA cluster 6,cluster 1,Stage X,FEMALE,45.0
TCGA-B6-A0IO-01,6.0,5.0,null,6.0,6.0,7.0,5.0,1.0,10.0,8.0,7.0,4.0,null,null,6.0,null,null,4.0,3.0,1.0,1.0,null,6.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Indeterminate,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Indeterminate,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),null,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,66.0
TCGA-B6-A0IP-01,3.0,5.0,null,null,null,null,5.0,1.0,7.0,10.0,8.0,3.0,6.0,6.0,4.0,null,1.0,4.0,8.0,2.0,1.0,null,4.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,74.0
TCGA-B6-A0IQ-01,1.0,7.0,null,3.0,3.0,4.0,7.0,1.0,1.0,1.0,3.0,8.0,7.0,null,5.0,null,1.0,6.0,10.0,7.0,1.0,null,4.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T3,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 5,Stage IIIA,FEMALE,40.0
TCGA-B6-A0RE-01,1.0,10.0,null,null,null,null,10.0,1.0,1.0,1.0,6.0,5.0,null,null,10.0,null,null,4.0,10.0,6.0,1.0,null,1.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,followup,null,TX,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),null,M0,TX,NO,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage X,FEMALE,61.0
TCGA-B6-A0RG-01,3.0,3.0,null,6.0,6.0,7.0,3.0,1.0,10.0,8.0,1.0,10.0,9.0,null,3.0,null,1.0,5.0,3.0,6.0,1.0,null,2.0,Stage IIB,Negative,Negative,N0,LumA,Luminal A,Negative,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T3,null,NO,NO,YES,LumA,Negative,miRNA cluster 3,cluster 4,Stage IIB,FEMALE,26.0
TCGA-B6-A0RH-01,3.0,9.0,null,6.0,6.0,7.0,9.0,1.0,10.0,6.0,4.0,7.0,9.0,9.0,7.0,null,1.0,6.0,3.0,9.0,1.0,null,2.0,Stage IIA,Positive,Negative,N0,Her2,HER2-enriched,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T2,YES,NO,NO,YES,Her2,Positive,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,51.0
TCGA-B6-A0RI-01,3.0,10.0,null,null,null,null,10.0,1.0,5.0,8.0,3.0,8.0,9.0,null,9.0,null,1.0,4.0,3.0,6.0,2.0,null,2.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T4,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T4b,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIB,FEMALE,44.0
TCGA-B6-A0RL-01,3.0,4.0,6.0,8.0,6.0,10.0,4.0,10.0,3.0,8.0,6.0,5.0,9.0,4.0,null,null,1.0,4.0,6.0,7.0,1.0,null,3.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 10,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,null,True,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,60.0
TCGA-B6-A0RM-01,8.0,4.0,6.0,6.0,6.0,7.0,4.0,10.0,3.0,8.0,5.0,6.0,9.0,4.0,null,null,1.0,1.0,3.0,2.0,null,null,3.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Positive,followup,null,TX,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,null,Positive,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),True,MX,TX,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage X,FEMALE,57.0
TCGA-B6-A0RN-01,3.0,8.0,null,1.0,8.0,7.0,8.0,1.0,7.0,8.0,6.0,5.0,9.0,null,10.0,null,1.0,5.0,8.0,2.0,1.0,null,3.0,Stage I,Negative,Negative,N0,LumA,Luminal A,Negative,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,60.0
TCGA-B6-A0RO-01,6.0,7.0,null,6.0,6.0,7.0,7.0,1.0,10.0,8.0,8.0,3.0,8.0,null,6.0,null,1.0,4.0,3.0,1.0,1.0,null,3.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T4,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T4,null,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIB,FEMALE,71.0
TCGA-B6-A0RP-01,8.0,5.0,7.0,6.0,6.0,7.0,5.0,10.0,1.0,7.0,8.0,3.0,null,5.0,null,null,null,4.0,3.0,6.0,1.0,null,3.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,Mixed Histology (please specify),8522/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,[Discrepancy],FEMALE,73.0
TCGA-B6-A0RQ-01,1.0,null,10.0,6.0,8.0,7.0,6.0,10.0,7.0,5.0,7.0,4.0,8.0,6.0,null,null,1.0,4.0,1.0,9.0,1.0,null,3.0,Stage IIB,Positive,Negative,N0,Normal,Luminal A,Positive,followup,T_Other,T3,Quiet,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,NO,NO,YES,Normal,Negative,miRNA cluster 4,cluster 6,Stage IIB,FEMALE,68.0
TCGA-B6-A0RS-01,1.0,5.0,7.0,null,null,null,5.0,10.0,10.0,10.0,2.0,9.0,null,5.0,null,null,null,4.0,10.0,6.0,1.0,null,1.0,Stage IIA,Negative,Negative,N0,Her2,HER2-enriched,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 5,Cluster 5,null,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Indeterminate (neither Pre or Postmenopausal),null,M0,T2,null,NO,NO,YES,Her2,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,38.0
TCGA-B6-A0RT-01,1.0,4.0,null,3.0,3.0,4.0,4.0,1.0,1.0,1.0,3.0,8.0,7.0,null,4.0,null,2.0,6.0,10.0,4.0,1.0,null,4.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T3,BRCA-LUAD+,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T3,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIIA,FEMALE,39.0
TCGA-B6-A0RU-01,1.0,6.0,null,3.0,3.0,4.0,6.0,1.0,1.0,1.0,3.0,8.0,10.0,null,10.0,null,1.0,4.0,10.0,9.0,1.0,null,1.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T1,T1,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Other,NO,null,null,null,"Other, specify",8523/3,null,Tumor resection,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T1c,YES,YES,NO,YES,Basal,Negative,miRNA cluster 13,cluster 6,Stage IA,FEMALE,49.0
TCGA-B6-A0RV-01,8.0,7.0,null,6.0,8.0,7.0,7.0,1.0,7.0,10.0,3.0,8.0,7.0,null,7.0,null,3.0,3.0,1.0,9.0,2.0,null,4.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T_Other,T3,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Incisional Biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIIA,FEMALE,42.0
TCGA-B6-A0WS-01,8.0,null,7.0,null,null,null,5.0,10.0,10.0,7.0,6.0,6.0,7.0,4.0,null,null,1.0,null,1.0,10.0,null,null,4.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,MX,T1c,null,NO,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage X,FEMALE,58.0
TCGA-B6-A0WT-01,6.0,9.0,null,null,null,null,9.0,1.0,9.0,7.0,6.0,5.0,8.0,null,7.0,null,1.0,4.0,3.0,6.0,1.0,null,3.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,61.0
TCGA-B6-A0WV-01,10.0,4.0,6.0,null,null,null,4.0,10.0,10.0,8.0,7.0,4.0,8.0,4.0,null,null,1.0,2.0,8.0,6.0,2.0,null,3.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,67.0
TCGA-B6-A0WW-01,8.0,1.0,1.0,null,null,null,1.0,10.0,10.0,8.0,6.0,5.0,6.0,1.0,null,null,1.0,5.0,8.0,2.0,2.0,null,4.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,MX,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage X,FEMALE,58.0
TCGA-B6-A0WX-01,1.0,1.0,2.0,3.0,3.0,4.0,1.0,10.0,1.0,10.0,3.0,8.0,6.0,1.0,null,null,2.0,5.0,10.0,6.0,3.0,null,5.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,"Other, specify",8520/3,null,Excisional Biopsy,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,40.0
TCGA-B6-A0WY-01,8.0,5.0,8.0,null,null,null,5.0,10.0,7.0,8.0,3.0,8.0,7.0,5.0,null,null,1.0,5.0,1.0,6.0,1.0,null,4.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Negative,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,40.0
TCGA-B6-A0WZ-01,3.0,6.0,null,null,null,null,6.0,1.0,1.0,8.0,4.0,7.0,null,null,8.0,null,null,5.0,8.0,6.0,4.0,null,4.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 4,Stage II,FEMALE,50.0
TCGA-B6-A0X0-01,3.0,null,9.0,6.0,6.0,7.0,6.0,10.0,7.0,8.0,5.0,6.0,7.0,6.0,null,null,1.0,8.0,3.0,10.0,1.0,null,4.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 12,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,"Other, specify",8201/3,null,Fine needle aspiration biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage I,FEMALE,54.0
TCGA-B6-A0X1-01,6.0,8.0,null,null,null,null,8.0,1.0,1.0,1.0,4.0,7.0,8.0,10.0,7.0,null,2.0,5.0,10.0,null,5.0,null,3.0,No_Conversion,Negative,Positive,N2,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Other,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M1,T2,NO,NO,NO,YES,Basal,null,null,null,Stage IIB,FEMALE,48.0
TCGA-B6-A0X4-01,6.0,2.0,2.0,null,null,null,2.0,10.0,1.0,8.0,6.0,5.0,7.0,2.0,null,null,1.0,5.0,3.0,1.0,1.0,null,4.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,62.0
TCGA-B6-A0X5-01,8.0,3.0,5.0,null,null,null,3.0,10.0,10.0,8.0,6.0,5.0,null,3.0,null,null,null,4.0,8.0,1.0,1.0,null,3.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,61.0
TCGA-B6-A0X7-01,3.0,3.0,4.0,null,null,null,3.0,10.0,7.0,8.0,6.0,5.0,null,3.0,null,null,null,1.0,3.0,4.0,null,null,3.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,No axillary staging,Positive,null,Positive,null,NO,null,null,null,Mixed Histology (please specify),8500/3,null,Excisional Biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage X,FEMALE,62.0
TCGA-B6-A1KC-01,8.0,2.0,null,null,null,null,2.0,1.0,null,null,7.0,4.0,null,null,2.0,null,null,1.0,6.0,7.0,1.0,null,7.0,Stage IIB,Positive,Positive,N1,LumB,null,Negative,followup,T_Other,T2,BRCA-LUAD+,null,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,LumB,null,miRNA c1uster 9,cluster 5,Stage IIB,FEMALE,67.0
TCGA-B6-A1KF-01,1.0,5.0,null,null,null,null,5.0,1.0,null,null,7.0,4.0,null,null,4.0,null,null,4.0,8.0,7.0,1.0,null,5.0,Stage IIB,Negative,Positive,N1,Basal,null,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,null,BRCA basal-like c8,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Other,NO,null,60-69%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,Basal,Positive,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,68.0
TCGA-B6-A1KI-01,3.0,4.0,null,null,null,null,4.0,1.0,null,null,6.0,5.0,4.0,null,3.0,1.0,1.0,1.0,1.0,2.0,1.0,null,7.0,Stage I,Positive,Negative,N0,LumA,null,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Other,NO,null,90-99%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,63.0
TCGA-B6-A1KN-01,10.0,6.0,null,null,null,null,6.0,1.0,null,null,5.0,6.0,6.0,null,5.0,null,1.0,7.0,6.0,9.0,7.0,null,5.0,Stage IIIC,Negative,Positive,N1,LumB,null,Negative,followup,T_Other,T4,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T4b,null,YES,NO,YES,LumB,Positive,miRNA cluster 4,cluster 6,Stage IIIB,FEMALE,57.0
TCGA-B6-A2IU-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,6.0,null,7.0,null,1.0,7.0,null,null,1.0,null,5.0,null,null,null,null,LumA,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,null,Indeterminate (neither Pre or Postmenopausal),True,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIA,FEMALE,null
TCGA-B6-A3ZX-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,2.0,2.0,null,null,2.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Negative,1+,Negative,Lumpectomy,NO,<10%,<10%,1+,Mixed Histology (please specify),8522/3,1+,Core needle biopsy,Negative,null,null,null,M1,T3,YES,YES,NO,YES,Basal,null,null,null,Stage IV,FEMALE,null
TCGA-B6-A400-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,3.0,null,1.0,null,1.0,2.0,null,null,2.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,1+,Negative,Lumpectomy,NO,<10%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,1+,Tumor resection,Negative,null,null,True,M0,T2,YES,YES,NO,YES,Basal,null,null,null,Stage IIIA,FEMALE,null
TCGA-B6-A401-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,3.0,null,4.0,null,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Lumpectomy,NO,80-89%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,null,True,M0,T1c,NO,NO,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-B6-A402-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,2.0,null,3.0,null,1.0,1.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,1+,Negative,Lumpectomy,YES,<10%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,1+,Core needle biopsy,Negative,null,null,True,M0,T1c,YES,YES,NO,YES,Basal,null,null,null,Stage I,FEMALE,null
TCGA-B6-A408-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,3.0,1.0,null,6.0,null,null,3.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Simple Mastectomy,NO,90-99%,20-29%,2+,Mixed Histology (please specify),8522/3,3+,Tumor resection,Equivocal,Negative,null,null,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-B6-A409-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,2.0,1.0,null,1.0,1.0,6.0,null,null,2.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,1+,Negative,Simple Mastectomy,NO,<10%,10-19%,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Fine needle aspiration biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,NO,NO,YES,Basal,null,null,null,Stage IIIA,FEMALE,null
TCGA-B6-A40B-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,4.0,null,4.0,null,1.0,1.0,null,null,1.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1b,NO,NO,NO,YES,LumA,null,null,null,Stage I,FEMALE,null
TCGA-B6-A40C-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,3.0,null,null,1.0,null,null,1.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,YES,50-59%,<10%,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,null,null,M0,T3,YES,YES,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-BH-A0AU-01,1.0,2.0,null,6.0,8.0,7.0,2.0,1.0,8.0,8.0,3.0,7.0,1.0,null,3.0,null,1.0,1.0,3.0,9.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,NO,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,45.0
TCGA-BH-A0AU-11,null,2.0,null,null,null,null,2.0,1.0,null,null,3.0,7.0,null,null,3.0,null,null,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,NO,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,45.0
TCGA-BH-A0AV-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,10.0,5.0,6.0,1.0,null,3.0,null,2.0,1.0,10.0,6.0,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,null,True,M0,T1c,YES,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,52.0
TCGA-BH-A0AW-01,6.0,1.0,null,null,null,null,1.0,1.0,2.0,6.0,5.0,6.0,1.0,null,1.0,null,1.0,3.0,1.0,7.0,1.0,1.0,9.0,No_Conversion,Positive,Positive,N1,Her2,HER2-enriched,Negative,followup,T1,T1,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Negative,Lumpectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,Her2,Positive,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,56.0
TCGA-BH-A0AY-01,6.0,2.0,null,1.0,8.0,7.0,2.0,1.0,10.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,1.0,1.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,62.0
TCGA-BH-A0AY-11,null,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,62.0
TCGA-BH-A0AZ-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,4.0,7.0,null,null,3.0,null,null,3.0,3.0,6.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,cM0 (i+),T3,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,47.0
TCGA-BH-A0AZ-11,null,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,null,null,3.0,null,null,3.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,cM0 (i+),T3,YES,NO,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,47.0
TCGA-BH-A0B0-01,3.0,3.0,null,6.0,8.0,7.0,3.0,1.0,7.0,5.0,5.0,6.0,2.0,null,3.0,null,2.0,1.0,1.0,9.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 9,cluster 6,Stage I,FEMALE,56.0
TCGA-BH-A0B1-01,null,2.0,null,null,null,null,2.0,1.0,8.0,8.0,7.0,4.0,2.0,null,2.0,null,4.0,4.0,null,9.0,1.0,1.0,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,null,null,null,null,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIB,FEMALE,66.0
TCGA-BH-A0B2-01,null,2.0,null,null,null,null,2.0,1.0,null,null,null,null,2.0,null,null,null,1.0,null,null,null,null,null,null,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,null,null,null,null,BRCA nonbasal-like c8,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,True,null,null,null,null,null,null,LumA,Negative,null,null,null,null,43.0
TCGA-BH-A0B2-11,null,2.0,null,null,null,null,2.0,1.0,null,null,null,null,2.0,null,null,null,1.0,null,null,null,null,null,null,null,null,null,null,Normal,null,null,enrollment,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,True,null,null,null,null,null,null,Normal,null,null,null,null,null,43.0
TCGA-BH-A0B3-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,1.0,1.0,5.0,6.0,2.0,null,2.0,null,2.0,7.0,10.0,6.0,1.0,null,8.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,0,Negative,Other,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,53.0
TCGA-BH-A0B3-11,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,null,null,2.0,null,null,7.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,followup,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,0,Negative,Other,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,53.0
TCGA-BH-A0B4-01,10.0,2.0,null,1.0,6.0,7.0,2.0,1.0,8.0,8.0,7.0,4.0,2.0,null,2.0,2.0,2.0,3.0,8.0,9.0,2.0,null,8.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,80-89%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Positive,null,True,M0,T2,null,YES,NO,YES,LumA,Positive,miRNA cluster 4,cluster 6,Stage IIIA,MALE,65.0
TCGA-BH-A0B5-01,3.0,3.0,null,1.0,6.0,10.0,3.0,1.0,5.0,8.0,3.0,8.0,2.0,null,3.0,null,4.0,6.0,8.0,10.0,2.0,null,8.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 1,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,40.0
TCGA-BH-A0B5-11,null,3.0,null,null,null,null,3.0,1.0,null,null,3.0,8.0,2.0,null,3.0,null,3.0,6.0,null,null,2.0,null,8.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 1,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,40.0
TCGA-BH-A0B6-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,3.0,null,null,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,Squamous,null,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,null,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,null,null,null,M0,T1c,NO,YES,NO,YES,LumA,null,miRNA cluster 3,null,Stage I,FEMALE,null
TCGA-BH-A0B7-01,6.0,3.0,null,3.0,3.0,1.0,3.0,1.0,2.0,4.0,3.0,8.0,2.0,null,3.0,null,2.0,4.0,10.0,4.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,Her2,HER2-enriched,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Her2,Positive,miRNA cluster 7,cluster 3,Stage IIB,FEMALE,42.0
TCGA-BH-A0B7-11,null,3.0,null,null,null,null,3.0,1.0,null,null,3.0,8.0,2.0,null,3.0,null,5.0,4.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,42.0
TCGA-BH-A0B8-01,null,3.0,null,null,null,null,3.0,1.0,3.0,8.0,6.0,5.0,null,null,2.0,1.0,null,1.0,6.0,10.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,null,null,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1b,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 7,Stage I,FEMALE,64.0
TCGA-BH-A0B8-11,null,3.0,null,null,null,null,3.0,1.0,null,null,6.0,5.0,2.0,null,2.0,1.0,2.0,1.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,followup,null,null,null,null,null,null,null,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1b,null,YES,NO,YES,Normal,null,null,null,Stage I,FEMALE,64.0
TCGA-BH-A0B9-01,1.0,3.0,null,3.0,3.0,4.0,3.0,1.0,1.0,1.0,3.0,8.0,2.0,null,2.0,null,1.0,1.0,10.0,7.0,1.0,null,8.0,Stage I,Negative,Negative,N0,null,Basal-like,Negative,followup,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,null,mutation cluster 5,Sentinel node biopsy alone,Negative,0,Negative,Other,NO,null,<10%,0,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,null,YES,NO,YES,Basal,Negative,miRNA cluster 14,cluster 5,Stage IA,FEMALE,44.0
TCGA-BH-A0BA-01,6.0,2.0,null,1.0,8.0,7.0,2.0,1.0,7.0,10.0,4.0,7.0,2.0,null,2.0,null,2.0,7.0,8.0,9.0,8.0,null,8.0,No_Conversion,Positive,Positive,N3,LumA,Luminal A,Positive,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Modified Radical Mastectomy,NO,80-89%,null,1+,Mixed Histology (please specify),8522/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage IIIC,FEMALE,51.0
TCGA-BH-A0BA-11,null,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,2.0,null,2.0,null,1.0,7.0,null,null,8.0,null,8.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Modified Radical Mastectomy,NO,80-89%,null,1+,Mixed Histology (please specify),8522/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,Normal,null,null,null,Stage IIIC,FEMALE,51.0
TCGA-BH-A0BC-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,7.0,6.0,5.0,2.0,null,2.0,null,1.0,5.0,3.0,6.0,4.0,null,8.0,No_Conversion,Positive,Positive,N3,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Other,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,60.0
TCGA-BH-A0BC-11,null,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,2.0,null,2.0,null,1.0,5.0,null,null,4.0,null,8.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Other,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIIC,FEMALE,60.0
TCGA-BH-A0BD-01,8.0,1.0,null,null,null,null,1.0,1.0,10.0,10.0,4.0,7.0,null,null,1.0,null,null,3.0,8.0,6.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,47.0
TCGA-BH-A0BF-01,3.0,2.0,null,6.0,1.0,10.0,2.0,1.0,9.0,6.0,5.0,6.0,1.0,2.0,1.0,null,2.0,1.0,1.0,6.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,56.0
TCGA-BH-A0BF-11,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,1.0,2.0,1.0,null,2.0,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,null,null,null,null,Stage IIB,FEMALE,56.0
TCGA-BH-A0BG-01,1.0,2.0,null,null,null,null,2.0,1.0,1.0,1.0,8.0,3.0,2.0,null,3.0,null,1.0,1.0,10.0,6.0,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,NO,YES,NO,YES,Basal,Negative,miRNA c1uster 9,cluster 4,Stage I,FEMALE,73.0
TCGA-BH-A0BJ-01,6.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,3.0,8.0,1.0,null,1.0,null,1.0,5.0,3.0,10.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 7,Stage IIB,FEMALE,41.0
TCGA-BH-A0BJ-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,1.0,5.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,41.0
TCGA-BH-A0BL-01,6.0,2.0,null,null,null,null,2.0,1.0,1.0,1.0,2.0,9.0,2.0,null,3.0,null,1.0,1.0,10.0,6.0,1.0,null,8.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,BRCA-LUAD+,C4-BRCA/Basal,cluster 5,Low purity c2,null,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,35.0
TCGA-BH-A0BL-11,null,2.0,null,null,null,null,2.0,1.0,null,null,2.0,9.0,2.0,null,3.0,null,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,NO,NO,YES,null,null,null,null,Stage I,FEMALE,35.0
TCGA-BH-A0BM-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,5.0,6.0,2.0,null,3.0,null,1.0,6.0,3.0,9.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Negative,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,0,Negative,Lumpectomy,NO,null,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 3,cluster 6,Stage IIB,FEMALE,54.0
TCGA-BH-A0BM-11,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,3.0,null,1.0,6.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,0,Negative,Lumpectomy,NO,null,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,54.0
TCGA-BH-A0BO-01,1.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,5.0,6.0,2.0,null,3.0,null,2.0,1.0,1.0,9.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1b,NO,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage I,FEMALE,54.0
TCGA-BH-A0BO-11,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,3.0,null,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1b,NO,YES,NO,YES,null,null,null,null,Stage I,FEMALE,54.0
TCGA-BH-A0BP-01,3.0,3.0,null,1.0,8.0,7.0,3.0,1.0,7.0,5.0,8.0,3.0,2.0,3.0,2.0,null,1.0,1.0,8.0,6.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,NO,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,76.0
TCGA-BH-A0BQ-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,3.0,8.0,2.0,null,3.0,null,1.0,1.0,1.0,9.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,NO,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage I,FEMALE,39.0
TCGA-BH-A0BQ-11,null,2.0,null,null,null,null,2.0,1.0,null,null,3.0,8.0,2.0,null,3.0,null,2.0,1.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,NO,NO,NO,YES,Normal,null,null,null,Stage I,FEMALE,39.0
TCGA-BH-A0BR-01,1.0,3.0,null,1.0,6.0,7.0,3.0,1.0,7.0,8.0,6.0,5.0,2.0,null,3.0,null,1.0,1.0,8.0,6.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,NO,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 4,Stage I,FEMALE,59.0
TCGA-BH-A0BS-01,3.0,3.0,null,6.0,6.0,7.0,3.0,1.0,10.0,9.0,5.0,6.0,2.0,null,4.0,null,1.0,3.0,3.0,10.0,1.0,null,8.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,55.0
TCGA-BH-A0BS-11,null,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,2.0,null,4.0,null,1.0,3.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,55.0
TCGA-BH-A0BT-01,8.0,2.0,null,6.0,6.0,7.0,2.0,1.0,1.0,8.0,5.0,6.0,2.0,null,3.0,null,1.0,null,3.0,9.0,null,null,8.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 7,cluster 6,Stage IIA,FEMALE,56.0
TCGA-BH-A0BT-11,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,3.0,null,1.0,null,null,null,null,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T1c,YES,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,56.0
TCGA-BH-A0BV-01,10.0,3.0,null,1.0,6.0,7.0,3.0,1.0,10.0,7.0,9.0,2.0,2.0,null,2.0,null,3.0,6.0,8.0,10.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 7,Stage IIB,FEMALE,78.0
TCGA-BH-A0BV-11,null,3.0,null,null,null,null,3.0,1.0,null,null,9.0,2.0,2.0,null,2.0,null,1.0,6.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,78.0
TCGA-BH-A0BW-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,8.0,3.0,2.0,null,3.0,null,1.0,2.0,10.0,4.0,1.0,null,8.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage I,FEMALE,71.0
TCGA-BH-A0BW-11,null,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,null,null,3.0,null,null,2.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation c1uster 9,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,YES,NO,YES,Normal,null,null,null,Stage I,FEMALE,71.0
TCGA-BH-A0BZ-01,8.0,3.0,null,1.0,1.0,10.0,3.0,1.0,9.0,6.0,6.0,5.0,2.0,null,3.0,null,4.0,6.0,8.0,9.0,1.0,null,8.0,Stage IIIA,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 10,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,LumB,Negative,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,59.0
TCGA-BH-A0BZ-11,null,3.0,null,null,null,null,3.0,1.0,null,null,6.0,5.0,2.0,null,3.0,null,3.0,6.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 10,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,59.0
TCGA-BH-A0C0-01,6.0,2.0,null,1.0,1.0,10.0,2.0,1.0,9.0,6.0,6.0,5.0,null,null,2.0,3.0,null,8.0,8.0,6.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,YES,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,62.0
TCGA-BH-A0C0-11,null,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,2.0,null,2.0,3.0,2.0,8.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,62.0
TCGA-BH-A0C1-01,3.0,2.0,null,1.0,6.0,7.0,2.0,1.0,10.0,10.0,6.0,5.0,2.0,2.0,2.0,null,2.0,3.0,8.0,7.0,3.0,null,8.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,61.0
TCGA-BH-A0C3-01,6.0,3.0,null,6.0,6.0,10.0,3.0,1.0,7.0,10.0,4.0,7.0,2.0,null,4.0,null,1.0,1.0,3.0,9.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Negative,Other,null,null,null,null,Mixed Histology (please specify),8522/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,YES,NO,YES,LumB,Negative,miRNA cluster 13,cluster 6,Stage I,FEMALE,47.0
TCGA-BH-A0C3-11,null,3.0,null,null,null,null,3.0,1.0,null,null,4.0,7.0,2.0,null,4.0,null,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,null,Positive,null,Negative,Other,null,null,null,null,Mixed Histology (please specify),8522/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,YES,NO,YES,Normal,null,null,null,Stage I,FEMALE,47.0
TCGA-BH-A0C7-01,10.0,2.0,null,1.0,6.0,10.0,2.0,1.0,10.0,8.0,4.0,7.0,2.0,null,4.0,null,1.0,5.0,8.0,6.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Positive,Peri (6-12 months since last menstrual period),True,M0,T2,YES,NO,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,48.0
TCGA-BH-A0DD-01,6.0,2.0,null,1.0,6.0,10.0,2.0,1.0,6.0,8.0,6.0,5.0,2.0,null,3.0,null,2.0,6.0,8.0,6.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,null,True,M0,T2,YES,NO,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIB,MALE,58.0
TCGA-BH-A0DD-11,null,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,2.0,null,3.0,null,3.0,6.0,null,null,1.0,null,8.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,null,True,M0,T2,YES,NO,NO,YES,LumA,null,null,null,Stage IIB,MALE,58.0
TCGA-BH-A0DE-01,10.0,2.0,null,null,null,null,2.0,1.0,7.0,5.0,6.0,5.0,null,null,3.0,null,null,1.0,8.0,9.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,NO,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,62.0
TCGA-BH-A0DE-11,null,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,2.0,null,3.0,null,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,YES,NO,YES,null,null,null,null,Stage IIA,FEMALE,62.0
TCGA-BH-A0DG-01,6.0,2.0,null,1.0,8.0,7.0,2.0,1.0,7.0,7.0,1.0,10.0,null,null,3.0,null,null,1.0,1.0,6.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,30.0
TCGA-BH-A0DG-11,null,2.0,null,null,null,null,2.0,1.0,null,null,1.0,10.0,2.0,null,3.0,null,3.0,1.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,30.0
TCGA-BH-A0DH-01,3.0,2.0,null,10.0,6.0,7.0,2.0,1.0,10.0,8.0,6.0,5.0,null,null,2.0,null,null,7.0,6.0,1.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,3+,Positive,Other,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,63.0
TCGA-BH-A0DH-11,null,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,2.0,null,2.0,null,2.0,7.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Positive,3+,Positive,Other,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,63.0
TCGA-BH-A0DI-01,10.0,1.0,null,1.0,8.0,7.0,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,2.0,null,1.0,7.0,1.0,6.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,63.0
TCGA-BH-A0DI-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,3.0,7.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,null,null,null,null,Stage IIB,FEMALE,63.0
TCGA-BH-A0DK-01,3.0,1.0,null,8.0,6.0,7.0,1.0,1.0,7.0,7.0,4.0,7.0,1.0,null,1.0,null,2.0,1.0,6.0,2.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,49.0
TCGA-BH-A0DK-11,null,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,3.0,1.0,null,null,1.0,null,9.0,null,null,null,null,LumA,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,0,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,49.0
TCGA-BH-A0DL-01,6.0,3.0,null,3.0,3.0,4.0,3.0,1.0,1.0,10.0,6.0,4.0,2.0,null,3.0,null,2.0,1.0,10.0,6.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,mutation cluster 3,null,Positive,null,Negative,Other,null,null,null,null,"Other, specify",8575/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 11,cluster 4,Stage IIA,FEMALE,64.0
TCGA-BH-A0DL-11,null,3.0,null,null,null,null,3.0,1.0,null,null,6.0,4.0,null,null,3.0,null,null,1.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 3,null,Positive,null,Negative,Other,null,null,null,null,"Other, specify",8575/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,64.0
TCGA-BH-A0DO-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,5.0,9.0,2.0,1.0,null,2.0,null,1.0,1.0,1.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,NO,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage I,FEMALE,78.0
TCGA-BH-A0DO-11,null,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,null,null,2.0,null,null,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,NO,NO,NO,YES,Normal,null,null,null,Stage I,FEMALE,78.0
TCGA-BH-A0DP-01,3.0,1.0,null,1.0,8.0,7.0,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,1.0,null,3.0,1.0,8.0,2.0,1.0,null,9.0,Stage IIB,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,NO,80-89%,<10%,0,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 3,cluster 2,Stage IIB,FEMALE,60.0
TCGA-BH-A0DP-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,NO,80-89%,<10%,0,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,60.0
TCGA-BH-A0DQ-01,10.0,1.0,null,null,null,null,1.0,1.0,7.0,10.0,3.0,8.0,1.0,null,1.0,null,1.0,6.0,3.0,9.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Other,NO,60-69%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,1+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIB,FEMALE,42.0
TCGA-BH-A0DQ-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,1.0,6.0,null,null,1.0,null,9.0,null,null,null,null,LumA,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Other,NO,60-69%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,1+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,42.0
TCGA-BH-A0DS-01,6.0,1.0,null,8.0,10.0,7.0,1.0,1.0,7.0,5.0,8.0,3.0,1.0,null,1.0,null,1.0,4.0,6.0,9.0,3.0,null,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Other,NO,70-79%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 6,Stage IIIA,FEMALE,71.0
TCGA-BH-A0DT-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,3.0,8.0,null,null,3.0,null,null,5.0,1.0,9.0,1.0,null,8.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,41.0
TCGA-BH-A0DT-11,null,2.0,null,null,null,null,2.0,1.0,null,null,3.0,8.0,2.0,null,3.0,null,2.0,5.0,null,null,1.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,41.0
TCGA-BH-A0DV-01,6.0,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,3.0,null,2.0,3.0,1.0,9.0,3.0,null,8.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 3,cluster 6,Stage IIIA,FEMALE,54.0
TCGA-BH-A0DV-11,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,3.0,null,1.0,3.0,null,null,3.0,null,8.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,54.0
TCGA-BH-A0DX-01,1.0,3.0,null,null,null,null,3.0,1.0,7.0,5.0,6.0,5.0,null,null,3.0,null,null,3.0,1.0,9.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1b,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 9,cluster 6,Stage I,FEMALE,62.0
TCGA-BH-A0DZ-01,10.0,1.0,null,null,null,null,1.0,1.0,9.0,8.0,3.0,8.0,1.0,null,1.0,null,1.0,2.0,8.0,6.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,HER2-enriched,Positive,followup,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 2,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Simple Mastectomy,NO,50-59%,30-39%,3+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,43.0
TCGA-BH-A0DZ-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,null,null,1.0,null,null,2.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 2,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Simple Mastectomy,NO,50-59%,30-39%,3+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,NO,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,43.0
TCGA-BH-A0E0-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,2.0,9.0,1.0,null,1.0,null,3.0,5.0,10.0,7.0,3.0,null,9.0,No_Conversion,Negative,Positive,N3,Basal,Basal-like,Negative,followup,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,0,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,Basal,Negative,miRNA cluster 11,cluster 5,Stage IIIC,FEMALE,38.0
TCGA-BH-A0E0-11,null,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,1.0,null,1.0,5.0,null,null,3.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,Axillary lymph node dissection alone,Negative,0,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,YES,NO,YES,Normal,null,null,null,Stage IIIC,FEMALE,38.0
TCGA-BH-A0E1-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,5.0,6.0,1.0,null,1.0,1.0,5.0,4.0,3.0,9.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 10,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Simple Mastectomy,NO,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Equivocal,Negative,Peri (6-12 months since last menstrual period),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 3,cluster 6,Stage IIB,FEMALE,52.0
TCGA-BH-A0E1-11,null,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,1.0,3.0,4.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 10,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Simple Mastectomy,NO,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Equivocal,Negative,Peri (6-12 months since last menstrual period),True,M0,T2,null,NO,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,52.0
TCGA-BH-A0E2-01,3.0,1.0,null,null,null,null,1.0,1.0,4.0,8.0,4.0,7.0,1.0,null,1.0,null,1.0,6.0,8.0,null,2.0,null,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,1+,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,NO,YES,LumA,Negative,null,null,Stage IIIA,FEMALE,49.0
TCGA-BH-A0E6-01,1.0,1.0,null,1.0,8.0,7.0,1.0,1.0,1.0,10.0,7.0,4.0,1.0,null,1.0,1.0,1.0,1.0,1.0,6.0,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T1,T1,High,C4-BRCA/Basal,cluster 1,BRCA basal-like c8,OV-like c4,BRCA basal-like c8,mutation cluster 2,Sentinel node biopsy alone,Negative,0,Negative,Other,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 4,Stage IA,FEMALE,69.0
TCGA-BH-A0E7-01,8.0,2.0,null,6.0,6.0,7.0,2.0,1.0,1.0,8.0,9.0,2.0,2.0,null,2.0,null,1.0,4.0,3.0,2.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,3+,Positive,Other,NO,50-59%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Excisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,79.0
TCGA-BH-A0E9-01,6.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,5.0,6.0,2.0,null,3.0,null,3.0,3.0,1.0,9.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 3,cluster 6,Stage IIB,FEMALE,53.0
TCGA-BH-A0EA-01,3.0,2.0,2.0,6.0,8.0,7.0,2.0,10.0,7.0,5.0,8.0,3.0,1.0,2.0,null,null,1.0,1.0,1.0,9.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA c1uster 9,cluster 6,Stage IIA,FEMALE,72.0
TCGA-BH-A0EB-01,3.0,2.0,null,null,null,null,2.0,1.0,1.0,7.0,7.0,4.0,null,null,1.0,1.0,null,1.0,1.0,null,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,YES,NO,YES,LumA,Negative,null,null,Stage IA,FEMALE,69.0
TCGA-BH-A0EE-01,10.0,2.0,null,3.0,6.0,1.0,2.0,1.0,2.0,3.0,7.0,4.0,2.0,null,2.0,null,5.0,1.0,1.0,10.0,1.0,null,8.0,Stage IIB,Negative,Negative,N0,Her2,HER2-enriched,Negative,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 1,Cluster 6,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Negative,0,Negative,Simple Mastectomy,NO,null,30-39%,3+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,NO,NO,YES,Her2,Positive,miRNA c1uster 10,cluster 7,Stage IIB,FEMALE,68.0
TCGA-BH-A0EI-01,10.0,2.0,null,1.0,6.0,7.0,2.0,1.0,7.0,5.0,4.0,7.0,null,null,3.0,null,null,1.0,8.0,6.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),null,M0,T1c,NO,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,51.0
TCGA-BH-A0GY-01,6.0,2.0,null,6.0,6.0,7.0,2.0,1.0,8.0,8.0,7.0,4.0,1.0,null,2.0,null,1.0,6.0,3.0,7.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,NO,40-49%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 5,Stage IIA,FEMALE,67.0
TCGA-BH-A0GZ-01,6.0,1.0,null,null,null,null,1.0,1.0,10.0,8.0,6.0,5.0,1.0,null,1.0,1.0,1.0,4.0,8.0,2.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,62.0
TCGA-BH-A0H0-01,3.0,1.0,null,null,null,null,1.0,1.0,3.0,8.0,7.0,4.0,1.0,null,1.0,null,1.0,1.0,8.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Positive,followup,T1,T1,Squamous,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,2+,Positive,Other,NO,50-59%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumB,Negative,miRNA cluster 3,cluster 2,Stage IA,FEMALE,69.0
TCGA-BH-A0H3-01,3.0,2.0,null,null,null,null,2.0,1.0,9.0,7.0,4.0,7.0,1.0,null,3.0,null,1.0,1.0,3.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,NO,YES,NO,YES,LumA,Negative,miRNA cluster 3,cluster 6,Stage I,FEMALE,46.0
TCGA-BH-A0H5-01,1.0,2.0,null,3.0,3.0,1.0,2.0,1.0,9.0,6.0,3.0,7.0,2.0,null,2.0,null,2.0,1.0,1.0,4.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Quiet,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage I,FEMALE,45.0
TCGA-BH-A0H5-11,null,2.0,null,null,null,null,2.0,1.0,null,null,3.0,7.0,null,null,2.0,null,null,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,NO,YES,Normal,null,null,null,Stage I,FEMALE,45.0
TCGA-BH-A0H6-01,8.0,2.0,null,6.0,6.0,7.0,2.0,1.0,7.0,8.0,9.0,2.0,null,null,1.0,null,null,1.0,3.0,2.0,1.0,1.0,9.0,No_Conversion,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,3+,Positive,Other,NO,50-59%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1b,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,82.0
TCGA-BH-A0H7-01,6.0,1.0,null,1.0,6.0,7.0,1.0,1.0,8.0,8.0,7.0,4.0,1.0,null,1.0,null,2.0,4.0,8.0,6.0,2.0,null,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Positive,followup,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,70-79%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 4,Stage IIIA,FEMALE,65.0
TCGA-BH-A0H7-11,null,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,4.0,null,null,2.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,70-79%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,65.0
TCGA-BH-A0H9-01,1.0,2.0,null,3.0,3.0,4.0,2.0,1.0,8.0,8.0,7.0,4.0,2.0,null,2.0,1.0,1.0,1.0,10.0,9.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 14,Sentinel node biopsy alone,Positive,1+,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,69.0
TCGA-BH-A0H9-11,null,2.0,null,null,null,null,2.0,1.0,null,null,7.0,4.0,2.0,null,2.0,1.0,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 14,Sentinel node biopsy alone,Positive,1+,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,69.0
TCGA-BH-A0HA-01,1.0,2.0,null,6.0,8.0,7.0,2.0,1.0,7.0,5.0,1.0,10.0,null,null,2.0,null,null,1.0,3.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,NO,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage I,FEMALE,31.0
TCGA-BH-A0HA-11,null,2.0,null,null,null,null,2.0,1.0,null,null,1.0,10.0,1.0,null,2.0,null,2.0,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,NO,NO,NO,YES,Normal,null,null,null,Stage I,FEMALE,31.0
TCGA-BH-A0HB-01,10.0,2.0,null,null,null,null,2.0,1.0,4.0,8.0,5.0,6.0,1.0,null,1.0,1.0,1.0,1.0,1.0,6.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 14,Sentinel node biopsy alone,Positive,1+,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,55.0
TCGA-BH-A0HF-01,null,2.0,null,null,null,null,2.0,1.0,7.0,5.0,8.0,3.0,1.0,null,1.0,null,1.0,1.0,3.0,6.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,null,null,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,1+,Positive,Other,NO,90-99%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,77.0
TCGA-BH-A0HI-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,9.0,2.0,1.0,null,1.0,null,1.0,1.0,3.0,10.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,1+,Positive,Other,YES,50-59%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IA,FEMALE,78.0
TCGA-BH-A0HK-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,10.0,10.0,9.0,2.0,1.0,null,1.0,null,4.0,4.0,6.0,10.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Negative,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,0,Negative,Modified Radical Mastectomy,NO,70-79%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIB,FEMALE,81.0
TCGA-BH-A0HK-11,null,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,2.0,4.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,followup,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Positive,0,Negative,Modified Radical Mastectomy,NO,70-79%,<10%,0,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,81.0
TCGA-BH-A0HL-01,null,1.0,null,null,null,null,1.0,1.0,1.0,10.0,5.0,6.0,1.0,null,1.0,1.0,2.0,4.0,6.0,6.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,null,Basal-like,Positive,followup,T_Other,T2,null,null,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,null,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8503/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 11,cluster 4,Stage IIB,FEMALE,56.0
TCGA-BH-A0HN-01,null,1.0,null,null,null,null,1.0,1.0,1.0,10.0,7.0,4.0,1.0,null,1.0,1.0,1.0,1.0,3.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,null,Basal-like,Positive,followup,T1,T1,null,null,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,mutation cluster 14,Sentinel node biopsy alone,Positive,3+,Positive,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 11,cluster 6,Stage IA,FEMALE,67.0
TCGA-BH-A0HO-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,4.0,7.0,1.0,null,1.0,null,1.0,5.0,3.0,2.0,1.0,2.0,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 2,Stage IIA,FEMALE,48.0
TCGA-BH-A0HP-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,7.0,4.0,1.0,null,1.0,null,4.0,4.0,1.0,9.0,3.0,null,9.0,No_Conversion,Positive,Positive,N2,LumA,Luminal A,Negative,followup,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,0,Negative,Modified Radical Mastectomy,NO,80-89%,null,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,65.0
TCGA-BH-A0HQ-01,null,2.0,null,null,null,null,2.0,1.0,7.0,8.0,5.0,6.0,2.0,null,2.0,null,1.0,1.0,8.0,2.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Other,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,56.0
TCGA-BH-A0HU-01,3.0,1.0,null,6.0,1.0,10.0,1.0,1.0,9.0,8.0,5.0,6.0,1.0,null,1.0,null,1.0,1.0,3.0,6.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Positive,followup,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,2+,Positive,Other,NO,40-49%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T1c,null,YES,NO,YES,LumB,Negative,miRNA cluster 14,cluster 4,Stage IA,FEMALE,52.0
TCGA-BH-A0HW-01,8.0,3.0,null,6.0,6.0,10.0,3.0,1.0,3.0,8.0,6.0,5.0,3.0,null,2.0,1.0,1.0,1.0,3.0,2.0,1.0,null,8.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Negative,followup,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,0,Negative,Other,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,62.0
TCGA-BH-A0HX-01,8.0,2.0,null,1.0,6.0,7.0,2.0,1.0,3.0,8.0,5.0,6.0,1.0,null,1.0,null,1.0,6.0,8.0,6.0,1.0,3.0,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Simple Mastectomy,YES,80-89%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,54.0
TCGA-BH-A0HY-01,null,2.0,null,null,null,null,2.0,1.0,10.0,6.0,6.0,5.0,null,null,2.0,null,null,1.0,6.0,6.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumB,HER2-enriched,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,NO,YES,LumB,null,miRNA cluster 4,cluster 4,Stage I,FEMALE,60.0
TCGA-BH-A0RX-01,8.0,1.0,null,6.0,3.0,4.0,1.0,1.0,1.0,1.0,6.0,5.0,1.0,null,1.0,null,1.0,1.0,10.0,6.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C4-BRCA/Basal,cluster 5,Low purity c2,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,0,Negative,Other,NO,<10%,null,1+,Infiltrating Ductal Carcinoma,8500/3,0,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 4,Stage IIA,FEMALE,59.0
TCGA-BH-A0W3-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,6.0,5.0,1.0,null,1.0,null,1.0,1.0,3.0,7.0,1.0,2.0,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Indeterminate (neither Pre or Postmenopausal),True,M0,T1c,null,YES,NO,YES,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,58.0
TCGA-BH-A0W4-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,7.0,5.0,4.0,7.0,1.0,null,1.0,null,1.0,1.0,3.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,46.0
TCGA-BH-A0W5-01,8.0,1.0,null,1.0,6.0,7.0,1.0,1.0,7.0,7.0,8.0,2.0,2.0,null,2.0,null,1.0,3.0,1.0,6.0,1.0,2.0,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Equivocal,null,True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 4,Stage IIA,FEMALE,77.0
TCGA-BH-A0W7-01,8.0,1.0,null,null,null,null,1.0,1.0,7.0,7.0,4.0,7.0,null,null,2.0,null,null,1.0,1.0,6.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,null,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,49.0
TCGA-BH-A0WA-01,1.0,1.0,null,null,null,null,1.0,1.0,1.0,1.0,9.0,2.0,1.0,null,1.0,null,1.0,1.0,10.0,7.0,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,null,null,8575/3,null,Fine needle aspiration biopsy,Negative,null,null,True,M0,T1c,null,NO,NO,YES,Basal,Negative,miRNA cluster 4,cluster 5,Stage I,FEMALE,82.0
TCGA-BH-A18F-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,4.0,7.0,1.0,null,2.0,null,1.0,1.0,1.0,9.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,3+,Positive,Other,null,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 6,Stage IIA,FEMALE,50.0
TCGA-BH-A18F-11,null,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,3+,Positive,Other,null,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,YES,NO,YES,null,null,null,null,Stage IIA,FEMALE,50.0
TCGA-BH-A18G-01,6.0,1.0,null,null,null,null,1.0,1.0,1.0,10.0,9.0,2.0,1.0,null,1.0,null,1.0,1.0,8.0,6.0,1.0,null,9.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T1,T1,Iq,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,NO,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,81.0
TCGA-BH-A18H-01,6.0,1.0,null,6.0,1.0,7.0,1.0,1.0,9.0,6.0,6.0,5.0,1.0,null,1.0,null,1.0,1.0,1.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Equivocal,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1b,YES,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IA,FEMALE,63.0
TCGA-BH-A18I-01,8.0,1.0,null,null,null,null,1.0,1.0,7.0,7.0,5.0,6.0,1.0,null,2.0,null,1.0,1.0,3.0,6.0,1.0,2.0,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,cM0 (i+),T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,53.0
TCGA-BH-A18J-01,3.0,1.0,2.0,6.0,6.0,10.0,1.0,10.0,10.0,8.0,5.0,6.0,6.0,1.0,null,null,3.0,null,1.0,6.0,null,null,5.0,No_Conversion,Positive,Positive,N2,LumA,Luminal B,Positive,enrollment,T_Other,T4,Squamous,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,40-49%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,null,null,True,M1,T4b,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IV,FEMALE,56.0
TCGA-BH-A18J-11,null,1.0,2.0,null,null,null,1.0,10.0,null,null,5.0,6.0,6.0,1.0,null,null,2.0,null,null,null,null,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,40-49%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,Negative,null,null,True,M1,T4b,null,null,NO,YES,Normal,null,null,null,Stage IV,FEMALE,56.0
TCGA-BH-A18K-01,3.0,4.0,7.0,null,null,null,4.0,10.0,1.0,1.0,4.0,7.0,6.0,4.0,null,null,1.0,3.0,3.0,7.0,1.0,null,5.0,Stage I,Positive,Negative,N0,LumA,Basal-like,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T1,null,null,NO,YES,LumA,Negative,miRNA cluster 2,cluster 5,Stage I,FEMALE,46.0
TCGA-BH-A18K-11,null,4.0,7.0,null,null,null,4.0,10.0,null,null,4.0,7.0,null,4.0,null,null,null,3.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,null,M0,T1,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,46.0
TCGA-BH-A18L-01,10.0,1.0,2.0,1.0,1.0,10.0,2.0,10.0,3.0,6.0,4.0,7.0,null,1.0,null,null,null,1.0,8.0,1.0,1.0,2.0,7.0,Stage IIIA,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,null,M0,T3,null,null,NO,YES,LumB,null,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,50.0
TCGA-BH-A18L-11,null,1.0,2.0,null,null,null,2.0,10.0,null,null,4.0,7.0,4.0,1.0,null,null,3.0,1.0,null,null,1.0,2.0,7.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T3,null,null,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,50.0
TCGA-BH-A18M-01,3.0,4.0,5.0,6.0,8.0,7.0,4.0,10.0,7.0,5.0,3.0,8.0,5.0,3.0,null,null,2.0,2.0,1.0,9.0,2.0,6.0,6.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,null,True,M0,T3,null,null,NO,YES,LumA,Positive,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,39.0
TCGA-BH-A18M-11,null,4.0,5.0,null,null,null,4.0,10.0,null,null,3.0,8.0,5.0,3.0,null,null,2.0,2.0,null,null,2.0,6.0,6.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Positive,null,True,M0,T3,null,null,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,39.0
TCGA-BH-A18N-01,6.0,2.0,3.0,6.0,6.0,7.0,2.0,10.0,1.0,8.0,10.0,1.0,null,2.0,null,null,null,6.0,3.0,9.0,1.0,3.0,6.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,null,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage IIA,FEMALE,88.0
TCGA-BH-A18N-11,null,2.0,3.0,null,null,null,2.0,10.0,null,null,10.0,1.0,5.0,2.0,null,null,3.0,6.0,null,null,1.0,3.0,6.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,True,M0,T2,NO,NO,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,88.0
TCGA-BH-A18P-01,3.0,2.0,2.0,1.0,6.0,1.0,2.0,10.0,10.0,10.0,6.0,5.0,4.0,2.0,null,null,2.0,1.0,8.0,7.0,1.0,null,7.0,Stage I,Positive,Negative,N0,Her2,HER2-enriched,Negative,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Negative,Simple Mastectomy,null,<10%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,1+,Fine needle aspiration biopsy,Positive,Positive,null,True,M0,T1,null,null,NO,YES,Her2,Negative,miRNA cluster 12,cluster 5,Stage I,FEMALE,60.0
TCGA-BH-A18P-11,null,2.0,2.0,null,null,null,2.0,10.0,null,null,6.0,5.0,4.0,2.0,null,null,3.0,1.0,null,null,1.0,null,7.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Negative,Simple Mastectomy,null,<10%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,1+,Fine needle aspiration biopsy,Positive,Positive,null,True,M0,T1,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,60.0
TCGA-BH-A18Q-01,1.0,3.0,4.0,3.0,3.0,4.0,3.0,10.0,1.0,1.0,5.0,6.0,5.0,3.0,null,null,1.0,6.0,10.0,7.0,1.0,3.0,6.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 13,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Negative,null,True,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 7,cluster 5,Stage IIB,FEMALE,56.0
TCGA-BH-A18Q-11,null,3.0,4.0,null,null,null,3.0,10.0,null,null,5.0,6.0,5.0,3.0,null,null,3.0,6.0,null,null,1.0,3.0,6.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 13,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Negative,null,True,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,56.0
TCGA-BH-A18R-01,6.0,2.0,3.0,1.0,1.0,1.0,2.0,10.0,9.0,10.0,4.0,7.0,null,2.0,null,null,null,4.0,8.0,6.0,3.0,null,6.0,No_Conversion,Indeterminate,Positive,N1,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,null,Indeterminate,null,Negative,Modified Radical Mastectomy,null,20-29%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,Positive,Positive,null,null,M0,T2b,null,null,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,50.0
TCGA-BH-A18R-11,null,2.0,3.0,null,null,null,2.0,10.0,null,null,4.0,7.0,5.0,2.0,null,null,2.0,4.0,null,null,3.0,null,6.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Indeterminate,null,Negative,Modified Radical Mastectomy,null,20-29%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,Positive,Positive,null,True,M0,T2b,null,null,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,50.0
TCGA-BH-A18S-01,10.0,3.0,5.0,6.0,6.0,7.0,3.0,10.0,1.0,8.0,9.0,2.0,null,3.0,null,null,null,1.0,3.0,10.0,1.0,null,7.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 12,Sentinel node biopsy alone,Positive,null,Positive,Other,null,null,null,null,Mucinous Carcinoma,8523/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,null,NO,YES,LumA,null,miRNA c1uster 10,cluster 7,Stage I,FEMALE,79.0
TCGA-BH-A18S-11,null,3.0,5.0,null,null,null,3.0,10.0,null,null,9.0,2.0,null,3.0,null,null,null,1.0,null,null,1.0,null,7.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 12,Sentinel node biopsy alone,Positive,null,Positive,Other,null,null,null,null,Mucinous Carcinoma,8523/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,79.0
TCGA-BH-A18T-01,1.0,1.0,1.0,3.0,3.0,4.0,1.0,10.0,10.0,8.0,7.0,4.0,4.0,1.0,null,null,1.0,null,10.0,2.0,null,null,7.0,Stage IIA,Negative,Negative,N0,Basal,Luminal A,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,70.0
TCGA-BH-A18U-01,6.0,2.0,4.0,8.0,10.0,10.0,3.0,10.0,9.0,6.0,8.0,3.0,4.0,2.0,null,null,3.0,4.0,6.0,7.0,3.0,null,7.0,Stage IIIA,Positive,Positive,N2,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 13,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,LumB,Positive,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,72.0
TCGA-BH-A18U-11,null,2.0,4.0,null,null,null,3.0,10.0,null,null,8.0,3.0,4.0,2.0,null,null,2.0,4.0,null,null,3.0,null,7.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 13,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,72.0
TCGA-BH-A18V-01,1.0,3.0,4.0,3.0,3.0,4.0,3.0,10.0,1.0,1.0,4.0,7.0,5.0,2.0,null,null,2.0,6.0,10.0,7.0,1.0,null,6.0,No_Conversion,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 2,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T2,null,null,NO,YES,Basal,Negative,miRNA cluster 11,cluster 5,Stage IIB,FEMALE,48.0
TCGA-BH-A18V-06,null,3.0,4.0,null,null,null,3.0,10.0,null,null,4.0,7.0,null,2.0,null,null,null,6.0,null,null,1.0,null,6.0,null,null,null,null,Basal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 2,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,null,M0,T2,null,null,NO,YES,Basal,null,miRNA cluster 11,null,Stage IIB,FEMALE,48.0
TCGA-BH-A18V-11,null,3.0,4.0,null,null,null,3.0,10.0,null,null,4.0,7.0,5.0,2.0,null,null,3.0,6.0,null,null,1.0,null,6.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 2,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,48.0
TCGA-BH-A1EN-01,6.0,null,5.0,null,null,null,3.0,10.0,null,null,9.0,2.0,6.0,3.0,null,null,1.0,null,6.0,4.0,null,null,5.0,Stage IIA,Negative,Negative,N0,Her2,null,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,Her2,Positive,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,78.0
TCGA-BH-A1EN-11,null,null,5.0,null,null,null,3.0,10.0,null,null,9.0,2.0,null,3.0,null,null,null,null,null,null,null,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,78.0
TCGA-BH-A1EO-01,6.0,null,7.0,null,null,null,4.0,10.0,7.0,8.0,7.0,4.0,6.0,4.0,null,null,1.0,4.0,8.0,9.0,1.0,null,5.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Mixed Histology (please specify),8522/3,null,Excisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage IIA,FEMALE,68.0
TCGA-BH-A1EO-11,null,null,7.0,null,null,null,4.0,10.0,null,null,7.0,4.0,6.0,4.0,null,null,2.0,4.0,null,null,1.0,null,5.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Mixed Histology (please specify),8522/3,null,Excisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,null,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,68.0
TCGA-BH-A1ES-01,10.0,null,8.0,null,null,null,5.0,10.0,4.0,8.0,2.0,9.0,null,5.0,null,null,null,1.0,8.0,7.0,1.0,null,5.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,35.0
TCGA-BH-A1ES-06,null,null,8.0,null,null,null,5.0,10.0,null,null,2.0,9.0,7.0,5.0,null,null,2.0,1.0,null,null,1.0,null,5.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,null,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,35.0
TCGA-BH-A1ES-11,null,null,8.0,null,null,null,5.0,10.0,null,null,2.0,9.0,6.0,5.0,null,null,2.0,1.0,null,null,1.0,null,5.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,null,NO,YES,null,null,null,null,Stage IIB,FEMALE,35.0
TCGA-BH-A1ET-01,3.0,null,6.0,null,null,null,4.0,10.0,1.0,5.0,5.0,6.0,null,4.0,null,null,null,5.0,3.0,9.0,1.0,null,5.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,null,M0,T1,null,null,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage I,FEMALE,55.0
TCGA-BH-A1ET-11,null,null,6.0,null,null,null,4.0,10.0,null,null,5.0,6.0,6.0,4.0,null,null,2.0,5.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,null,False,M0,T1,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,55.0
TCGA-BH-A1EU-01,1.0,null,3.0,null,null,null,2.0,10.0,7.0,5.0,9.0,2.0,6.0,2.0,null,null,2.0,null,1.0,9.0,null,null,5.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage I,FEMALE,83.0
TCGA-BH-A1EU-11,null,null,3.0,null,null,null,2.0,10.0,null,null,9.0,2.0,6.0,2.0,null,null,2.0,null,null,null,null,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,83.0
TCGA-BH-A1EV-01,3.0,null,1.0,null,null,null,1.0,10.0,10.0,6.0,3.0,8.0,6.0,1.0,null,null,3.0,3.0,3.0,10.0,1.0,null,5.0,null,Positive,null,null,Her2,HER2-enriched,Positive,enrollment,null,null,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,null,null,True,M0,T3,NO,YES,NO,YES,Her2,null,miRNA cluster 7,cluster 7,Stage IIIA,FEMALE,45.0
TCGA-BH-A1EV-11,null,null,1.0,null,null,null,1.0,10.0,null,null,3.0,8.0,6.0,1.0,null,null,3.0,3.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,null,null,True,M0,T3,NO,YES,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,45.0
TCGA-BH-A1EW-01,6.0,null,4.0,null,null,null,3.0,10.0,8.0,8.0,2.0,9.0,6.0,3.0,null,null,3.0,4.0,1.0,9.0,1.0,null,5.0,No_Conversion,Negative,Positive,N1,LumA,Luminal B,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,38.0
TCGA-BH-A1EW-11,null,null,4.0,null,null,null,3.0,10.0,null,null,2.0,9.0,6.0,3.0,null,null,5.0,4.0,null,null,1.0,null,5.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,null,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,38.0
TCGA-BH-A1EX-01,6.0,null,4.0,null,null,null,3.0,10.0,null,null,7.0,4.0,null,2.0,null,null,null,6.0,8.0,7.0,1.0,null,5.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,67.0
TCGA-BH-A1EY-01,3.0,null,1.0,null,null,null,1.0,10.0,null,null,9.0,2.0,5.0,1.0,null,null,2.0,3.0,8.0,1.0,1.0,null,5.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,79.0
TCGA-BH-A1EY-11,null,null,1.0,null,null,null,1.0,10.0,null,null,9.0,2.0,5.0,1.0,null,null,3.0,3.0,null,null,1.0,null,5.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,NO,YES,null,null,null,null,Stage IIA,FEMALE,79.0
TCGA-BH-A1F0-01,1.0,null,2.0,null,null,null,2.0,10.0,1.0,1.0,9.0,2.0,null,1.0,null,null,null,3.0,10.0,9.0,1.0,null,5.0,Stage IIA,Negative,Positive,N1,Basal,Basal-like,Indeterminate,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Indeterminate,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1a,null,null,NO,YES,Basal,Negative,miRNA c1uster 9,cluster 6,Stage IIA,FEMALE,80.0
TCGA-BH-A1F0-11,null,null,2.0,null,null,null,2.0,10.0,null,null,9.0,2.0,5.0,1.0,null,null,1.0,3.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,null,Negative,null,Indeterminate,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1a,null,null,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,80.0
TCGA-BH-A1F2-01,10.0,null,2.0,null,null,null,2.0,10.0,null,null,5.0,6.0,6.0,2.0,null,null,2.0,5.0,3.0,9.0,2.0,null,5.0,Stage,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 14,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8541/3,null,Core needle biopsy,Positive,null,null,True,M0,T4b,null,null,NO,YES,LumB,Positive,miRNA c1uster 9,cluster 6,Stage IIIB,FEMALE,53.0
TCGA-BH-A1F2-11,null,null,2.0,null,null,null,2.0,10.0,null,null,5.0,6.0,6.0,2.0,null,null,2.0,5.0,null,null,2.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 14,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8541/3,null,Core needle biopsy,Positive,null,null,True,M0,T4b,null,null,NO,YES,Normal,null,null,null,Stage IIIB,FEMALE,53.0
TCGA-BH-A1F5-01,null,null,6.0,null,null,null,4.0,10.0,null,null,6.0,5.0,4.0,4.0,null,null,1.0,1.0,null,null,1.0,null,6.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,Kirc+,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T1c,null,null,NO,YES,LumA,null,miRNA cluster 14,null,Stage IIA,FEMALE,62.0
TCGA-BH-A1F5-11,null,null,6.0,null,null,null,4.0,10.0,null,null,6.0,5.0,4.0,4.0,null,null,2.0,1.0,null,null,1.0,null,6.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T1c,null,null,NO,YES,null,null,null,null,Stage IIA,FEMALE,62.0
TCGA-BH-A1F6-01,null,null,7.0,null,null,null,5.0,10.0,null,null,4.0,7.0,7.0,4.0,null,null,2.0,2.0,null,null,2.0,null,4.0,null,Negative,null,null,Basal,null,Negative,enrollment,null,null,High,C4-BRCA/Basal,null,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,MX,T4d,null,null,NO,YES,Basal,null,miRNA cluster 12,null,null,FEMALE,51.0
TCGA-BH-A1F6-11,null,null,7.0,null,null,null,5.0,10.0,null,null,4.0,7.0,null,4.0,null,null,null,2.0,null,null,2.0,null,4.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,null,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,null,MX,T4d,null,null,NO,YES,Normal,null,null,null,null,FEMALE,51.0
TCGA-BH-A1F8-01,1.0,null,2.0,null,null,null,2.0,10.0,null,null,10.0,1.0,null,1.0,null,null,null,3.0,8.0,6.0,4.0,null,5.0,Stage IIIC,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T4b,null,null,NO,YES,LumB,Negative,miRNA c1uster 9,cluster 4,Stage IIIB,FEMALE,90.0
TCGA-BH-A1F8-11,null,null,2.0,null,null,null,2.0,10.0,null,null,10.0,1.0,6.0,1.0,null,null,4.0,3.0,null,null,4.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,null,NO,YES,Normal,null,null,null,Stage IIIB,FEMALE,90.0
TCGA-BH-A1FB-01,8.0,null,9.0,null,null,null,6.0,10.0,null,null,6.0,5.0,5.0,5.0,null,null,2.0,4.0,1.0,9.0,1.0,null,5.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIB,FEMALE,60.0
TCGA-BH-A1FB-11,null,null,9.0,null,null,null,6.0,10.0,null,null,6.0,5.0,5.0,5.0,null,null,2.0,4.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,null,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,60.0
TCGA-BH-A1FC-01,8.0,null,8.0,null,null,null,5.0,10.0,null,null,9.0,2.0,6.0,5.0,null,null,1.0,6.0,8.0,4.0,1.0,null,5.0,Stage IIA,Negative,Positive,N1,Basal,null,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,null,Medullary Carcinoma,8510/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,null,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,78.0
TCGA-BH-A1FC-11,null,null,8.0,null,null,null,5.0,10.0,null,null,9.0,2.0,6.0,5.0,null,null,2.0,6.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,null,Medullary Carcinoma,8510/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,null,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,78.0
TCGA-BH-A1FD-01,8.0,null,2.0,null,null,null,2.0,10.0,null,null,7.0,4.0,6.0,2.0,null,null,1.0,5.0,6.0,null,1.0,null,5.0,Stage I,Positive,Negative,N0,LumB,null,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,null,NO,YES,LumB,Negative,null,null,Stage I,FEMALE,68.0
TCGA-BH-A1FD-11,null,null,2.0,null,null,null,2.0,10.0,null,null,7.0,4.0,6.0,2.0,null,null,2.0,5.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,68.0
TCGA-BH-A1FE-01,3.0,null,5.0,null,null,null,4.0,10.0,null,null,1.0,10.0,6.0,3.0,null,null,1.0,3.0,8.0,9.0,1.0,null,5.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIB,FEMALE,31.0
TCGA-BH-A1FE-06,null,null,5.0,null,null,null,4.0,10.0,null,null,1.0,10.0,null,3.0,null,null,null,3.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,Low purity c2,null,GBM-like c6,mutation cluster 3,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,null,M0,T2,null,null,NO,YES,Normal,null,miRNA cluster 5,null,Stage IIB,FEMALE,31.0
TCGA-BH-A1FE-11,null,null,5.0,null,null,null,4.0,10.0,null,null,1.0,10.0,6.0,3.0,null,null,3.0,3.0,null,null,1.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,True,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,31.0
TCGA-BH-A1FG-01,8.0,null,9.0,null,null,null,6.0,10.0,null,null,10.0,1.0,6.0,5.0,null,null,1.0,null,3.0,2.0,null,null,5.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,null,NO,YES,LumA,null,miRNA cluster 14,cluster 2,Stage I,FEMALE,88.0
TCGA-BH-A1FG-11,null,null,9.0,null,null,null,6.0,10.0,null,null,10.0,1.0,null,5.0,null,null,null,null,null,null,null,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,88.0
TCGA-BH-A1FH-01,8.0,null,3.0,null,null,null,2.0,10.0,null,null,4.0,7.0,6.0,2.0,null,null,2.0,3.0,1.0,9.0,3.0,null,5.0,No_Conversion,Positive,Positive,N1,LumA,null,Negative,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 1,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,True,M1,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 14,cluster 6,Stage IV,FEMALE,47.0
TCGA-BH-A1FH-11,null,null,3.0,null,null,null,2.0,10.0,null,null,4.0,7.0,6.0,2.0,null,null,2.0,3.0,null,null,3.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,False,M1,T2,null,null,NO,YES,Normal,null,null,null,Stage IV,FEMALE,47.0
TCGA-BH-A1FJ-01,6.0,null,5.0,null,null,null,3.0,10.0,null,null,7.0,4.0,6.0,3.0,null,null,1.0,8.0,8.0,2.0,2.0,null,5.0,Stage IIIA,Negative,Positive,N1,LumB,null,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Negative,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,True,M0,T3,null,null,NO,YES,LumB,Negative,miRNA cluster 4,cluster 2,Stage IIIA,FEMALE,66.0
TCGA-BH-A1FJ-11,null,null,5.0,null,null,null,3.0,10.0,null,null,7.0,4.0,6.0,3.0,null,null,2.0,8.0,null,null,2.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Negative,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,False,M0,T3,null,null,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,66.0
TCGA-BH-A1FL-01,3.0,null,4.0,null,null,null,3.0,10.0,null,null,7.0,4.0,6.0,3.0,null,null,1.0,6.0,8.0,9.0,2.0,null,5.0,Stage IIIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,null,True,M0,T2,null,null,NO,YES,LumA,Negative,miRNA cluster 12,cluster 6,Stage IIB,FEMALE,69.0
TCGA-BH-A1FM-01,1.0,null,3.0,null,null,null,2.0,10.0,null,null,3.0,8.0,7.0,2.0,null,null,2.0,3.0,6.0,6.0,3.0,null,5.0,Stage IIIA,Positive,Positive,N2,LumB,null,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,True,M0,T2,null,null,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,44.0
TCGA-BH-A1FM-11,null,null,3.0,null,null,null,2.0,10.0,null,null,3.0,8.0,7.0,2.0,null,null,1.0,3.0,null,null,3.0,null,5.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,False,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,44.0
TCGA-BH-A1FN-01,1.0,null,5.0,null,null,null,4.0,10.0,null,null,2.0,9.0,7.0,3.0,null,null,1.0,7.0,10.0,6.0,1.0,null,4.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 5,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,null,True,M0,T2,null,null,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,34.0
TCGA-BH-A1FN-11,null,null,5.0,null,null,null,4.0,10.0,null,null,2.0,9.0,7.0,3.0,null,null,null,7.0,null,null,1.0,null,4.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,null,True,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,34.0
TCGA-BH-A1FR-01,1.0,null,10.0,null,null,null,7.0,10.0,null,null,8.0,3.0,7.0,3.0,null,null,1.0,3.0,3.0,1.0,2.0,null,4.0,No_Conversion,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T4,Quiet,C3-BRCA/Luminal,cluster 2,KIRC-like c17,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,"Other, specify",8523/3,null,Core needle biopsy,null,null,null,True,M0,T4b,null,null,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIB,FEMALE,73.0
TCGA-BH-A1FR-11,null,null,10.0,null,null,null,7.0,10.0,null,null,8.0,3.0,null,3.0,null,null,null,3.0,null,null,2.0,null,4.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,"Other, specify",8523/3,null,Core needle biopsy,null,null,null,null,M0,T4b,null,null,NO,YES,Normal,null,null,null,Stage IIIB,FEMALE,73.0
TCGA-BH-A1FU-01,8.0,null,5.0,null,null,null,4.0,10.0,null,null,3.0,8.0,7.0,3.0,null,null,1.0,2.0,1.0,9.0,1.0,null,4.0,Stage I,Negative,Negative,N0,Normal,null,Negative,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,Cluster 5,null,BRCA nonbasal-like c7,mutation cluster 5,null,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,null,True,M0,T1c,null,null,NO,YES,Normal,Positive,miRNA cluster 4,cluster 6,Stage IA,FEMALE,44.0
TCGA-BH-A1FU-11,null,null,5.0,null,null,null,4.0,10.0,null,null,3.0,8.0,null,3.0,null,null,null,2.0,null,null,1.0,null,4.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,null,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,null,null,M0,T1c,null,null,NO,YES,Normal,null,null,null,Stage IA,FEMALE,44.0
TCGA-BH-A201-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,1.0,1.0,8.0,9.0,1.0,null,10.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,NO,YES,NO,YES,LumA,null,miRNA c1uster 9,cluster 6,Stage IA,FEMALE,64.0
TCGA-BH-A202-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,null,null,1.0,null,null,1.0,8.0,9.0,1.0,null,10.0,null,Positive,null,null,LumB,null,Positive,enrollment,null,null,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,LumB,null,miRNA cluster 4,cluster 6,Stage II,FEMALE,60.0
TCGA-BH-A203-01,6.0,null,3.0,null,null,null,2.0,10.0,null,null,9.0,2.0,7.0,2.0,null,null,2.0,9.0,6.0,null,10.0,null,4.0,null,null,null,null,Her2,null,null,enrollment,null,null,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 4,null,null,null,null,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,Her2,null,miRNA cluster 4,null,Stage IIB,FEMALE,78.0
TCGA-BH-A203-11,null,null,3.0,null,null,null,2.0,10.0,null,null,9.0,2.0,7.0,2.0,null,null,3.0,9.0,null,null,10.0,null,4.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,null,null,null,null,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,null,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,78.0
TCGA-BH-A204-01,8.0,null,6.0,null,null,null,4.0,10.0,null,null,9.0,2.0,8.0,4.0,null,null,2.0,4.0,6.0,null,1.0,null,4.0,null,null,null,null,LumB,null,null,enrollment,null,null,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 14,null,null,null,null,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,NO,YES,LumB,null,miRNA cluster 6,null,Stage IIB,FEMALE,80.0
TCGA-BH-A204-11,null,null,6.0,null,null,null,4.0,10.0,null,null,9.0,2.0,8.0,4.0,null,null,3.0,4.0,null,null,1.0,null,4.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 14,null,null,null,null,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,80.0
TCGA-BH-A208-01,6.0,null,4.0,null,null,null,3.0,10.0,null,null,4.0,7.0,8.0,3.0,null,null,3.0,4.0,10.0,null,1.0,null,3.0,null,null,null,null,Normal,null,null,enrollment,null,null,High,C3-BRCA/Luminal,cluster 5,OV-like c1,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,null,null,null,null,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,True,M0,T2,null,null,NO,YES,Normal,null,miRNA cluster 11,null,Stage IIB,FEMALE,48.0
TCGA-BH-A208-11,null,null,4.0,null,null,null,3.0,10.0,null,null,4.0,7.0,8.0,3.0,null,null,5.0,4.0,null,null,1.0,null,3.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 8,null,null,null,null,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,False,M0,T2,null,null,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,48.0
TCGA-BH-A209-01,8.0,null,9.0,null,null,null,6.0,10.0,null,null,8.0,2.0,7.0,6.0,null,null,2.0,3.0,6.0,null,1.0,null,4.0,null,Positive,null,null,LumB,null,Positive,enrollment,null,null,High,C3-BRCA/Luminal,cluster 3,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 14,null,Positive,null,Positive,Lumpectomy,null,null,null,null,Medullary Carcinoma,8510/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,null,NO,YES,LumB,null,miRNA cluster 7,null,Stage I,FEMALE,77.0
TCGA-BH-A209-11,null,null,9.0,null,null,null,6.0,10.0,null,null,8.0,2.0,7.0,6.0,null,null,2.0,3.0,null,null,1.0,null,4.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 14,null,Positive,null,Positive,Lumpectomy,null,null,null,null,Medullary Carcinoma,8510/3,null,Fine needle aspiration biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,null,NO,YES,Normal,null,null,null,Stage I,FEMALE,77.0
TCGA-BH-A28O-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,null,1.0,4.0,null,null,5.0,null,9.0,null,null,null,null,null,null,null,null,null,null,Quiet,null,null,Low purity c2,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Other,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,Negative,null,null,True,M0,T3a,YES,YES,YES,NO,Normal,null,miRNA cluster 4,null,Stage IIIC,FEMALE,null
TCGA-BH-A28Q-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,2.0,5.0,8.0,null,1.0,null,9.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,Negative,Indeterminate,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,NO,NO,NO,YES,LumA,null,miRNA cluster 3,null,Stage IIB,FEMALE,46.0
TCGA-BH-A2L8-01,null,null,null,null,null,null,null,null,null,null,3.0,7.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,LumA,null,null,null,null,null,Kirc+,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Other,NO,70-79%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-BH-A42T-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,1.0,1.0,null,1.0,1.0,null,null,null,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,null,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,Equivocal,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,LumB,null,null,null,Stage IIA,FEMALE,null
TCGA-BH-A42U-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,4.0,null,4.0,null,2.0,1.0,null,null,null,null,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Negative,null,Negative,Simple Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,null
TCGA-BH-A42V-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,NO,YES,YES,NO,LumA,null,null,null,Stage IB,FEMALE,null
TCGA-BH-A5IZ-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Negative,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,cM0 (i+),T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-BH-A5J0-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,null,null,1.0,null,null,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,NO,NO,YES,NO,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-BH-A6R8-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,null,True,M0,T2,NO,YES,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-BH-A6R9-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,1.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Negative,null,Positive,Modified Radical Mastectomy,null,null,null,null,Metaplastic Carcinoma,8575/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,null
TCGA-BH-A8FY-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,1.0,null,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,NO,NO,YES,NO,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-BH-A8FZ-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,1.0,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1b,NO,YES,YES,NO,Normal,null,null,null,Stage IA,FEMALE,null
TCGA-BH-A8G0-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Simple Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-BH-AB28-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,2.0,5.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Indeterminate,null,True,M0,T3,YES,NO,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-C8-A12K-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,9.0,2.0,1.0,null,1.0,null,5.0,2.0,10.0,4.0,1.0,null,9.0,No_Conversion,null,Positive,N1,Basal,Basal-like,null,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 8,Other (specify),null,null,null,Other,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,null,YES,NO,Basal,Negative,miRNA cluster 4,cluster 3,Stage IIB,FEMALE,80.0
TCGA-C8-A12L-01,1.0,1.0,null,1.0,1.0,1.0,1.0,1.0,2.0,3.0,7.0,4.0,1.0,null,1.0,null,3.0,1.0,8.0,6.0,null,null,9.0,Stage IIA,Negative,Negative,N0,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,67.0
TCGA-C8-A12M-01,10.0,1.0,null,8.0,1.0,10.0,1.0,1.0,3.0,6.0,7.0,4.0,1.0,null,1.0,null,3.0,3.0,6.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,LumB,null,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,70.0
TCGA-C8-A12N-01,8.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,6.0,5.0,1.0,null,1.0,null,2.0,3.0,3.0,9.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,58.0
TCGA-C8-A12O-01,null,1.0,null,null,null,null,1.0,1.0,9.0,10.0,4.0,7.0,1.0,null,1.0,null,3.0,3.0,1.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,null,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 13,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,YES,NO,LumA,null,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,50.0
TCGA-C8-A12P-01,6.0,1.0,null,1.0,1.0,1.0,1.0,1.0,2.0,2.0,5.0,6.0,1.0,null,1.0,null,2.0,2.0,1.0,6.0,null,null,9.0,No_Conversion,Negative,Positive,N1,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,null,Negative,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,55.0
TCGA-C8-A12Q-01,10.0,1.0,null,1.0,1.0,1.0,1.0,1.0,2.0,6.0,9.0,2.0,1.0,1.0,1.0,null,4.0,2.0,3.0,6.0,null,null,9.0,No_Conversion,Negative,Positive,N2,Her2,HER2-enriched,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 2,Cluster 5,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,NO,YES,NO,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,78.0
TCGA-C8-A12T-01,8.0,1.0,null,1.0,1.0,1.0,1.0,1.0,9.0,10.0,3.0,null,1.0,null,1.0,null,3.0,2.0,8.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,Her2,HER2-enriched,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,null,YES,NO,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,43.0
TCGA-C8-A12U-01,10.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,4.0,7.0,1.0,null,1.0,null,3.0,2.0,8.0,7.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 5,Stage IIB,FEMALE,46.0
TCGA-C8-A12V-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,5.0,6.0,1.0,null,1.0,null,3.0,2.0,10.0,4.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,55.0
TCGA-C8-A12W-01,6.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,4.0,7.0,1.0,null,1.0,null,5.0,2.0,8.0,6.0,null,null,9.0,Stage IIIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T4,null,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIB,FEMALE,49.0
TCGA-C8-A12X-01,8.0,1.0,null,8.0,6.0,10.0,1.0,1.0,3.0,8.0,6.0,5.0,1.0,null,1.0,null,2.0,2.0,6.0,1.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal B,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,1+,Mucinous Carcinoma,8480/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,62.0
TCGA-C8-A12Y-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,10.0,8.0,3.0,null,1.0,null,2.0,null,2.0,3.0,3.0,9.0,null,null,9.0,Stage IIB,null,Positive,N1,LumA,Luminal A,null,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIB,FEMALE,44.0
TCGA-C8-A12Z-01,3.0,1.0,null,1.0,1.0,1.0,1.0,1.0,2.0,6.0,3.0,8.0,1.0,null,1.0,null,3.0,1.0,8.0,6.0,1.0,null,9.0,Stage IIB,Negative,Positive,N1,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,NO,YES,NO,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,45.0
TCGA-C8-A130-01,1.0,1.0,null,1.0,1.0,1.0,1.0,1.0,9.0,10.0,5.0,6.0,1.0,null,1.0,null,3.0,2.0,3.0,6.0,null,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,HER2-enriched,Positive,enrollment,T_Other,T3,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,null,Peri (6-12 months since last menstrual period),True,M0,T3,[Discrepancy],NO,YES,NO,LumB,Equivocal,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,52.0
TCGA-C8-A131-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,9.0,2.0,1.0,null,1.0,null,3.0,2.0,1.0,7.0,2.0,null,9.0,Stage IIIA,Negative,Positive,N2,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,OV-like c4,BRCA nonbasal-like c7,mutation cluster 2,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIIA,FEMALE,82.0
TCGA-C8-A132-01,10.0,1.0,null,3.0,6.0,7.0,1.0,1.0,9.0,7.0,5.0,6.0,1.0,null,1.0,null,2.0,1.0,1.0,7.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,[Discrepancy],NO,YES,NO,LumA,Positive,miRNA c1uster 9,cluster 5,Stage IIB,FEMALE,56.0
TCGA-C8-A133-01,1.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,7.0,4.0,1.0,null,1.0,null,3.0,6.0,3.0,1.0,null,null,9.0,Stage IIIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T3,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,"Other, specify",8523/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,null,YES,NO,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,65.0
TCGA-C8-A134-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,5.0,6.0,null,null,1.0,null,null,2.0,8.0,9.0,null,null,9.0,No_Conversion,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C8-BLCA,cluster 4,Cluster 6,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,null,Peri (6-12 months since last menstrual period),null,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 5,cluster 6,Stage IIA,FEMALE,52.0
TCGA-C8-A135-01,1.0,1.0,null,3.0,3.0,1.0,1.0,1.0,2.0,6.0,6.0,4.0,1.0,null,1.0,null,4.0,1.0,1.0,10.0,1.0,null,9.0,Stage IIB,Negative,Positive,N1,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Her2,Positive,miRNA cluster 4,cluster 7,Stage IIB,FEMALE,64.0
TCGA-C8-A137-01,10.0,1.0,null,null,null,null,1.0,1.0,2.0,6.0,2.0,9.0,1.0,null,1.0,null,3.0,1.0,8.0,null,null,null,9.0,Stage IIB,Negative,Positive,N1,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,[Discrepancy],NO,YES,NO,Her2,Positive,null,null,Stage IIB,FEMALE,34.0
TCGA-C8-A138-01,3.0,1.0,null,6.0,3.0,1.0,1.0,1.0,9.0,6.0,5.0,6.0,1.0,null,1.0,null,2.0,1.0,3.0,1.0,null,null,9.0,Stage IIIA,Positive,Positive,N2,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Her2,Positive,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,54.0
TCGA-C8-A1HE-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,null,null,null,1.0,null,null,2.0,8.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,59.0
TCGA-C8-A1HF-01,3.0,1.0,null,null,null,null,1.0,1.0,2.0,6.0,4.0,null,1.0,null,1.0,null,3.0,3.0,3.0,9.0,null,null,9.0,Stage IIA,Negative,Negative,N0,Her2,HER2-enriched,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Positive,Other,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,YES,NO,Her2,Positive,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,48.0
TCGA-C8-A1HG-01,8.0,1.0,null,null,null,null,1.0,1.0,9.0,6.0,4.0,null,1.0,null,1.0,null,2.0,null,10.0,4.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 5,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 8,Axillary lymph node dissection alone,Positive,null,Positive,Other,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,50.0
TCGA-C8-A1HI-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,10.0,3.0,null,1.0,null,1.0,null,3.0,2.0,3.0,9.0,null,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIIA,FEMALE,40.0
TCGA-C8-A1HJ-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,5.0,3.0,10.0,7.0,null,null,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,mutation cluster 13,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,null,null,YES,NO,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,53.0
TCGA-C8-A1HK-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,null,1.0,null,1.0,null,3.0,2.0,8.0,1.0,null,null,9.0,Stage IIB,Negative,Positive,N1,Her2,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Peri (6-12 months since last menstrual period),True,M0,T2,null,NO,YES,NO,Her2,Positive,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,53.0
TCGA-C8-A1HL-01,10.0,1.0,null,null,null,null,1.0,1.0,9.0,8.0,2.0,null,1.0,null,1.0,null,5.0,3.0,3.0,6.0,null,null,9.0,Stage IIIA,Positive,Positive,N1,LumB,Luminal B,Negative,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Negative,Other,null,null,null,2+,"Other, specify",8480/3,null,"Other method, specify:",Equivocal,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,null,NO,YES,NO,LumB,Positive,miRNA cluster 12,cluster 4,Stage IIIA,FEMALE,38.0
TCGA-C8-A1HM-01,6.0,1.0,null,null,null,null,1.0,1.0,9.0,6.0,8.0,3.0,null,null,1.0,null,null,null,8.0,6.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 13,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,74.0
TCGA-C8-A1HN-01,null,1.0,null,null,null,null,1.0,1.0,3.0,6.0,5.0,6.0,1.0,null,1.0,null,2.0,null,3.0,10.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumB,Equivocal,miRNA c1uster 10,cluster 7,Stage IIA,FEMALE,56.0
TCGA-C8-A1HO-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,1.0,null,2.0,null,6.0,7.0,null,null,9.0,Stage IIIC,Positive,Positive,N3,LumA,null,Positive,enrollment,T_Other,T3,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,[Discrepancy],null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T3,YES,NO,YES,NO,LumA,Negative,miRNA cluster 12,cluster 5,Stage IIIC,FEMALE,34.0
TCGA-C8-A26V-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,2.0,null,8.0,null,null,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T3,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 8,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Peri (6-12 months since last menstrual period),True,M0,T3,YES,YES,YES,NO,LumB,Negative,miRNA cluster 12,null,Stage IIIA,FEMALE,47.0
TCGA-C8-A26W-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,null,1.0,null,null,null,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 8,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumB,Positive,miRNA cluster 12,null,Stage IIB,FEMALE,58.0
TCGA-C8-A26X-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,null,8.0,null,null,null,9.0,Stage IIA,Negative,Positive,N1,Her2,null,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,null,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,YES,NO,YES,NO,Her2,Negative,miRNA cluster 7,null,Stage IIA,FEMALE,58.0
TCGA-C8-A26Y-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,null,1.0,null,1.0,null,8.0,null,null,null,9.0,Stage IIA,Negative,Negative,N0,Her2,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,null,null,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,Her2,Negative,miRNA cluster 4,null,Stage IIA,FEMALE,90.0
TCGA-C8-A26Z-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,null,1.0,null,1.0,null,3.0,null,8.0,null,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 14,null,Stage IIA,FEMALE,59.0
TCGA-C8-A273-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,1.0,null,1.0,null,1.0,null,3.0,2.0,8.0,null,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 4,null,Stage IIB,FEMALE,29.0
TCGA-C8-A274-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,3.0,null,6.0,null,null,null,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 1,null,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumB,Negative,miRNA cluster 13,null,Stage IIA,FEMALE,63.0
TCGA-C8-A275-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,2.0,null,8.0,null,null,null,9.0,Stage IIA,null,Positive,N1,Her2,null,null,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,null,null,null,null,Other,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1,null,null,YES,NO,Her2,Positive,miRNA cluster 4,null,Stage IIA,FEMALE,56.0
TCGA-C8-A278-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,3.0,null,8.0,null,null,null,9.0,Stage IIIA,Negative,Positive,N2,Her2,null,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,null,Negative,null,Negative,Other,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,Her2,Positive,miRNA cluster 7,null,Stage IIIA,FEMALE,61.0
TCGA-C8-A27A-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,2.0,null,6.0,7.0,null,null,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T2,YES,NO,YES,NO,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,48.0
TCGA-C8-A27B-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,2.0,null,10.0,7.0,null,null,10.0,Stage IIB,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,mutation cluster 13,null,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Peri (6-12 months since last menstrual period),True,M0,T3,YES,NO,YES,NO,Basal,Negative,miRNA cluster 4,cluster 5,Stage IIB,FEMALE,48.0
TCGA-C8-A3M7-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,null,2.0,1.0,null,null,2.0,null,null,1.0,null,9.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T4b,YES,YES,YES,NO,LumA,null,miRNA cluster 5,null,Stage IIIB,FEMALE,null
TCGA-C8-A3M8-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,2.0,null,null,null,null,null,10.0,null,null,null,null,LumB,null,null,null,null,null,High,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,3+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,NO,YES,NO,LumB,null,miRNA cluster 4,null,Stage IA,FEMALE,null
TCGA-C8-A8HP-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,null,null,2.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Metaplastic Carcinoma,8575/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Her2,null,null,null,Stage IIIA,FEMALE,null
TCGA-C8-A8HQ-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,2.0,2.0,null,null,1.0,6.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Mucinous Carcinoma,8480/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,LumB,null,null,null,Stage IIB,FEMALE,null
TCGA-C8-A8HR-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,2.0,2.0,null,null,2.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,null,Peri (6-12 months since last menstrual period),True,M0,T3,YES,NO,YES,NO,Normal,null,null,null,Stage IIIA,FEMALE,null
TCGA-C8-A9FZ-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,2.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Mixed Histology (please specify),8524/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,null,null,null,null,Stage IIB,FEMALE,null
TCGA-D8-A13Y-01,10.0,1.0,null,6.0,3.0,10.0,1.0,1.0,9.0,6.0,5.0,6.0,1.0,null,3.0,null,2.0,2.0,3.0,1.0,1.0,null,9.0,No_Conversion,Positive,Negative,N0,LumB,Luminal B,Positive,followup,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,GBM-like c6,mutation cluster 2,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,70-79%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,NO,YES,NO,LumB,Negative,miRNA cluster 6,cluster 1,Stage IA,FEMALE,52.0
TCGA-D8-A13Z-01,1.0,1.0,null,3.0,3.0,1.0,1.0,1.0,1.0,2.0,4.0,7.0,1.0,null,1.0,null,3.0,3.0,1.0,6.0,3.0,null,9.0,Stage IIIA,Negative,Positive,N2,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,Her2,Negative,miRNA cluster 4,cluster 4,null,FEMALE,51.0
TCGA-D8-A140-01,null,1.0,null,null,null,null,1.0,1.0,3.0,6.0,6.0,5.0,1.0,null,1.0,null,2.0,4.0,6.0,9.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal B,Positive,followup,T_Other,T2,null,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,LumA,Positive,miRNA cluster 4,cluster 6,Stage IIB,FEMALE,62.0
TCGA-D8-A141-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,7.0,3.0,8.0,null,null,1.0,null,null,4.0,1.0,6.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Indeterminate (neither Pre or Postmenopausal),null,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 4,cluster 4,null,FEMALE,40.0
TCGA-D8-A142-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,8.0,3.0,1.0,null,1.0,null,3.0,4.0,10.0,4.0,1.0,null,9.0,Stage IIB,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T3,High,C4-BRCA/Basal,cluster 5,Cluster 5,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,NO,YES,NO,Basal,Negative,miRNA c1uster 9,cluster 3,Stage IIB,FEMALE,74.0
TCGA-D8-A143-01,6.0,1.0,null,null,null,null,1.0,1.0,1.0,10.0,4.0,6.0,1.0,null,1.0,null,1.0,3.0,10.0,null,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 5,BRCA CIMP c7,squamous c3,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,Basal,Negative,null,null,Stage IIA,FEMALE,51.0
TCGA-D8-A145-01,1.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,9.0,2.0,1.0,null,1.0,null,1.0,2.0,3.0,9.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T1,T1,COAD-READ,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,80.0
TCGA-D8-A146-01,null,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,2.0,3.0,null,null,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 4,null,Stage IIA,FEMALE,57.0
TCGA-D8-A147-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,3.0,7.0,1.0,null,1.0,null,1.0,1.0,10.0,7.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 13,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Indeterminate (neither Pre or Postmenopausal),False,M0,T2,null,YES,YES,NO,Basal,Negative,miRNA cluster 4,cluster 5,null,FEMALE,45.0
TCGA-D8-A1J8-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,2.0,null,null,1.0,null,null,4.0,6.0,6.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,70-79%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,77.0
TCGA-D8-A1J9-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,2.0,2.0,6.0,1.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumB,null,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,LumB,Positive,miRNA cluster 6,cluster 1,Stage IA,FEMALE,48.0
TCGA-D8-A1JA-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,null,8.0,7.0,null,null,9.0,Stage IIIB,Negative,Negative,N0,Her2,null,Negative,enrollment,T_Other,T4,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,null,No axillary staging,Negative,null,Negative,Modified Radical Mastectomy,NO,<10%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,YES,YES,NO,Her2,Positive,miRNA cluster 12,cluster 5,null,FEMALE,60.0
TCGA-D8-A1JB-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,2.0,null,2.0,2.0,1.0,9.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,Positive,miRNA cluster 13,cluster 6,Stage IIB,FEMALE,54.0
TCGA-D8-A1JC-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,3.0,3.0,6.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,59.0
TCGA-D8-A1JD-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,2.0,4.0,3.0,6.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,YES,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,41.0
TCGA-D8-A1JE-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,null,null,1.0,null,null,3.0,3.0,6.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumB,null,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,62.0
TCGA-D8-A1JF-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,null,null,1.0,null,null,6.0,1.0,4.0,3.0,null,9.0,Stage IIIA,Negative,Positive,N2,Her2,null,Negative,enrollment,T1,T1,COAD-READ,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,NO,YES,NO,Her2,Negative,miRNA cluster 7,cluster 3,Stage IIIA,FEMALE,79.0
TCGA-D8-A1JG-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,null,null,2.0,null,null,1.0,8.0,4.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Her2,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,YES,NO,Her2,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,62.0
TCGA-D8-A1JH-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,3.0,8.0,9.0,null,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,followup,T1,T1,Quiet,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 14,cluster 6,Stage IA,FEMALE,56.0
TCGA-D8-A1JI-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,6.0,8.0,1.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumB,null,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,null,YES,YES,NO,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,54.0
TCGA-D8-A1JJ-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,2.0,1.0,8.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel node biopsy alone,Positive,null,Positive,Other,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,LumB,Negative,miRNA cluster 6,cluster 4,Stage IIA,FEMALE,54.0
TCGA-D8-A1JK-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,null,1.0,null,2.0,3.0,1.0,6.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Negative,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,Basal,Negative,miRNA cluster 7,cluster 4,Stage IIA,FEMALE,90.0
TCGA-D8-A1JL-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,null,null,1.0,null,null,3.0,10.0,2.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,YES,NO,Basal,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,72.0
TCGA-D8-A1JM-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,8.0,null,1.0,null,9.0,Stage IIB,Positive,Positive,N1,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,null,<10%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,Basal,Negative,null,null,Stage IIB,FEMALE,59.0
TCGA-D8-A1JN-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,1.0,3.0,6.0,4.0,4.0,null,9.0,Stage IIIC,Positive,Positive,N3,LumA,null,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Incisional Biopsy,Indeterminate,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,null,NO,YES,NO,LumA,Negative,miRNA cluster 7,cluster 3,Stage IIIC,FEMALE,80.0
TCGA-D8-A1JP-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,null,null,1.0,null,null,1.0,10.0,9.0,null,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 13,cluster 6,Stage IA,FEMALE,73.0
TCGA-D8-A1JS-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,1.0,3.0,8.0,4.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,null,null,1+,"Other, specify",8503/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 7,cluster 3,Stage IA,FEMALE,77.0
TCGA-D8-A1JT-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,4.0,8.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,70-79%,null,2+,"Other, specify",8523/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,70.0
TCGA-D8-A1JU-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,3.0,1.0,10.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,followup,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 13,cluster 6,Stage IA,FEMALE,51.0
TCGA-D8-A1X5-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,2.0,4.0,6.0,7.0,5.0,null,9.0,Stage IIIC,Positive,Positive,N3,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,squamous c3,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,YES,YES,NO,LumB,Positive,miRNA cluster 12,cluster 5,Stage IIIC,FEMALE,81.0
TCGA-D8-A1X6-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,3.0,2.0,8.0,7.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T3,Squamous,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,null,NO,YES,NO,LumB,Negative,miRNA cluster 2,cluster 5,Stage IIIA,FEMALE,80.0
TCGA-D8-A1X7-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,1.0,1.0,8.0,9.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Simple Mastectomy,null,null,null,null,"Other, specify",8503/3,null,Fine needle aspiration biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,MX,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,40.0
TCGA-D8-A1X8-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,8.0,1.0,3.0,1.0,9.0,Stage IIIA,Positive,Positive,N2,LumA,null,Indeterminate,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,2+,Indeterminate,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIA,FEMALE,62.0
TCGA-D8-A1X9-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,1.0,6.0,6.0,null,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 14,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Indeterminate,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 4,null,Stage IIB,FEMALE,66.0
TCGA-D8-A1XA-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,1.0,1.0,8.0,2.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,64.0
TCGA-D8-A1XB-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,3.0,8.0,6.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,62.0
TCGA-D8-A1XC-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,1.0,1.0,null,2.0,5.0,3.0,10.0,1.0,1.0,9.0,Stage IIIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T4,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Mucinous Carcinoma,8480/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,NO,YES,NO,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIB,FEMALE,85.0
TCGA-D8-A1XD-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,1.0,null,1.0,5.0,8.0,7.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,[Discrepancy],Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 2,cluster 5,Stage IIIA,FEMALE,36.0
TCGA-D8-A1XF-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,7.0,1.0,null,1.0,null,1.0,2.0,6.0,7.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,45.0
TCGA-D8-A1XG-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,null,1.0,null,3.0,1.0,3.0,1.0,1.0,1.0,9.0,Stage IIIB,Positive,Positive,N1,LumA,null,Negative,enrollment,T_Other,T4,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,NO,YES,NO,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIIB,FEMALE,86.0
TCGA-D8-A1XJ-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,2.0,10.0,6.0,10.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N1,Her2,null,Positive,enrollment,T_Other,T3,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,3+,"Other, specify",8523/3,null,Fine needle aspiration biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,null,NO,YES,NO,Her2,Positive,miRNA cluster 6,cluster 7,Stage IIIA,FEMALE,76.0
TCGA-D8-A1XK-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,2.0,5.0,10.0,7.0,1.0,null,9.0,Stage IIB,Negative,Positive,N1,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,YES,YES,NO,Basal,Negative,miRNA cluster 14,cluster 5,Stage IIB,FEMALE,55.0
TCGA-D8-A1XL-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,1.0,null,2.0,3.0,1.0,10.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,MX,T2,null,YES,YES,NO,LumB,Negative,miRNA c1uster 10,cluster 7,Stage IIB,FEMALE,34.0
TCGA-D8-A1XM-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,1.0,1.0,6.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,57.0
TCGA-D8-A1XO-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,null,null,2.0,null,null,3.0,1.0,10.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,YES,NO,LumA,Negative,miRNA cluster 13,cluster 7,Stage IIB,FEMALE,56.0
TCGA-D8-A1XQ-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,1.0,2.0,10.0,4.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,69.0
TCGA-D8-A1XR-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,2.0,3.0,4.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 7,cluster 3,Stage IIB,FEMALE,56.0
TCGA-D8-A1XS-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,2.0,7.0,3.0,6.0,8.0,1.0,9.0,Stage IIIC,Positive,Positive,N3,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,3+,"Other, specify",8507/3,null,Core needle biopsy,Positive,null,null,False,M0,T2,null,YES,YES,NO,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIIC,MALE,48.0
TCGA-D8-A1XT-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,8.0,6.0,1.0,1.0,9.0,Stage IIA,Negative,Positive,N1,Her2,null,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,61.0
TCGA-D8-A1XU-01,null,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,1.0,6.0,9.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 13,cluster 6,Stage IA,FEMALE,56.0
TCGA-D8-A1XV-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,10.0,1.0,1.0,null,1.0,null,2.0,1.0,6.0,10.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Mucinous Carcinoma,8480/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 14,cluster 7,Stage IIA,FEMALE,84.0
TCGA-D8-A1XW-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,2.0,null,2.0,1.0,10.0,4.0,1.0,1.0,10.0,Stage IIA,Negative,Negative,N0,Normal,null,Positive,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,Low purity c2,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,Normal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,53.0
TCGA-D8-A1XY-01,null,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,3.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Simple Mastectomy,null,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,NO,YES,NO,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,74.0
TCGA-D8-A1XZ-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,1.0,4.0,8.0,7.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumB,null,Negative,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 13,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,null,YES,YES,NO,LumB,Negative,miRNA cluster 7,cluster 5,Stage IIIA,FEMALE,81.0
TCGA-D8-A1Y0-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,1.0,4.0,8.0,10.0,3.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Incisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,null,YES,YES,NO,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,65.0
TCGA-D8-A1Y1-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,1.0,1.0,null,1.0,6.0,8.0,10.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 1,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,null,NO,YES,NO,LumB,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,80.0
TCGA-D8-A1Y2-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,3.0,2.0,1.0,null,1.0,null,10.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Indeterminate,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,NO,YES,NO,LumB,Negative,miRNA c1uster 9,null,Stage IIA,FEMALE,71.0
TCGA-D8-A1Y3-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,2.0,6.0,null,2.0,null,10.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,null,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Indeterminate,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,null,YES,YES,NO,LumB,Negative,miRNA c1uster 10,null,Stage IIIA,FEMALE,61.0
TCGA-D8-A27E-01,null,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,10.0,null,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Quiet,C3-BRCA/Luminal,cluster 5,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,[Discrepancy],NO,null,null,1+,"Other, specify",8523/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 14,null,Stage IA,FEMALE,66.0
TCGA-D8-A27F-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,2.0,3.0,10.0,null,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C1-LUAD-enriched,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,mutation cluster 12,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,YES,YES,NO,Basal,Negative,miRNA cluster 12,null,Stage IIA,FEMALE,40.0
TCGA-D8-A27G-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,1.0,8.0,6.0,null,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 4,null,Stage IIA,FEMALE,75.0
TCGA-D8-A27H-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,10.0,null,null,null,10.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 2,No axillary staging,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,Basal,Negative,miRNA cluster 3,null,Stage IIA,FEMALE,72.0
TCGA-D8-A27I-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,5.0,3.0,1.0,null,2.0,1.0,9.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 5,null,Stage IIIA,FEMALE,58.0
TCGA-D8-A27K-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,null,null,2.0,null,null,4.0,1.0,null,1.0,null,10.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 3,null,Stage IIB,FEMALE,47.0
TCGA-D8-A27L-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,1.0,4.0,1.0,null,1.0,null,10.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 14,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 5,null,Stage IIIA,FEMALE,49.0
TCGA-D8-A27M-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,10.0,null,null,null,10.0,Stage I,Negative,Negative,N0,Basal,null,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,Basal,Negative,miRNA cluster 5,null,Stage IA,FEMALE,59.0
TCGA-D8-A27N-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,1.0,null,1.0,5.0,8.0,null,2.0,1.0,10.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,NO,YES,NO,LumB,Positive,miRNA cluster 4,null,Stage IIIA,FEMALE,36.0
TCGA-D8-A27P-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,3.0,null,1.0,null,10.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,YES,NO,LumA,Negative,miRNA cluster 3,null,Stage IA,FEMALE,64.0
TCGA-D8-A27R-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,2.0,3.0,1.0,null,4.0,null,10.0,Stage IIIC,Positive,Positive,N3,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,null,YES,NO,LumB,Negative,miRNA cluster 5,null,Stage IIIC,FEMALE,41.0
TCGA-D8-A27T-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,3.0,8.0,null,4.0,null,10.0,Stage IIIC,Positive,Positive,N3,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 12,null,Stage IIIC,FEMALE,53.0
TCGA-D8-A27V-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,null,null,1.0,null,null,1.0,8.0,null,1.0,null,10.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA c1uster 10,null,Stage IIA,FEMALE,62.0
TCGA-D8-A27W-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,2.0,3.0,8.0,null,1.0,null,10.0,Stage IIIB,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,2+,Mucinous Carcinoma,8480/3,null,Fine needle aspiration biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,YES,YES,NO,LumB,Positive,miRNA cluster 5,null,Stage IIIB,FEMALE,55.0
TCGA-D8-A3Z5-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,2.0,null,2.0,5.0,null,null,6.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Other (specify),Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-D8-A3Z6-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,1.0,6.0,null,null,6.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Other (specify),Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-D8-A4Z1-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,null,null,1.0,null,null,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Positive,null,Positive,Simple Mastectomy,NO,70-79%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,YES,NO,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-D8-A73U-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,null,1.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,70-79%,<10%,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-D8-A73W-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,1.0,1.0,null,2.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Simple Mastectomy,NO,70-79%,null,1+,Mucinous Carcinoma,8480/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-D8-A73X-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,1.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,70-79%,null,1+,"Other, specify",8211/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-E2-A105-01,10.0,2.0,null,null,null,null,2.0,1.0,3.0,8.0,9.0,2.0,null,null,2.0,null,null,1.0,6.0,1.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,70-79%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,LumA,Equivocal,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,79.0
TCGA-E2-A106-01,8.0,3.0,null,null,null,null,3.0,1.0,10.0,8.0,2.0,9.0,null,null,3.0,1.0,null,4.0,8.0,6.0,1.0,null,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T1,T1,Kirc+,null,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,90-99%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IB,FEMALE,34.0
TCGA-E2-A107-01,3.0,2.0,null,1.0,6.0,10.0,2.0,1.0,10.0,8.0,5.0,6.0,1.0,null,2.0,1.0,1.0,7.0,8.0,6.0,2.0,null,9.0,No_Conversion,Positive,Positive,N2,null,Luminal B,Negative,followup,T_Other,T3,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,null,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,NO,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,54.0
TCGA-E2-A108-01,8.0,2.0,null,1.0,8.0,7.0,2.0,1.0,7.0,4.0,6.0,5.0,1.0,null,2.0,null,2.0,7.0,1.0,6.0,2.0,null,9.0,No_Conversion,Positive,Positive,N2,Normal,Normal-like,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 5,null,Positive,null,Positive,Lumpectomy,null,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,Normal,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,64.0
TCGA-E2-A109-01,10.0,2.0,null,8.0,1.0,10.0,2.0,1.0,3.0,6.0,6.0,5.0,null,null,2.0,1.0,null,2.0,6.0,9.0,1.0,null,8.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Negative,followup,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Positive,null,Negative,Simple Mastectomy,NO,null,50-59%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 6,cluster 6,Stage IIA,FEMALE,64.0
TCGA-E2-A10A-01,3.0,2.0,null,6.0,6.0,10.0,2.0,1.0,10.0,8.0,3.0,8.0,2.0,null,2.0,1.0,2.0,1.0,3.0,1.0,1.0,1.0,8.0,Stage IIB,Positive,Negative,N0,LumA,Luminal B,Positive,followup,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,40-49%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T3,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIB,FEMALE,41.0
TCGA-E2-A10B-01,6.0,2.0,null,1.0,6.0,7.0,2.0,1.0,1.0,8.0,7.0,4.0,2.0,null,2.0,1.0,1.0,7.0,8.0,6.0,1.0,1.0,8.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,67.0
TCGA-E2-A10C-01,6.0,2.0,null,1.0,1.0,10.0,2.0,1.0,9.0,6.0,5.0,6.0,2.0,null,2.0,null,1.0,3.0,8.0,10.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumB,Luminal B,Positive,followup,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA c1uster 10,cluster 7,Stage IIB,FEMALE,54.0
TCGA-E2-A10E-01,3.0,2.0,null,1.0,6.0,7.0,2.0,1.0,1.0,8.0,6.0,4.0,2.0,null,2.0,1.0,2.0,5.0,8.0,6.0,1.0,null,9.0,No_Conversion,Positive,Positive,N1,LumA,Luminal A,Positive,followup,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,40-49%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,64.0
TCGA-E2-A10F-01,3.0,2.0,null,null,null,null,2.0,1.0,7.0,7.0,4.0,7.0,2.0,null,2.0,1.0,1.0,1.0,8.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,followup,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,20-29%,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,47.0
TCGA-E2-A14N-01,8.0,2.0,null,null,null,null,2.0,1.0,1.0,1.0,2.0,9.0,2.0,null,2.0,null,2.0,9.0,10.0,9.0,1.0,null,8.0,Stage IIB,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Simple Mastectomy,NO,null,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 5,cluster 6,Stage IIB,FEMALE,37.0
TCGA-E2-A14O-01,3.0,2.0,null,1.0,6.0,10.0,2.0,1.0,10.0,8.0,8.0,3.0,2.0,null,2.0,1.0,1.0,5.0,8.0,6.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T3,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,null,50-59%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,76.0
TCGA-E2-A14P-01,6.0,1.0,null,1.0,1.0,1.0,1.0,1.0,2.0,6.0,9.0,2.0,2.0,null,2.0,null,2.0,6.0,1.0,6.0,3.0,null,9.0,Stage IIIC,Negative,Positive,N3,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,79.0
TCGA-E2-A14Q-01,3.0,2.0,null,6.0,8.0,7.0,2.0,1.0,10.0,5.0,4.0,7.0,2.0,null,2.0,null,1.0,2.0,3.0,2.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,50.0
TCGA-E2-A14R-01,1.0,2.0,null,null,null,null,2.0,1.0,1.0,1.0,6.0,5.0,2.0,null,2.0,null,1.0,2.0,10.0,7.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,62.0
TCGA-E2-A14S-01,8.0,2.0,null,1.0,6.0,10.0,2.0,1.0,3.0,8.0,7.0,4.0,2.0,null,2.0,1.0,1.0,1.0,8.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,65.0
TCGA-E2-A14T-01,null,2.0,null,null,null,null,2.0,1.0,10.0,8.0,5.0,6.0,1.0,null,3.0,1.0,1.0,2.0,3.0,1.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,null,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,52.0
TCGA-E2-A14U-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,2.0,1.0,1.0,2.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,Quiet,null,null,BRCA non-CIMP c9,null,null,null,Other (specify),Positive,null,Positive,Lumpectomy,NO,null,40-49%,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,NO,YES,LumA,null,miRNA cluster 5,null,Stage I,FEMALE,null
TCGA-E2-A14V-01,10.0,2.0,null,1.0,1.0,1.0,2.0,1.0,10.0,6.0,5.0,6.0,1.0,null,2.0,null,1.0,6.0,8.0,6.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,Her2,HER2-enriched,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,53.0
TCGA-E2-A14W-01,10.0,2.0,null,6.0,6.0,10.0,2.0,1.0,10.0,8.0,9.0,2.0,null,null,2.0,null,null,2.0,3.0,10.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 12,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,Positive,null,null,M0,T2,null,NO,NO,YES,LumB,Positive,miRNA cluster 6,cluster 7,Stage IIA,MALE,78.0
TCGA-E2-A14X-01,8.0,1.0,null,6.0,3.0,4.0,1.0,1.0,1.0,1.0,5.0,6.0,1.0,null,2.0,null,1.0,5.0,10.0,4.0,2.0,null,9.0,Stage IIIA,Negative,Positive,N2,Basal,Basal-like,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIIA,FEMALE,55.0
TCGA-E2-A14Y-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,10.0,2.0,9.0,1.0,null,3.0,null,1.0,2.0,3.0,7.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,Basal,Basal-like,Positive,enrollment,T_Other,T2,Iq,C4-BRCA/Basal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 3,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,NO,YES,Basal,Positive,miRNA cluster 11,cluster 5,Stage IIA,FEMALE,35.0
TCGA-E2-A14Y-11,null,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,3.0,null,2.0,2.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 3,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,NO,YES,null,null,null,null,Stage IIA,FEMALE,35.0
TCGA-E2-A14Z-01,1.0,1.0,null,6.0,3.0,7.0,1.0,1.0,10.0,9.0,6.0,4.0,1.0,1.0,1.0,null,1.0,1.0,1.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage I,FEMALE,64.0
TCGA-E2-A150-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,1.0,4.0,7.0,1.0,null,3.0,null,1.0,1.0,10.0,4.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,squamous c3,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,48.0
TCGA-E2-A152-01,1.0,1.0,null,3.0,3.0,1.0,1.0,1.0,10.0,6.0,5.0,6.0,null,null,3.0,null,null,1.0,1.0,7.0,1.0,null,9.0,Stage I,Positive,Negative,N0,Her2,HER2-enriched,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 1,Cluster 5,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,NO,YES,Her2,Positive,miRNA cluster 12,cluster 5,Stage I,FEMALE,56.0
TCGA-E2-A153-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,4.0,7.0,null,null,1.0,null,null,4.0,1.0,6.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,51.0
TCGA-E2-A153-11,null,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,null,null,1.0,null,null,4.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,51.0
TCGA-E2-A154-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,7.0,4.0,1.0,null,1.0,null,2.0,1.0,8.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage I,FEMALE,68.0
TCGA-E2-A155-01,1.0,1.0,null,8.0,6.0,10.0,1.0,1.0,3.0,8.0,6.0,5.0,1.0,null,1.0,null,2.0,4.0,6.0,7.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Negative,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,NO,YES,LumB,Negative,miRNA cluster 4,cluster 5,Stage IIB,FEMALE,58.0
TCGA-E2-A156-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,6.0,5.0,null,null,1.0,null,null,1.0,3.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,61.0
TCGA-E2-A158-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,10.0,3.0,8.0,1.0,null,1.0,null,1.0,1.0,10.0,7.0,1.0,null,9.0,Stage IIA,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,43.0
TCGA-E2-A158-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,NO,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,43.0
TCGA-E2-A159-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,1.0,2.0,4.0,7.0,1.0,null,1.0,null,2.0,1.0,10.0,4.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,Cluster 5,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,50.0
TCGA-E2-A15A-01,8.0,1.0,null,1.0,1.0,10.0,1.0,1.0,9.0,6.0,3.0,7.0,null,null,1.0,null,null,5.0,8.0,6.0,4.0,null,9.0,Stage IIIC,Positive,Positive,N3,LumB,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,45.0
TCGA-E2-A15A-06,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,7.0,1.0,null,1.0,null,1.0,5.0,null,null,4.0,null,9.0,null,null,null,null,LumB,null,null,enrollment,null,null,null,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,YES,NO,YES,LumB,null,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,45.0
TCGA-E2-A15C-01,8.0,1.0,null,6.0,6.0,7.0,1.0,1.0,7.0,7.0,6.0,5.0,1.0,null,1.0,1.0,1.0,1.0,3.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,20-29%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,61.0
TCGA-E2-A15D-01,null,1.0,null,null,null,null,1.0,1.0,7.0,8.0,4.0,7.0,1.0,null,1.0,1.0,2.0,1.0,1.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,null,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,47.0
TCGA-E2-A15E-01,8.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,3.0,8.0,1.0,null,1.0,null,3.0,3.0,3.0,9.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 2,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,YES,NO,YES,LumA,Positive,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,40.0
TCGA-E2-A15E-06,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,1.0,3.0,null,null,1.0,null,9.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,cluster 2,Low purity c2,null,BRCA nonbasal-like c7,mutation cluster 3,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,YES,NO,YES,LumA,null,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,40.0
TCGA-E2-A15F-01,null,1.0,null,null,null,null,1.0,1.0,8.0,8.0,6.0,4.0,1.0,null,1.0,null,1.0,1.0,3.0,6.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,null,Luminal A,Positive,enrollment,T_Other,T2,null,null,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,64.0
TCGA-E2-A15G-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,1.0,8.0,8.0,3.0,1.0,null,1.0,null,1.0,1.0,1.0,1.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,1+,Mixed Histology (please specify),8522/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 1,Stage IIA,FEMALE,76.0
TCGA-E2-A15H-01,3.0,1.0,null,6.0,1.0,7.0,1.0,1.0,10.0,10.0,2.0,9.0,1.0,null,1.0,null,1.0,1.0,3.0,6.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,NO,NO,YES,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,38.0
TCGA-E2-A15I-01,3.0,1.0,null,null,null,null,1.0,1.0,7.0,5.0,3.0,8.0,1.0,null,2.0,1.0,1.0,1.0,3.0,10.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIA,FEMALE,44.0
TCGA-E2-A15I-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,null,null,2.0,1.0,null,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,NO,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,44.0
TCGA-E2-A15J-01,3.0,1.0,null,1.0,6.0,7.0,1.0,1.0,1.0,8.0,4.0,7.0,1.0,null,2.0,null,1.0,3.0,8.0,6.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,51.0
TCGA-E2-A15K-01,3.0,1.0,null,6.0,6.0,10.0,1.0,1.0,1.0,8.0,6.0,5.0,1.0,null,1.0,1.0,1.0,4.0,3.0,6.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,58.0
TCGA-E2-A15K-06,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,1.0,2.0,4.0,null,null,1.0,null,9.0,null,null,null,null,LumB,null,null,enrollment,null,null,null,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,LumB,null,miRNA cluster 7,cluster 3,Stage IIB,FEMALE,58.0
TCGA-E2-A15K-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,1.0,1.0,4.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,58.0
TCGA-E2-A15L-01,3.0,1.0,null,null,null,null,1.0,1.0,1.0,8.0,7.0,4.0,1.0,null,1.0,1.0,2.0,1.0,3.0,null,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,30-39%,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,NO,YES,LumA,Negative,null,null,Stage IIA,FEMALE,65.0
TCGA-E2-A15L-11,null,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,1.0,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,30-39%,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,NO,YES,null,null,null,null,Stage IIA,FEMALE,65.0
TCGA-E2-A15M-01,6.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,7.0,7.0,4.0,1.0,1.0,1.0,null,2.0,2.0,1.0,9.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal B,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,66.0
TCGA-E2-A15M-11,null,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,null,1.0,1.0,null,null,2.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,66.0
TCGA-E2-A15O-01,8.0,1.0,null,1.0,6.0,7.0,1.0,1.0,10.0,8.0,10.0,1.0,1.0,null,2.0,1.0,1.0,null,8.0,2.0,null,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,No axillary staging,Positive,null,Positive,Lumpectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,89.0
TCGA-E2-A15P-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,1.0,null,1.0,1.0,3.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IA,FEMALE,61.0
TCGA-E2-A15R-01,8.0,1.0,null,8.0,6.0,7.0,1.0,1.0,3.0,8.0,6.0,5.0,1.0,null,3.0,1.0,1.0,1.0,6.0,7.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,64.0
TCGA-E2-A15S-01,null,1.0,null,null,null,null,1.0,1.0,3.0,8.0,2.0,9.0,1.0,null,1.0,null,3.0,4.0,8.0,9.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,Luminal B,Negative,enrollment,T_Other,T2,null,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 2,cluster 6,Stage IIB,FEMALE,34.0
TCGA-E2-A15T-01,null,1.0,null,null,null,null,1.0,1.0,3.0,8.0,7.0,4.0,1.0,null,2.0,1.0,2.0,1.0,8.0,2.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,null,Luminal B,Positive,enrollment,T_Other,T2,null,null,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,65.0
TCGA-E2-A1AZ-01,8.0,3.0,null,null,null,null,3.0,1.0,1.0,1.0,6.0,5.0,4.0,null,3.0,1.0,2.0,1.0,10.0,null,1.0,null,7.0,Stage IIB,Negative,Positive,N1,Basal,Basal-like,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation c1uster 9,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Indeterminate,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Basal,Negative,null,null,Stage IIB,FEMALE,63.0
TCGA-E2-A1B0-01,6.0,2.0,null,1.0,3.0,4.0,2.0,1.0,1.0,2.0,4.0,7.0,2.0,null,2.0,null,1.0,7.0,10.0,6.0,2.0,null,8.0,Stage IIIA,Negative,Positive,N2,Her2,HER2-enriched,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 5,Cluster 5,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Modified Radical Mastectomy,NO,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,Her2,Positive,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,50.0
TCGA-E2-A1B1-01,6.0,2.0,null,1.0,3.0,7.0,2.0,1.0,7.0,5.0,3.0,8.0,2.0,null,4.0,10.0,2.0,2.0,10.0,6.0,1.0,null,8.0,Stage IIB,Positive,Positive,N1,LumA,Luminal A,Positive,enrollment,T_Other,T2,Kirc+,C5-KIRC,cluster 5,Low purity c2,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,70-79%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,45.0
TCGA-E2-A1B4-01,3.0,2.0,null,6.0,6.0,7.0,2.0,1.0,1.0,8.0,8.0,3.0,2.0,2.0,2.0,null,1.0,1.0,3.0,9.0,1.0,null,9.0,Stage IIIA,Positive,Positive,N2,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,10-19%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 3,cluster 6,Stage IIIA,FEMALE,74.0
TCGA-E2-A1B5-01,6.0,2.0,null,6.0,8.0,7.0,2.0,1.0,1.0,1.0,4.0,7.0,1.0,null,2.0,null,2.0,2.0,1.0,9.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Basal-like,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,<10%,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,46.0
TCGA-E2-A1B5-11,null,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,2.0,2.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,<10%,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,null,null,null,null,Stage IIA,FEMALE,46.0
TCGA-E2-A1B6-01,1.0,1.0,null,3.0,3.0,4.0,1.0,1.0,7.0,5.0,3.0,8.0,null,null,2.0,1.0,null,2.0,10.0,9.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,null,Luminal A,Negative,enrollment,T_Other,T2,Quiet,C13-AML,cluster 5,Low purity c2,BRCA basal-like c6,null,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,null,NO,NO,YES,Basal,Negative,miRNA cluster 15,cluster 6,Stage IIA,FEMALE,44.0
TCGA-E2-A1BC-01,3.0,1.0,null,6.0,8.0,7.0,1.0,1.0,7.0,5.0,6.0,5.0,1.0,null,1.0,null,1.0,1.0,3.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8524/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IA,FEMALE,63.0
TCGA-E2-A1BC-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,null,null,1.0,null,null,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8524/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,NO,NO,YES,Normal,null,null,null,Stage IA,FEMALE,63.0
TCGA-E2-A1BD-01,3.0,1.0,null,6.0,6.0,7.0,1.0,1.0,5.0,8.0,5.0,6.0,1.0,null,2.0,1.0,1.0,1.0,8.0,9.0,1.0,null,9.0,Stage IIA,Positive,Negative,N0,LumA,Luminal A,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,53.0
TCGA-E2-A1IE-01,10.0,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,null,null,3.0,1.0,null,1.0,6.0,9.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,20-29%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 6,Stage IIB,FEMALE,61.0
TCGA-E2-A1IF-01,3.0,2.0,null,null,null,null,2.0,1.0,null,null,8.0,3.0,2.0,null,2.0,null,1.0,1.0,10.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 1,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA c1uster 9,cluster 6,Stage I,FEMALE,74.0
TCGA-E2-A1IF-11,null,2.0,null,null,null,null,2.0,1.0,null,null,8.0,3.0,2.0,null,2.0,null,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 1,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,NO,YES,null,null,null,null,Stage I,FEMALE,74.0
TCGA-E2-A1IG-01,10.0,2.0,null,null,null,null,2.0,1.0,null,null,3.0,7.0,null,null,3.0,null,null,1.0,8.0,6.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 12,cluster 4,Stage IIB,FEMALE,45.0
TCGA-E2-A1IG-11,null,2.0,null,null,null,null,2.0,1.0,null,null,3.0,7.0,1.0,null,3.0,null,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,45.0
TCGA-E2-A1IH-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,2.0,null,2.0,null,1.0,1.0,3.0,9.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 10,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,20-29%,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage I,FEMALE,80.0
TCGA-E2-A1II-01,3.0,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,null,null,2.0,null,null,2.0,10.0,7.0,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,null,Positive,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Positive,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,YES,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage I,FEMALE,51.0
TCGA-E2-A1II-11,null,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,2.0,null,2.0,null,1.0,2.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Positive,Lumpectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,null,null,null,null,Stage I,FEMALE,51.0
TCGA-E2-A1IJ-01,6.0,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,1.0,null,2.0,1.0,1.0,1.0,8.0,6.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,57.0
TCGA-E2-A1IK-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,3.0,null,1.0,2.0,1.0,10.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,Quiet,C5-KIRC,cluster 1,Low purity c2,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,NO,NO,YES,LumA,Negative,miRNA cluster 6,cluster 7,Stage IIA,FEMALE,71.0
TCGA-E2-A1IL-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,1.0,1.0,3.0,9.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIA,FEMALE,78.0
TCGA-E2-A1IN-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,null,null,1.0,null,null,1.0,3.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 3,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,60.0
TCGA-E2-A1IO-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,3.0,1.0,1.0,1.0,1.0,6.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 3,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,30-39%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage I,FEMALE,37.0
TCGA-E2-A1IO-11,null,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,3.0,1.0,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,30-39%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,YES,NO,YES,null,null,null,null,Stage I,FEMALE,37.0
TCGA-E2-A1IP-01,null,1.0,null,null,null,null,1.0,1.0,null,null,null,null,1.0,null,null,null,1.0,null,null,null,null,null,null,Stage IIB,Positive,Positive,N1,Basal,null,Negative,enrollment,T_Other,T2,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,False,null,null,null,null,null,null,Basal,Negative,null,null,null,null,42.0
TCGA-E2-A1IU-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,1.0,2.0,1.0,null,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 7,cluster 2,Stage IA,FEMALE,60.0
TCGA-E2-A1L6-01,3.0,2.0,null,null,null,null,2.0,1.0,null,null,3.0,8.0,2.0,null,2.0,null,1.0,2.0,8.0,10.0,1.0,null,8.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,40-49%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 12,cluster 7,Stage IIA,FEMALE,44.0
TCGA-E2-A1L7-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,3.0,null,1.0,5.0,3.0,7.0,3.0,null,9.0,Stage IIIA,Negative,Positive,N2,LumB,null,Negative,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumB,Negative,miRNA cluster 2,cluster 5,Stage IIIA,FEMALE,40.0
TCGA-E2-A1L7-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,3.0,null,2.0,5.0,null,null,3.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIIA,FEMALE,40.0
TCGA-E2-A1L8-01,3.0,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,3.0,1.0,1.0,3.0,8.0,9.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,40-49%,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,Negative,miRNA c1uster 9,cluster 6,Stage IIB,FEMALE,52.0
TCGA-E2-A1L9-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,1.0,null,1.0,1.0,1.0,9.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,80-89%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 4,cluster 6,Stage IIA,FEMALE,40.0
TCGA-E2-A1LA-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,1.0,1.0,8.0,3.0,2.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 12,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,59.0
TCGA-E2-A1LB-01,1.0,2.0,null,null,null,null,2.0,1.0,null,null,3.0,8.0,2.0,null,3.0,null,1.0,6.0,8.0,4.0,1.0,null,9.0,Stage IIB,Negative,Positive,N1,Her2,null,Negative,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,Her2,Positive,miRNA cluster 7,cluster 3,Stage IIB,FEMALE,41.0
TCGA-E2-A1LB-11,null,2.0,null,null,null,null,2.0,1.0,null,null,3.0,8.0,null,null,3.0,null,null,6.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,41.0
TCGA-E2-A1LE-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,2.0,2.0,null,null,3.0,7.0,null,null,8.0,null,9.0,null,null,null,null,null,null,null,null,null,null,Squamous,null,null,BRCA CIMP c7,BRCA basal-like c6,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Simple Mastectomy,NO,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,Her2,null,miRNA cluster 7,null,Stage IIIC,FEMALE,null
TCGA-E2-A1LG-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,1.0,2.0,5.0,10.0,7.0,1.0,null,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,Low purity c2,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,60-69%,2+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Equivocal,Negative,Peri (6-12 months since last menstrual period),False,M0,T2,YES,NO,NO,YES,Basal,Negative,miRNA cluster 11,cluster 5,Stage IIA,FEMALE,50.0
TCGA-E2-A1LH-01,6.0,5.0,null,null,null,null,5.0,1.0,null,null,6.0,5.0,4.0,null,4.0,null,1.0,1.0,10.0,null,1.0,null,6.0,Stage I,Negative,Negative,N0,Basal,null,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,Low purity c2,null,BRCA basal-like c8,mutation cluster 2,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,null,YES,NO,YES,Basal,Negative,null,null,Stage I,FEMALE,59.0
TCGA-E2-A1LH-11,null,5.0,null,null,null,null,5.0,1.0,null,null,6.0,5.0,null,null,4.0,null,null,1.0,null,null,1.0,null,6.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 2,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,YES,NO,YES,Normal,null,null,null,Stage I,FEMALE,59.0
TCGA-E2-A1LI-01,6.0,4.0,null,null,null,null,4.0,1.0,null,null,5.0,6.0,null,null,4.0,1.0,null,1.0,8.0,null,1.0,null,7.0,Stage IIB,Negative,Positive,N1,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 4,BRCA basal-like c8,null,BRCA basal-like c8,mutation c1uster 9,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 7,null,Stage IIB,FEMALE,57.0
TCGA-E2-A1LI-11,null,4.0,null,null,null,null,4.0,1.0,null,null,5.0,6.0,4.0,null,4.0,1.0,1.0,1.0,null,null,1.0,null,7.0,null,null,null,null,null,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation c1uster 9,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,NO,YES,null,null,null,null,Stage IIB,FEMALE,57.0
TCGA-E2-A1LK-01,8.0,null,1.0,null,null,null,1.0,10.0,null,null,10.0,1.0,null,1.0,null,1.0,null,4.0,6.0,7.0,4.0,null,9.0,Stage IIIA,Negative,Positive,N1,Basal,null,Negative,enrollment,T_Other,T3,Squamous,C4-BRCA/Basal,cluster 3,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,80-89%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T4b,null,NO,NO,YES,Basal,Negative,miRNA cluster 11,cluster 5,Stage IIIC,FEMALE,84.0
TCGA-E2-A1LL-01,1.0,2.0,null,null,null,null,2.0,1.0,null,null,8.0,3.0,2.0,null,2.0,null,2.0,10.0,1.0,6.0,2.0,null,9.0,Stage IIIA,Negative,Positive,N2,Basal,null,Negative,enrollment,T_Other,T3,Squamous,C2-Squamous-like,cluster 1,BRCA CIMP c7,KIRC-like c1,squamous-like c4,mutation cluster 4,Axillary lymph node dissection alone,Negative,null,Negative,Simple Mastectomy,NO,null,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,null,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,73.0
TCGA-E2-A1LS-01,null,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,1.0,2.0,6.0,null,1.0,null,9.0,Stage I,Negative,Negative,N0,Basal,null,Negative,enrollment,T1,T1,null,C4-BRCA/Basal,cluster 3,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,NO,NO,YES,Basal,Negative,miRNA cluster 14,null,Stage IA,FEMALE,46.0
TCGA-E2-A1LS-11,null,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,2.0,2.0,null,null,1.0,null,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,NO,NO,YES,Normal,null,null,null,Stage IA,FEMALE,46.0
TCGA-E2-A2P5-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,1.0,1.0,1.0,2.0,6.0,null,null,7.0,null,10.0,null,null,null,null,null,null,null,null,null,null,High,null,null,BRCA CIMP c7,BRCA nonbasal-like c8,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIIC,FEMALE,null
TCGA-E2-A2P6-01,null,null,null,null,null,null,null,null,null,null,8.0,2.0,null,null,2.0,null,null,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,Iq,null,null,BRCA CIMP c7,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,NO,NO,YES,LumA,null,miRNA cluster 14,null,Stage IIB,FEMALE,null
TCGA-E2-A3DX-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,2.0,5.0,1.0,9.0,null,null,8.0,null,10.0,null,null,null,null,LumA,null,null,null,null,null,Quiet,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Positive,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIIC,FEMALE,null
TCGA-E2-A56Z-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,1.0,1.0,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,10-19%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumB,null,null,null,Stage IIB,FEMALE,null
TCGA-E2-A570-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,1.0,1.0,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,NO,NO,YES,LumA,null,null,null,Stage IB,FEMALE,null
TCGA-E2-A572-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,2.0,null,1.0,3.0,null,null,1.0,10.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,1+,Positive,Modified Radical Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-E2-A573-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,2.0,1.0,null,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Other,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Peri (6-12 months since last menstrual period),null,M0,T1c,YES,YES,NO,YES,Basal,null,null,null,Stage IA,FEMALE,null
TCGA-E2-A574-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,2.0,1.0,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,NO,null,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-E2-A576-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,2.0,null,1.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,null,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T1c,YES,YES,NO,YES,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-E2-A9RU-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,1.0,1.0,6.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Lumpectomy,YES,70-79%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,YES,YES,NO,YES,LumB,null,null,null,Stage IIIC,FEMALE,null
TCGA-E9-A1N3-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,2.0,null,2.0,2.0,8.0,null,3.0,null,9.0,Stage IIIA,null,Positive,N2,LumA,null,null,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,NO,YES,NO,LumA,Negative,miRNA cluster 7,null,Stage IIIA,FEMALE,70.0
TCGA-E9-A1N4-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,2.0,2.0,3.0,10.0,2.0,1.0,9.0,Stage IIIA,Positive,Positive,N2,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,null,NO,null,null,null,Mixed Histology (please specify),8520/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIIA,FEMALE,41.0
TCGA-E9-A1N4-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,2.0,2.0,null,null,2.0,1.0,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,null,NO,null,null,null,Mixed Histology (please specify),8520/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIIA,FEMALE,41.0
TCGA-E9-A1N5-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,7.0,1.0,null,2.0,null,1.0,3.0,8.0,2.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,Positive,null,Positive,null,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,45.0
TCGA-E9-A1N5-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,7.0,1.0,null,2.0,null,null,3.0,null,null,1.0,1.0,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 3,Axillary lymph node dissection alone,Positive,null,Positive,null,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Normal,null,null,null,Stage IIB,FEMALE,45.0
TCGA-E9-A1N6-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,1.0,1.0,null,1.0,3.0,8.0,6.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumB,Positive,miRNA c1uster 9,cluster 4,Stage IIB,FEMALE,52.0
TCGA-E9-A1N6-11,null,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,1.0,1.0,null,4.0,3.0,null,null,1.0,1.0,9.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIB,FEMALE,52.0
TCGA-E9-A1N8-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,4.0,2.0,10.0,7.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,null,null,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,null,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,48.0
TCGA-E9-A1N8-11,null,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,3.0,2.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,null,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,null,null,null,null,Stage IIA,FEMALE,48.0
TCGA-E9-A1N9-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,6.0,null,null,2.0,null,null,2.0,1.0,7.0,1.0,1.0,10.0,Stage IIA,Negative,Negative,N0,Basal,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,58.0
TCGA-E9-A1N9-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,6.0,1.0,null,2.0,null,6.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,58.0
TCGA-E9-A1NA-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,1.0,3.0,6.0,6.0,1.0,1.0,10.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,58.0
TCGA-E9-A1NA-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,2.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,58.0
TCGA-E9-A1NC-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,1.0,3.0,10.0,null,1.0,1.0,10.0,Stage IIB,Negative,Positive,N1,null,null,Positive,enrollment,T_Other,T2,Squamous,null,cluster 5,Low purity c2,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Negative,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 13,null,Stage IIB,FEMALE,61.0
TCGA-E9-A1ND-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,2.0,null,2.0,3.0,10.0,7.0,1.0,1.0,10.0,Stage IIB,Negative,Positive,N1,Basal,null,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 5,Cluster 5,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 2,Axillary lymph node dissection alone,Negative,null,Negative,null,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 11,cluster 5,Stage IIB,FEMALE,75.0
TCGA-E9-A1ND-11,null,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,2.0,null,5.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C4-BRCA/Basal,null,null,null,null,mutation cluster 2,Axillary lymph node dissection alone,Negative,null,Negative,null,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Normal,null,null,null,Stage IIB,FEMALE,75.0
TCGA-E9-A1NE-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,1.0,10.0,1.0,null,2.0,null,2.0,1.0,8.0,9.0,1.0,1.0,10.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Infiltrating Ductal Carcinoma,8522/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumA,Negative,miRNA cluster 13,cluster 6,Stage IIB,FEMALE,28.0
TCGA-E9-A1NE-11,null,1.0,null,null,null,null,1.0,1.0,null,null,1.0,10.0,1.0,null,2.0,null,4.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Infiltrating Ductal Carcinoma,8522/3,null,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,null,null,null,null,Stage IIB,FEMALE,28.0
TCGA-E9-A1NF-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,2.0,1.0,null,2.0,3.0,8.0,6.0,1.0,1.0,10.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 13,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,60.0
TCGA-E9-A1NF-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,2.0,1.0,null,7.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 13,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,60.0
TCGA-E9-A1NG-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,1.0,1.0,null,2.0,2.0,3.0,6.0,1.0,1.0,10.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 1,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,62.0
TCGA-E9-A1NG-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,1.0,1.0,null,4.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 1,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,62.0
TCGA-E9-A1NH-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,1.0,2.0,8.0,6.0,1.0,1.0,10.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumA,Negative,miRNA cluster 12,cluster 4,Stage IIB,FEMALE,71.0
TCGA-E9-A1NH-11,null,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,1.0,null,4.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,null,null,null,null,Stage IIB,FEMALE,71.0
TCGA-E9-A1NI-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,6.0,1.0,null,1.0,null,2.0,1.0,8.0,6.0,1.0,1.0,10.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,null,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,51.0
TCGA-E9-A1QZ-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,3.0,5.0,1.0,null,1.0,null,10.0,Stage IIA,null,Negative,N0,LumA,null,null,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,LumA,Negative,miRNA cluster 13,null,Stage IIA,FEMALE,61.0
TCGA-E9-A1R0-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,2.0,3.0,8.0,null,1.0,null,10.0,Stage IIA,null,Positive,N1,LumA,null,null,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,NO,YES,NO,LumA,Negative,miRNA cluster 5,null,Stage IIA,FEMALE,58.0
TCGA-E9-A1R2-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,null,null,2.0,null,null,5.0,8.0,10.0,5.0,null,10.0,Stage IIIC,Positive,Positive,N3,LumA,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Negative,Lumpectomy,NO,90-99%,90-99%,null,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 6,cluster 7,Stage IIIC,FEMALE,51.0
TCGA-E9-A1R3-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,3.0,1.0,6.0,3.0,null,9.0,Stage IIIC,null,Positive,N3,LumA,null,null,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIIC,FEMALE,70.0
TCGA-E9-A1R4-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,3.0,1.0,6.0,1.0,null,10.0,Stage I,null,Negative,N0,LumB,null,null,enrollment,T1,T1,Squamous,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,YES,NO,LumB,Negative,miRNA cluster 6,cluster 4,Stage IA,FEMALE,66.0
TCGA-E9-A1R5-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,6.0,6.0,1.0,null,10.0,Stage I,null,Negative,N0,LumA,null,null,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,YES,NO,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,63.0
TCGA-E9-A1R6-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,4.0,3.0,6.0,2.0,1.0,null,9.0,Stage IIA,null,Negative,N0,LumA,null,null,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,63.0
TCGA-E9-A1R7-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,2.0,3.0,6.0,1.0,1.0,null,10.0,Stage IIA,null,Negative,N0,LumB,null,null,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,64.0
TCGA-E9-A1R7-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,2.0,3.0,null,null,1.0,null,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,64.0
TCGA-E9-A1RA-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,null,null,2.0,null,null,3.0,1.0,9.0,1.0,null,10.0,Stage I,null,Negative,N0,null,null,null,enrollment,T1,T1,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,null,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T1c,YES,YES,YES,NO,LumA,Negative,miRNA cluster 4,cluster 6,Stage IA,FEMALE,48.0
TCGA-E9-A1RB-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,2.0,1.0,null,3.0,3.0,1.0,null,1.0,1.0,10.0,Stage IIA,null,Negative,N0,LumB,null,null,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,YES,NO,LumB,Negative,miRNA cluster 4,null,Stage IIA,FEMALE,40.0
TCGA-E9-A1RB-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,2.0,1.0,null,3.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 5,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,40.0
TCGA-E9-A1RC-01,6.0,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,2.0,null,3.0,3.0,6.0,null,3.0,1.0,8.0,Stage IIIC,null,Positive,N3,LumA,null,null,enrollment,T_Other,T4,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T4b,null,NO,YES,NO,LumA,Negative,miRNA cluster 14,null,Stage IIIC,FEMALE,56.0
TCGA-E9-A1RC-11,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,2.0,null,5.0,3.0,null,null,3.0,1.0,8.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,null,NO,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,56.0
TCGA-E9-A1RD-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,null,null,1.0,null,null,3.0,6.0,null,1.0,null,10.0,Stage IIA,null,Negative,N0,LumA,null,null,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 3,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 13,null,Stage IIA,FEMALE,67.0
TCGA-E9-A1RD-11,null,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,3.0,3.0,null,null,1.0,null,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,NO,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,67.0
TCGA-E9-A1RE-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,2.0,null,4.0,3.0,6.0,null,3.0,null,10.0,Stage IIIA,null,Positive,N2,LumB,null,null,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA c1uster 9,null,Stage IIIA,FEMALE,74.0
TCGA-E9-A1RF-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,3.0,6.0,null,2.0,null,10.0,Stage IIIA,null,Positive,N2,LumA,null,null,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 4,null,Stage IIIA,FEMALE,68.0
TCGA-E9-A1RF-11,null,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,5.0,3.0,null,null,2.0,null,10.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,null,YES,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,68.0
TCGA-E9-A1RG-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,3.0,3.0,3.0,7.0,2.0,null,10.0,Stage IIIA,null,Positive,N2,null,null,null,enrollment,T1,T1,High,C1-LUAD-enriched,cluster 2,Cluster 5,BRCA nonbasal-like c8,null,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,YES,NO,LumB,Negative,miRNA cluster 2,cluster 5,Stage IIIA,FEMALE,62.0
TCGA-E9-A1RH-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,2.0,3.0,8.0,6.0,1.0,null,10.0,Stage IIA,null,Negative,N0,Her2,null,null,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,Her2,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,63.0
TCGA-E9-A1RH-11,null,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,4.0,3.0,null,null,1.0,null,10.0,null,null,null,null,Normal,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Normal,null,null,null,Stage IIA,FEMALE,63.0
TCGA-E9-A1RI-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,2.0,3.0,1.0,6.0,2.0,null,10.0,Stage IIIA,null,Positive,N2,LumA,null,null,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,YES,YES,NO,LumA,null,miRNA cluster 4,cluster 4,Stage IIIA,FEMALE,43.0
TCGA-E9-A1RI-11,null,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,4.0,3.0,null,null,2.0,null,10.0,null,null,null,null,LumA,null,null,enrollment,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Mixed Histology (please specify),8522/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,YES,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,43.0
TCGA-E9-A226-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,2.0,1.0,null,3.0,3.0,6.0,null,2.0,null,10.0,Stage IIIA,null,Positive,N2,LumB,null,null,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 3,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA cluster 4,null,Stage IIIA,FEMALE,45.0
TCGA-E9-A227-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,1.0,4.0,1.0,null,1.0,null,10.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 1,Sentinel lymph node biopsy plus axillary dissection,Positive,4+,Positive,Lumpectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,4+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,YES,NO,LumA,Negative,miRNA cluster 14,null,Stage IIB,FEMALE,42.0
TCGA-E9-A228-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,4.0,3.0,6.0,null,1.0,null,10.0,Stage IIB,null,Positive,N1,LumB,null,null,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumB,Positive,miRNA cluster 14,null,Stage IIB,FEMALE,58.0
TCGA-E9-A229-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,2.0,null,1.0,4.0,1.0,null,1.0,null,10.0,Stage I,null,Negative,N0,LumA,null,null,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,YES,YES,NO,LumA,Negative,miRNA cluster 4,null,Stage IA,FEMALE,37.0
TCGA-E9-A22A-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,1.0,null,2.0,null,2.0,1.0,6.0,null,1.0,1.0,10.0,Stage IIA,Positive,Negative,N0,LumB,null,Negative,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Negative,null,YES,10-19%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumB,Negative,miRNA c1uster 9,null,Stage IIA,FEMALE,74.0
TCGA-E9-A22B-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,null,null,2.0,null,null,1.0,6.0,null,1.0,1.0,10.0,Stage I,Positive,Negative,N0,LumA,null,Negative,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Negative,null,YES,10-19%,null,null,Mixed Histology (please specify),8522/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,YES,NO,LumA,Negative,miRNA c1uster 9,null,Stage IA,FEMALE,71.0
TCGA-E9-A22D-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,2.0,null,3.0,3.0,6.0,null,1.0,1.0,10.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,YES,10-19%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,YES,NO,LumB,Positive,miRNA cluster 4,null,Stage IIA,FEMALE,38.0
TCGA-E9-A22E-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,2.0,null,3.0,3.0,8.0,null,2.0,1.0,10.0,Stage IIIA,Positive,Positive,N2,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,10-19%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA c1uster 9,null,Stage IIIA,FEMALE,56.0
TCGA-E9-A22G-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,2.0,null,3.0,2.0,6.0,null,1.0,1.0,10.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,Squamous,C4-BRCA/Basal,cluster 3,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,null,YES,null,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,Negative,miRNA cluster 1,null,Stage IIA,FEMALE,47.0
TCGA-E9-A22H-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,3.0,2.0,1.0,null,1.0,1.0,10.0,Stage IIB,Positive,Positive,N1,LumB,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,YES,<10%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,Positive,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA cluster 6,null,Stage IIB,FEMALE,42.0
TCGA-E9-A243-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,2.0,3.0,10.0,4.0,1.0,null,10.0,Stage IIA,null,Negative,N0,Basal,null,null,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,OV-like c1,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Peri (6-12 months since last menstrual period),True,M0,T2,null,YES,YES,NO,Basal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,52.0
TCGA-E9-A244-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,2.0,3.0,10.0,null,1.0,null,10.0,Stage IIA,null,Negative,N0,Basal,null,null,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,YES,NO,Basal,Negative,miRNA c1uster 9,null,Stage IIA,FEMALE,54.0
TCGA-E9-A245-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,3.0,3.0,3.0,null,1.0,null,10.0,Stage IIB,null,Positive,N1,LumA,null,null,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,NO,YES,NO,LumA,Negative,miRNA cluster 6,null,Stage IIB,FEMALE,47.0
TCGA-E9-A247-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,2.0,3.0,6.0,null,1.0,null,10.0,Stage I,null,Negative,N0,LumA,null,null,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,YES,NO,LumA,Negative,miRNA cluster 6,null,Stage IA,FEMALE,59.0
TCGA-E9-A248-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,3.0,3.0,1.0,4.0,1.0,null,10.0,Stage IIA,null,Negative,N0,Her2,null,null,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 1,OV-like c1,BRCA basal-like c6,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Peri (6-12 months since last menstrual period),True,M0,T2,null,NO,YES,NO,Her2,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,51.0
TCGA-E9-A249-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,7.0,1.0,null,1.0,null,3.0,3.0,8.0,4.0,1.0,null,10.0,Stage IIA,null,Negative,N0,LumB,null,null,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,YES,NO,LumB,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,45.0
TCGA-E9-A24A-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,3.0,3.0,2.0,1.0,null,10.0,Stage IIA,null,Positive,N1,LumA,null,null,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Axillary lymph node dissection alone,null,null,null,null,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,YES,NO,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIA,FEMALE,69.0
TCGA-E9-A295-01,6.0,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,4.0,2.0,8.0,null,1.0,1.0,10.0,null,null,null,null,LumA,null,null,null,null,null,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,YES,80-89%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,miRNA cluster 6,null,Stage IIA,FEMALE,null
TCGA-E9-A2JS-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,2.0,1.0,null,2.0,3.0,null,null,1.0,null,10.0,null,null,null,null,LumB,null,null,null,null,null,High,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumB,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-E9-A2JT-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,null,null,1.0,null,10.0,null,null,null,null,LumA,null,null,null,null,null,Kirc+,C3-BRCA/Luminal,null,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,null,null,null,Lumpectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumA,null,miRNA cluster 5,null,Stage IIA,FEMALE,null
TCGA-E9-A3HO-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,null,null,2.0,null,null,3.0,null,null,1.0,null,10.0,null,null,null,null,LumB,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,null,null,null,Modified Radical Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Cytology (e.g. Peritoneal or pleural fluid),null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T2,YES,NO,YES,NO,LumB,null,null,null,Stage IIA,FEMALE,null
TCGA-E9-A3Q9-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,null,2.0,null,3.0,6.0,null,null,7.0,1.0,10.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,null,YES,40-49%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Indeterminate,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,NO,YES,NO,LumA,null,miRNA cluster 6,null,Stage IIIC,FEMALE,null
TCGA-E9-A3QA-01,null,null,null,null,null,null,null,null,null,null,2.0,9.0,1.0,null,2.0,null,4.0,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,High,null,null,Low purity c2,BRCA basal-like c6,null,null,Axillary lymph node dissection alone,null,null,null,null,null,null,null,null,Medullary Carcinoma,8510/3,null,Tumor resection,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,NO,NO,YES,NO,Basal,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-E9-A3X8-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,null,2.0,2.0,null,null,2.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA nonbasal-like c8,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,YES,20-29%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-E9-A54X-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Lumpectomy,NO,90-99%,null,null,Mucinous Carcinoma,8480/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1b,NO,NO,YES,NO,LumB,null,null,null,Stage IA,FEMALE,null
TCGA-E9-A54Y-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,2.0,3.0,null,null,3.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,NO,NO,YES,NO,LumB,null,null,null,Stage IIIA,FEMALE,null
TCGA-E9-A5FK-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,3.0,3.0,null,null,3.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,80-89%,null,null,Infiltrating Lobular Carcinoma,8520/3,3+,Cytology (e.g. Peritoneal or pleural fluid),Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-E9-A5FL-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,3.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Negative,null,Negative,Modified Radical Mastectomy,NO,null,null,null,Metaplastic Carcinoma,8575/3,null,Cytology (e.g. Peritoneal or pleural fluid),Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,NO,NO,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-E9-A5UO-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,1.0,null,2.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,null,null,null,Other,NO,null,null,null,Mucinous Carcinoma,8480/3,null,Fine needle aspiration biopsy,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,NO,NO,YES,NO,LumB,null,null,null,Stage IIA,FEMALE,null
TCGA-E9-A5UP-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,1.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,null,null,null,null,NO,null,null,null,"Other, specify",8503/3,null,Tumor resection,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-E9-A6HE-01,null,null,null,null,null,null,null,null,null,null,3.0,7.0,null,null,2.0,1.0,null,3.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,NO,90-99%,<10%,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-EW-A1IW-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,9.0,2.0,1.0,null,1.0,null,1.0,3.0,6.0,6.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Iq,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,null,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,YES,90-99%,90-99%,3+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,NO,NO,YES,LumA,Positive,miRNA cluster 4,cluster 4,Stage IIB,FEMALE,80.0
TCGA-EW-A1IX-01,8.0,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,2.0,null,2.0,null,1.0,7.0,1.0,6.0,1.0,2.0,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,Kirc+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,KIRC-like c1,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,YES,90-99%,<10%,null,"Other, specify",8524/3,3+,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),True,MX,T1b,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,48.0
TCGA-EW-A1IY-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,1.0,null,1.0,2.0,1.0,10.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumB,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation cluster 4,Other (specify),Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T1c,null,NO,NO,YES,LumB,Negative,miRNA cluster 12,cluster 7,Stage I,FEMALE,38.0
TCGA-EW-A1IZ-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,4.0,3.0,4.0,2.0,null,9.0,Stage IIIA,Positive,Positive,N2,null,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,null,mutation cluster 4,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,"Other method, specify:",Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage IIIA,FEMALE,53.0
TCGA-EW-A1J1-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,2.0,9.0,1.0,null,1.0,null,1.0,4.0,3.0,7.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,38.0
TCGA-EW-A1J2-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,1.0,null,1.0,null,1.0,5.0,3.0,9.0,1.0,2.0,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Other,YES,90-99%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 13,cluster 6,[Discrepancy],FEMALE,50.0
TCGA-EW-A1J3-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,8.0,2.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Other,YES,90-99%,90-99%,3+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,NO,NO,YES,LumA,Positive,miRNA cluster 14,cluster 2,Stage IA,FEMALE,61.0
TCGA-EW-A1J5-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,8.0,10.0,1.0,1.0,9.0,Stage IIB,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T3,Iq,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Positive,3+,Positive,Other,YES,90-99%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,NO,NO,YES,LumA,Negative,miRNA c1uster 10,cluster 7,Stage IIB,FEMALE,59.0
TCGA-EW-A1J6-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,2.0,null,1.0,1.0,10.0,2.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumB,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,NO,NO,YES,LumB,Negative,miRNA cluster 14,cluster 2,Stage I,FEMALE,70.0
TCGA-EW-A1OV-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,null,null,1.0,1.0,null,2.0,8.0,7.0,1.0,2.0,9.0,Stage IIB,Negative,Positive,N1,Her2,null,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T2,null,NO,NO,YES,Her2,Negative,miRNA cluster 12,cluster 5,Stage IIB,FEMALE,56.0
TCGA-EW-A1OW-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,10.0,null,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,<10%,1+,Infiltrating Ductal Carcinoma,8090/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,YES,NO,YES,Basal,Negative,null,null,Stage IIA,FEMALE,58.0
TCGA-EW-A1OX-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,1.0,1.0,6.0,1.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Other (specify),Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,null,Mucinous Carcinoma,8523/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 6,cluster 1,Stage IIA,FEMALE,43.0
TCGA-EW-A1OY-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,2.0,null,1.0,1.0,3.0,6.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,YES,NO,YES,LumB,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,63.0
TCGA-EW-A1OZ-01,10.0,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,2.0,2.0,1.0,1.0,8.0,6.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumB,null,Negative,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,mutation cluster 8,Sentinel node biopsy alone,Positive,null,Negative,Other,YES,90-99%,20-29%,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,LumB,Positive,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,56.0
TCGA-EW-A1P0-01,8.0,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,2.0,null,1.0,5.0,10.0,10.0,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumB,null,Negative,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 5,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,NO,90-99%,<10%,null,"Other, specify",8523/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,YES,NO,YES,LumB,Negative,miRNA c1uster 10,cluster 7,Stage IIB,FEMALE,55.0
TCGA-EW-A1P1-01,1.0,2.0,null,null,null,null,2.0,1.0,null,null,7.0,4.0,2.0,null,2.0,1.0,1.0,8.0,1.0,9.0,4.0,null,9.0,Stage IIIC,Negative,Positive,N3,null,null,Negative,enrollment,T_Other,T2,Kirc+,C5-KIRC,cluster 1,Low purity c2,KIRC-like c1,null,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,<10%,<10%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,YES,NO,YES,Normal,Negative,miRNA cluster 13,cluster 6,Stage IIIC,FEMALE,68.0
TCGA-EW-A1P3-01,3.0,2.0,null,null,null,null,2.0,1.0,null,null,4.0,7.0,2.0,null,2.0,null,1.0,1.0,1.0,6.0,1.0,1.0,9.0,Stage IIA,Positive,Negative,N0,LumA,null,Positive,enrollment,T_Other,T2,BRCA-LUAD+,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Other (specify),Positive,3+,Positive,Simple Mastectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T2,YES,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IIA,FEMALE,48.0
TCGA-EW-A1P4-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,8.0,1.0,null,2.0,null,2.0,1.0,10.0,7.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,mutation cluster 5,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,<10%,null,Medullary Carcinoma,8510/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,null,YES,NO,YES,Basal,Negative,miRNA cluster 4,cluster 5,Stage IIA,FEMALE,43.0
TCGA-EW-A1P5-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,8.0,3.0,null,null,1.0,1.0,null,10.0,8.0,4.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,High,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 6,cluster 3,Stage IIB,FEMALE,77.0
TCGA-EW-A1P6-01,8.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,6.0,3.0,2.0,1.0,1.0,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Kirc+,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,miRNA cluster 14,cluster 2,Stage IIB,FEMALE,64.0
TCGA-EW-A1P7-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,null,null,2.0,1.0,null,1.0,10.0,4.0,1.0,1.0,9.0,Stage IIA,Negative,Negative,N0,Normal,null,Negative,enrollment,T_Other,T2,Kirc+,C4-BRCA/Basal,cluster 5,Low purity c2,null,BRCA basal-like c8,mutation c1uster 9,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,null,NO,NO,YES,Normal,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,59.0
TCGA-EW-A1P8-01,6.0,1.0,1.0,null,null,null,1.0,10.0,null,null,6.0,5.0,1.0,1.0,null,null,1.0,4.0,10.0,7.0,5.0,null,9.0,Stage IIIC,Negative,Positive,N3,Basal,null,Negative,enrollment,T_Other,T2,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 12,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,NO,<10%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,NO,NO,YES,Basal,Negative,miRNA cluster 12,cluster 5,Stage IIIC,FEMALE,58.0
TCGA-EW-A1PA-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,null,1.0,3.0,8.0,null,1.0,null,9.0,Stage IIB,Positive,Positive,N1,LumA,null,Positive,enrollment,T_Other,T2,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 5,Axillary lymph node dissection alone,Positive,3+,Positive,Lumpectomy,NO,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,null,YES,NO,YES,LumA,Negative,null,null,Stage IIB,FEMALE,59.0
TCGA-EW-A1PB-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,7.0,4.0,1.0,null,1.0,null,2.0,2.0,10.0,2.0,1.0,null,9.0,Stage IIIA,Negative,Positive,N1,Basal,null,Negative,enrollment,T_Other,T3,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,mutation cluster 5,Axillary lymph node dissection alone,Negative,null,Negative,Simple Mastectomy,NO,<10%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T3,null,NO,NO,YES,Basal,Negative,miRNA cluster 14,cluster 2,Stage IIIA,FEMALE,70.0
TCGA-EW-A1PC-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,LumB,null,null,null,null,null,High,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,3+,Positive,Modified Radical Mastectomy,YES,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T3,null,NO,NO,YES,LumB,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-EW-A1PD-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,6.0,5.0,1.0,null,1.0,2.0,1.0,2.0,3.0,6.0,1.0,null,9.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,High,C3-BRCA/Luminal,cluster 2,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,20-29%,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Positive,null,True,M0,T1c,null,NO,NO,YES,LumA,Positive,miRNA cluster 14,cluster 4,Stage IIA,MALE,61.0
TCGA-EW-A1PE-01,3.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,6.0,1.0,4.0,1.0,null,10.0,Stage IIA,Positive,Positive,N1,LumA,null,Positive,enrollment,T1,T1,Iq,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation cluster 4,Axillary lymph node dissection alone,Positive,3+,Positive,Lumpectomy,NO,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8507/3,3+,[Discrepancy],Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,null,YES,NO,YES,LumA,Negative,miRNA cluster 7,cluster 3,Stage IIA,FEMALE,56.0
TCGA-EW-A1PF-01,10.0,1.0,null,null,null,null,1.0,1.0,null,null,4.0,7.0,null,null,1.0,null,null,3.0,1.0,6.0,1.0,1.0,9.0,Stage I,Positive,Negative,N0,LumA,null,Positive,enrollment,T1,T1,Kirc+,null,cluster 1,BRCA CIMP c7,null,BRCA nonbasal-like c7,null,Other (specify),Positive,3+,Positive,Other,YES,90-99%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,null,NO,NO,YES,LumA,Negative,miRNA cluster 4,cluster 4,Stage IA,FEMALE,50.0
TCGA-EW-A1PG-01,1.0,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,2.0,1.0,1.0,6.0,1.0,9.0,1.0,2.0,9.0,Stage IIB,Positive,Positive,N1,Normal,null,Positive,enrollment,T_Other,T2,Quiet,C3-BRCA/Luminal,cluster 1,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,YES,90-99%,10-19%,2+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,null,NO,NO,YES,Normal,Negative,miRNA cluster 14,cluster 6,Stage IIB,FEMALE,53.0
TCGA-EW-A1PH-01,1.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,3.0,10.0,7.0,1.0,1.0,9.0,Stage IIA,Negative,Positive,N1,Basal,null,Negative,enrollment,T1,T1,High,C4-BRCA/Basal,cluster 5,BRCA basal-like c8,null,BRCA basal-like c8,mutation cluster 5,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,<10%,<10%,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,YES,NO,YES,Basal,null,miRNA cluster 12,cluster 5,Stage IIA,FEMALE,52.0
TCGA-EW-A2FR-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,2.0,null,2.0,2.0,1.0,5.0,null,null,6.0,null,9.0,null,null,null,null,Her2,null,null,null,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Negative,1+,Negative,Lumpectomy,NO,<10%,10-19%,2+,Infiltrating Ductal Carcinoma,8500/3,1+,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T1b,YES,YES,NO,YES,Her2,null,miRNA cluster 4,null,Stage IIIC,FEMALE,null
TCGA-EW-A2FS-01,10.0,2.0,null,null,null,null,2.0,1.0,null,null,3.0,8.0,null,null,2.0,null,null,2.0,8.0,null,1.0,null,9.0,null,Positive,null,null,LumA,null,Negative,enrollment,null,null,Squamous,C3-BRCA/Luminal,cluster 4,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,1+,Negative,Lumpectomy,YES,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,MX,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIB,FEMALE,41.0
TCGA-EW-A2FV-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,3.0,9.0,1.0,null,1.0,null,1.0,8.0,8.0,null,9.0,null,10.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,BRCA-LUAD+,C3-BRCA/Luminal,cluster 4,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,1+,"Other, specify",8507/3,3+,Excisional Biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T3,YES,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIIC,FEMALE,39.0
TCGA-EW-A2FW-01,6.0,1.0,null,null,null,null,1.0,1.0,null,null,5.0,6.0,1.0,null,1.0,null,1.0,2.0,3.0,null,1.0,1.0,10.0,null,Positive,null,null,LumB,null,Positive,enrollment,null,null,Iq,C3-BRCA/Luminal,cluster 2,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,YES,90-99%,<10%,1+,"Other, specify",8503/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,YES,YES,NO,YES,LumB,null,miRNA cluster 6,null,Stage IIA,FEMALE,52.0
TCGA-EW-A3E8-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,2.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,null,True,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-EW-A3U0-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,2.0,6.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,High,null,null,Low purity c2,BRCA basal-like c6,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Other,NO,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,YES,YES,YES,NO,Basal,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-EW-A423-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,NO,50-59%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,[Discrepancy],[Discrepancy],YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-EW-A424-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,50-59%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Positive,null,null,True,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-EW-A6S9-01,null,null,null,null,null,null,null,null,null,null,2.0,9.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Lumpectomy,null,50-59%,50-59%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,null,True,M0,T1c,NO,NO,null,null,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-EW-A6SA-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,1.0,1.0,null,null,null,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Negative,Simple Mastectomy,YES,50-59%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,MX,T2,YES,NO,YES,NO,LumB,null,null,null,Stage II,MALE,null
TCGA-EW-A6SB-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,1.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Modified Radical Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,null,True,M0,T2,YES,YES,null,null,Basal,null,null,null,Stage II,FEMALE,null
TCGA-EW-A6SC-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,2.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,50-59%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,null,True,M0,T2,YES,YES,null,null,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-EW-A6SD-01,null,null,null,null,null,null,null,null,null,null,1.0,10.0,1.0,null,2.0,null,1.0,8.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Negative,null,Negative,Lumpectomy,null,<10%,null,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,null,null,True,M0,T2,YES,YES,YES,NO,Her2,null,null,null,Stage IIB,FEMALE,null
TCGA-GI-A2C8-01,6.0,null,null,null,null,null,null,null,null,null,6.0,5.0,4.0,null,1.0,null,1.0,3.0,6.0,null,1.0,null,7.0,null,null,null,null,LumA,null,null,null,null,null,Squamous,C3-BRCA/Luminal,cluster 3,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,mutation c1uster 9,Sentinel node biopsy alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,null,Negative,Negative,null,False,MX,T4b,null,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIIB,FEMALE,null
TCGA-GI-A2C8-11,null,null,null,null,null,null,null,null,null,null,6.0,5.0,4.0,null,1.0,null,1.0,3.0,null,null,1.0,null,7.0,null,null,null,null,LumA,null,null,null,null,null,null,C3-BRCA/Luminal,null,null,null,null,mutation c1uster 9,Sentinel node biopsy alone,Positive,2+,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,null,Negative,Negative,null,False,MX,T4b,null,YES,NO,YES,LumA,null,null,null,Stage IIIB,FEMALE,null
TCGA-GI-A2C9-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,4.0,null,4.0,null,1.0,1.0,null,null,1.0,1.0,7.0,null,null,null,null,Basal,null,null,null,null,null,High,C4-BRCA/Basal,null,BRCA basal-like c8,BRCA basal-like c6,BRCA basal-like c8,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,null,YES,NO,YES,Basal,null,miRNA cluster 4,null,Stage IIB,FEMALE,null
TCGA-GI-A2C9-11,null,null,null,null,null,null,null,null,null,null,6.0,5.0,4.0,null,4.0,null,1.0,1.0,null,null,1.0,1.0,7.0,null,null,null,null,Normal,null,null,null,null,null,null,C4-BRCA/Basal,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,null,YES,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,null
TCGA-GM-A2D9-01,null,null,4.0,null,null,null,3.0,10.0,null,null,7.0,4.0,3.0,3.0,null,1.0,1.0,1.0,null,null,1.0,1.0,8.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,YES,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumA,null,miRNA cluster 3,null,Stage I,FEMALE,69.0
TCGA-GM-A2DA-01,null,9.0,null,null,null,null,9.0,1.0,null,null,4.0,7.0,null,9.0,7.0,3.0,null,3.0,null,null,1.0,1.0,3.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,Iq,null,null,BRCA non-CIMP c9,null,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,90-99%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIB,FEMALE,46.0
TCGA-GM-A2DB-01,null,3.0,null,null,null,null,3.0,1.0,null,null,6.0,5.0,3.0,null,3.0,1.0,1.0,1.0,null,null,1.0,1.0,8.0,null,Negative,null,null,Her2,null,Negative,enrollment,null,null,Squamous,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA basal-like c6,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Her2,null,miRNA cluster 5,null,Stage IIA,FEMALE,62.0
TCGA-GM-A2DC-01,null,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,null,null,3.0,1.0,null,5.0,null,null,1.0,1.0,8.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,YES,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIA,FEMALE,57.0
TCGA-GM-A2DD-01,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,null,null,3.0,1.0,null,1.0,null,null,1.0,1.0,8.0,null,Negative,null,null,Normal,null,Negative,enrollment,null,null,High,C3-BRCA/Luminal,null,BRCA CIMP c7,KIRC-like c1,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,<10%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,NO,YES,Normal,null,miRNA cluster 5,null,Stage I,FEMALE,53.0
TCGA-GM-A2DF-01,null,2.0,null,null,null,null,2.0,1.0,null,null,5.0,6.0,2.0,null,3.0,1.0,1.0,8.0,null,null,1.0,1.0,8.0,null,Negative,null,null,Basal,null,Negative,enrollment,null,null,High,C4-BRCA/Basal,null,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,null,Axillary lymph node dissection alone,Negative,null,Negative,Lumpectomy,NO,<10%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,Basal,null,miRNA cluster 5,null,Stage IIA,FEMALE,53.0
TCGA-GM-A2DH-01,null,2.0,null,null,null,null,2.0,1.0,null,null,6.0,5.0,null,null,3.0,1.0,null,1.0,null,null,1.0,2.0,8.0,null,Negative,null,null,Her2,null,Negative,enrollment,null,null,High,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA basal-like c6,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,NO,NO,YES,Her2,null,miRNA c1uster 10,null,Stage I,FEMALE,58.0
TCGA-GM-A2DI-01,null,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,3.0,null,4.0,1.0,1.0,3.0,null,null,1.0,2.0,7.0,null,Negative,null,null,LumA,null,Negative,enrollment,null,null,Squamous,C3-BRCA/Luminal,null,Low purity c2,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T1c,YES,NO,NO,YES,LumA,null,miRNA cluster 3,null,Stage I,FEMALE,52.0
TCGA-GM-A2DK-01,null,3.0,null,null,null,null,3.0,1.0,null,null,6.0,6.0,3.0,null,4.0,null,1.0,1.0,null,null,1.0,1.0,7.0,null,Positive,null,null,LumA,null,Negative,enrollment,null,null,COAD-READ,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,YES,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumA,null,miRNA cluster 5,null,Stage I,FEMALE,58.0
TCGA-GM-A2DL-01,null,4.0,null,null,null,null,4.0,1.0,null,null,4.0,7.0,4.0,null,5.0,null,1.0,1.0,null,null,1.0,1.0,7.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,BRCA-LUAD+,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Peri (6-12 months since last menstrual period),False,M0,T1c,YES,YES,NO,YES,LumA,null,miRNA cluster 5,null,Stage I,FEMALE,50.0
TCGA-GM-A2DM-01,null,4.0,null,null,null,null,4.0,1.0,null,null,5.0,6.0,4.0,null,4.0,null,1.0,1.0,null,null,1.0,1.0,7.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,Quiet,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,40-49%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 6,null,Stage IIA,FEMALE,57.0
TCGA-GM-A2DN-01,null,4.0,null,null,null,null,4.0,1.0,null,null,6.0,6.0,4.0,null,4.0,null,1.0,3.0,null,null,1.0,1.0,7.0,null,Positive,null,null,LumA,null,Positive,enrollment,null,null,Iq,C3-BRCA/Luminal,null,BRCA non-CIMP c9,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumA,null,miRNA cluster 5,null,Stage IIA,FEMALE,58.0
TCGA-GM-A2DO-01,null,3.0,null,null,null,null,3.0,1.0,null,null,5.0,6.0,3.0,null,4.0,null,1.0,1.0,null,null,1.0,1.0,8.0,null,Positive,null,null,LumB,null,Positive,enrollment,null,null,Kirc+,C3-BRCA/Luminal,null,Cluster 5,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumB,null,miRNA cluster 4,null,Stage I,FEMALE,54.0
TCGA-GM-A3NW-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,null,null,4.0,1.0,null,1.0,null,null,1.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,BRCA-LUAD+,null,null,BRCA CIMP c7,null,null,null,Sentinel node biopsy alone,Negative,null,Positive,Simple Mastectomy,YES,null,30-39%,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,YES,NO,NO,YES,LumA,null,miRNA cluster 14,null,Stage IIA,FEMALE,null
TCGA-GM-A3NY-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,2.0,null,1.0,3.0,null,null,1.0,1.0,9.0,null,null,null,null,LumA,null,null,null,null,null,Iq,C3-BRCA/Luminal,null,BRCA CIMP c7,BRCA nonbasal-like c8,BRCA nonbasal-like c7,null,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,LumA,null,miRNA cluster 6,null,Stage IIB,FEMALE,null
TCGA-GM-A3XG-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,2.0,null,2.0,1.0,2.0,6.0,null,null,1.0,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T3,YES,YES,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-GM-A3XL-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,3.0,null,3.0,1.0,1.0,1.0,null,null,1.0,1.0,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA basal-like c6,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,<10%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,NO,YES,Basal,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-GM-A3XN-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,3.0,null,3.0,1.0,1.0,8.0,null,null,2.0,1.0,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA nonbasal-like c8,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Lumpectomy,NO,80-89%,null,1+,Infiltrating Lobular Carcinoma,8520/3,null,Incisional Biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T1c,YES,YES,NO,YES,LumA,null,miRNA cluster 4,null,Stage IIIA,FEMALE,null
TCGA-GM-A4E0-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,3.0,null,3.0,null,1.0,6.0,null,null,3.0,2.0,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,YES,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T3,YES,YES,NO,YES,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-GM-A5PV-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,1.0,6.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-GM-A5PX-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,3.0,null,null,1.0,3.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,YES,90-99%,30-39%,1+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-HN-A2NL-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,1.0,null,1.0,1.0,null,null,1.0,1.0,null,null,null,null,null,Basal,null,null,null,null,null,Squamous,C4-BRCA/Basal,null,BRCA basal-like c8,KIRC-like c1,BRCA basal-like c8,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Tumor resection,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,null,NO,YES,Basal,null,miRNA cluster 1,null,Stage IIA,FEMALE,null
TCGA-HN-A2OB-01,null,null,null,null,null,null,null,null,null,null,3.0,7.0,null,3.0,3.0,1.0,2.0,3.0,null,null,1.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,NO,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-JL-A3YW-01,null,null,null,null,null,null,null,null,null,null,4.0,null,null,null,1.0,null,null,4.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,BRCA basal-like c6,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,null,30-39%,30-39%,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T2,NO,NO,YES,NO,Her2,null,null,null,Stage IIB,FEMALE,null
TCGA-JL-A3YX-01,null,null,null,null,null,null,null,null,null,null,4.0,null,1.0,null,1.0,null,5.0,4.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,KIRC-like c1,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,null,30-39%,30-39%,3+,Infiltrating Lobular Carcinoma,8520/3,2+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,YES,NO,LumA,null,miRNA cluster 4,null,Stage IIA,FEMALE,null
TCGA-LD-A66U-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,null,null,1.0,null,null,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,NO,90-99%,<10%,null,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,null,null,MX,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-LD-A74U-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,null,1.0,null,1.0,3.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Lumpectomy,null,<10%,null,null,"Other, specify",8524/3,3+,Core needle biopsy,Negative,null,null,True,M0,T3,YES,NO,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-LD-A7W5-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,2.0,6.0,null,null,7.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Lumpectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-LD-A7W6-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,3.0,5.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,"Other, specify",8524/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-LD-A9QF-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,YES,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T1c,YES,NO,YES,NO,Normal,null,null,null,Stage IA,FEMALE,null
TCGA-LL-A440-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,NO,YES,NO,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-LL-A441-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,2.0,null,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,YES,YES,NO,Normal,null,null,null,Stage IA,FEMALE,null
TCGA-LL-A442-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,2.0,1.0,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-LL-A50Y-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,1.0,1.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,YES,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-LL-A5YL-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,3.0,6.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,null,90-99%,null,3+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Positive,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-LL-A5YM-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,1.0,null,1.0,2.0,2.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Positive,3+,Positive,Other,null,90-99%,null,2+,Infiltrating Ductal Carcinoma,8541/3,3+,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T4b,NO,NO,YES,NO,LumB,null,null,null,Stage IIIB,FEMALE,null
TCGA-LL-A5YN-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,2.0,2.0,2.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Lumpectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-LL-A5YO-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,MX,T1b,YES,YES,YES,NO,Her2,null,null,null,Stage IA,FEMALE,null
TCGA-LL-A5YP-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,2.0,3.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Modified Radical Mastectomy,NO,<10%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-LL-A6FP-01,null,null,null,null,null,null,null,null,null,null,10.0,1.0,null,null,1.0,1.0,null,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Positive,1+,Positive,Simple Mastectomy,NO,90-99%,null,2+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-LL-A6FQ-01,null,null,null,null,null,null,null,null,null,null,8.0,2.0,1.0,null,1.0,null,2.0,5.0,null,null,3.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,NO,NO,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-LL-A6FR-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,2.0,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,1+,Positive,Lumpectomy,YES,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-LL-A73Y-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,3+,Negative,Simple Mastectomy,NO,null,null,3+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,NO,YES,NO,Basal,null,null,null,Stage IA,FEMALE,null
TCGA-LL-A73Z-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,1.0,1.0,1.0,2.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Positive,1+,Positive,Lumpectomy,NO,10-19%,null,2+,Infiltrating Ductal Carcinoma,8500/3,1+,Excisional Biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M1,T1c,YES,YES,YES,NO,Normal,null,null,null,Stage IV,FEMALE,null
TCGA-LL-A740-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,YES,null,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,NO,YES,NO,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-LL-A7SZ-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,2.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Other,YES,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,MX,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-LL-A7T0-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,1+,Positive,Simple Mastectomy,NO,90-99%,null,3+,Infiltrating Ductal Carcinoma,8500/3,3+,Tumor resection,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,NO,NO,YES,NO,LumB,null,null,null,Stage IIB,FEMALE,null
TCGA-LL-A8F5-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,YES,20-29%,<10%,1+,Infiltrating Ductal Carcinoma,8500/3,1+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-LL-A9Q3-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,3.0,7.0,null,null,9.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,2+,Positive,Modified Radical Mastectomy,YES,90-99%,null,3+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-LQ-A4E4-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,2.0,1.0,1.0,6.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,1+,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T3,YES,YES,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-MS-A51U-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,1.0,null,1.0,5.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,Negative,Negative,null,True,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-OK-A5Q2-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,null,null,1.0,null,null,3.0,null,null,1.0,3.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,3+,Positive,Modified Radical Mastectomy,YES,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,3+,null,Negative,null,null,null,MX,T2,null,null,YES,NO,LumA,null,null,null,Stage II,FEMALE,null
TCGA-OL-A5D6-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,2.0,2.0,1.0,1.0,1.0,1.0,null,null,null,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,YES,NO,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A5D7-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,2.0,null,3.0,1.0,2.0,1.0,null,null,null,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,YES,YES,NO,YES,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A5D8-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,2.0,null,2.0,1.0,2.0,1.0,null,null,null,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Other (specify),Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T3,YES,YES,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-OL-A5DA-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,2.0,null,3.0,null,2.0,1.0,null,null,null,1.0,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Other,null,60-69%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,"Other method, specify:",null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,NO,NO,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A5RU-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,2.0,null,2.0,1.0,2.0,4.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T1c,YES,YES,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A5RV-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,2.0,1.0,2.0,7.0,null,null,6.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-OL-A5RW-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,null,null,2.0,1.0,null,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,MX,T1c,YES,YES,NO,YES,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A5RX-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,2.0,1.0,2.0,1.0,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T1c,NO,NO,NO,YES,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-OL-A5RY-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,5.0,2.0,6.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Negative,Lumpectomy,null,10-19%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,"Other method, specify:",null,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T1c,YES,YES,NO,YES,Normal,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A5RZ-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,null,null,1.0,7.0,null,1.0,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Negative,Simple Mastectomy,null,30-39%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T1b,YES,NO,NO,YES,Her2,null,null,null,Stage IA,FEMALE,null
TCGA-OL-A5S0-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,3.0,3.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Negative,Modified Radical Mastectomy,null,30-39%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,YES,YES,NO,YES,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-OL-A66H-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,1.0,1.0,1.0,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Mucinous Carcinoma,8480/3,null,Fine needle aspiration biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T1c,NO,YES,NO,YES,LumA,null,null,null,Stage IB,FEMALE,null
TCGA-OL-A66I-01,null,null,null,null,null,null,null,null,null,null,2.0,9.0,3.0,null,1.0,1.0,2.0,3.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,null,True,MX,T1c,YES,YES,NO,YES,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A66J-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,null,null,3.0,1.0,null,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,MX,T1c,NO,YES,NO,YES,LumA,null,null,null,Stage I,FEMALE,null
TCGA-OL-A66K-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,2.0,2.0,2.0,1.0,2.0,1.0,null,null,null,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,null,70-79%,null,2+,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,NO,NO,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A66L-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,2.0,null,2.0,1.0,1.0,1.0,null,null,null,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T1c,NO,YES,NO,YES,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-OL-A66N-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,2.0,4.0,null,null,4.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Negative,Modified Radical Mastectomy,null,80-89%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T3,NO,YES,NO,YES,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-OL-A66O-01,null,null,null,null,null,null,null,null,null,null,3.0,9.0,1.0,null,1.0,1.0,2.0,4.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-OL-A66P-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,1.0,1.0,1.0,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Simple Mastectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,null,Negative,null,True,MX,T2,YES,NO,NO,YES,Her2,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A6VO-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,1.0,null,2.0,1.0,1.0,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Negative,null,Negative,Lumpectomy,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,null,True,MX,T1c,YES,YES,NO,YES,Basal,null,null,null,Stage IA,FEMALE,null
TCGA-OL-A6VQ-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,1.0,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Lumpectomy,null,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,null,Negative,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,MX,T2,NO,NO,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-OL-A6VR-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,2.0,null,2.0,1.0,2.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Simple Mastectomy,null,30-39%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,Negative,null,True,MX,T1b,NO,NO,NO,YES,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-OL-A97C-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,2.0,2.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Negative,null,Negative,Simple Mastectomy,null,null,null,null,"Other, specify",9020/3,null,Fine needle aspiration biopsy,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T3,null,NO,NO,YES,Normal,null,null,null,Stage IIB,FEMALE,null
TCGA-PE-A5DC-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,4.0,2.0,null,null,2.0,8.0,null,null,2.0,null,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,null,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,null,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-PE-A5DD-01,null,null,null,null,null,null,null,null,null,null,6.0,4.0,4.0,null,3.0,null,2.0,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Negative,Other,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Incisional Biopsy,Positive,Positive,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-PE-A5DE-01,null,null,null,null,null,null,null,null,null,null,3.0,8.0,3.0,null,4.0,null,1.0,1.0,null,null,1.0,null,8.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Other,null,null,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T2,YES,YES,NO,YES,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-PL-A8LV-01,null,null,null,null,null,null,null,null,null,null,5.0,6.0,1.0,null,1.0,null,4.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,null,null,null,null,null,null,null,null,Medullary Carcinoma,8510/3,null,Excisional Biopsy,null,null,null,False,M0,T4,null,NO,YES,NO,Basal,null,null,null,Stage IIIB,FEMALE,null
TCGA-PL-A8LX-01,null,null,null,null,null,null,null,null,null,null,2.0,9.0,1.0,null,1.0,null,3.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M1,T4,NO,NO,YES,NO,LumA,null,null,null,Stage IV,FEMALE,null
TCGA-PL-A8LY-01,null,null,null,null,null,null,null,null,null,null,1.0,10.0,1.0,null,1.0,null,2.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),False,M0,T3,NO,NO,YES,NO,Normal,null,null,null,Stage IIB,FEMALE,null
TCGA-PL-A8LZ-01,null,null,null,null,null,null,null,null,null,null,1.0,10.0,null,null,1.0,null,null,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Excisional Biopsy,null,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),null,M0,T4b,YES,NO,YES,NO,Basal,null,null,null,Stage IIIB,FEMALE,null
TCGA-S3-A6ZF-01,null,null,null,null,null,null,null,null,null,null,6.0,4.0,1.0,null,1.0,1.0,7.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Simple Mastectomy,YES,90-99%,50-59%,2+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,NO,YES,NO,LumB,null,null,null,Stage IIA,FEMALE,null
TCGA-S3-A6ZG-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,5.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,null,Positive,Lumpectomy,YES,90-99%,<10%,null,Mixed Histology (please specify),8520/3,null,Excisional Biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-S3-A6ZH-01,null,null,null,null,null,null,null,null,null,null,1.0,10.0,1.0,null,1.0,1.0,3.0,5.0,null,null,5.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Positive,null,Positive,Simple Mastectomy,NO,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,null,False,MX,T3,YES,YES,YES,NO,LumA,null,null,null,Stage IIIC,FEMALE,null
TCGA-S3-AA0Z-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,null,1.0,1.0,2.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Modified Radical Mastectomy,YES,90-99%,10-19%,1+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-S3-AA10-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Axillary lymph node dissection alone,Negative,null,Negative,Simple Mastectomy,NO,null,null,1+,Infiltrating Ductal Carcinoma,8500/3,null,Fine needle aspiration biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,NO,YES,NO,Basal,null,null,null,Stage IIA,FEMALE,null
TCGA-S3-AA11-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,1.0,2.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,2+,Positive,Lumpectomy,YES,90-99%,<10%,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M0,T2,YES,YES,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-S3-AA12-01,null,null,null,null,null,null,null,null,null,null,9.0,2.0,1.0,null,1.0,null,10.0,4.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Negative,Simple Mastectomy,NO,90-99%,null,1+,Infiltrating Ductal Carcinoma,8500/3,2+,Core needle biopsy,Negative,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T3,YES,NO,YES,NO,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-S3-AA14-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,2.0,1.0,null,null,1.0,4.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,3+,Positive,Other,YES,70-79%,70-79%,3+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,cM0 (i+),T1,YES,YES,YES,NO,LumA,null,null,null,Stage I,FEMALE,null
TCGA-S3-AA15-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,5.0,3.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Negative,null,Negative,Simple Mastectomy,YES,null,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,cM0 (i+),T2,YES,YES,YES,NO,Basal,null,null,null,Stage IIB,FEMALE,null
TCGA-S3-AA17-01,null,null,null,null,null,null,null,null,null,null,6.0,4.0,1.0,null,1.0,1.0,3.0,1.0,null,null,1.0,2.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,2+,Positive,Simple Mastectomy,YES,90-99%,null,2+,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,Equivocal,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,cM0 (i+),T2,YES,YES,YES,NO,LumB,null,null,null,Stage IIB,FEMALE,null
TCGA-UL-AAZ6-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,1.0,null,1.0,null,1.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,null,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,null,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T2,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-UU-A93S-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,1.0,1.0,null,null,5.0,null,null,null,null,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Negative,null,Negative,Modified Radical Mastectomy,YES,null,90-99%,3+,Infiltrating Ductal Carcinoma,8500/3,null,Core needle biopsy,Positive,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,M1,T4d,NO,NO,YES,NO,Her2,null,null,null,Stage IV,FEMALE,null
TCGA-V7-A7HQ-01,null,null,null,null,null,null,null,null,null,null,8.0,3.0,null,null,3.0,1.0,null,5.0,null,null,2.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,3+,Positive,Modified Radical Mastectomy,NO,60-69%,null,null,Infiltrating Ductal Carcinoma,8500/3,null,Tumor resection,null,Negative,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),null,M0,T1c,YES,YES,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-W8-A86G-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,1.0,1.0,null,null,1.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel node biopsy alone,Positive,1+,Positive,Lumpectomy,YES,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,1+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2a,YES,NO,YES,NO,LumA,null,null,null,Stage IIA,FEMALE,null
TCGA-WT-AB41-01,null,null,null,null,null,null,null,null,null,null,5.0,null,2.0,null,2.0,null,1.0,1.0,null,null,1.0,null,9.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Positive,1+,Positive,Modified Radical Mastectomy,null,90-99%,null,null,Infiltrating Ductal Carcinoma,8500/3,3+,Core needle biopsy,null,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T2,YES,NO,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-WT-AB44-01,null,null,null,null,null,null,null,null,null,null,8.0,null,1.0,null,2.0,null,1.0,1.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,No axillary staging,Positive,3+,Positive,Lumpectomy,null,90-99%,null,1+,Infiltrating Lobular Carcinoma,8520/3,3+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,YES,NO,YES,LumA,null,null,null,Stage IA,FEMALE,null
TCGA-XX-A899-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,2.0,6.0,null,null,2.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,YES,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-XX-A899-11,null,null,null,null,null,null,null,null,null,null,4.0,7.0,1.0,null,1.0,null,3.0,6.0,null,null,2.0,1.0,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,null,Positive,Modified Radical Mastectomy,NO,90-99%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T1c,YES,YES,NO,YES,null,null,null,null,Stage IIIA,FEMALE,null
TCGA-XX-A89A-01,null,null,null,null,null,null,null,null,null,null,7.0,4.0,1.0,null,1.0,null,2.0,3.0,null,null,1.0,null,10.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Positive,null,Positive,Simple Mastectomy,null,70-79%,null,null,Infiltrating Lobular Carcinoma,8520/3,null,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),False,MX,T3,NO,YES,NO,YES,LumA,null,null,null,Stage IIB,FEMALE,null
TCGA-Z7-A8R5-01,null,null,null,null,null,null,null,null,null,null,6.0,5.0,4.0,null,4.0,null,3.0,2.0,null,null,1.0,4.0,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,1+,Positive,Other,YES,null,null,null,Infiltrating Lobular Carcinoma,8520/3,2+,Core needle biopsy,Negative,null,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),True,MX,T3,YES,NO,NO,YES,LumA,null,null,null,Stage IIIA,FEMALE,null
TCGA-Z7-A8R6-01,null,null,null,null,null,null,null,null,null,null,4.0,7.0,4.0,null,4.0,null,3.0,1.0,null,null,1.0,1.0,7.0,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,Sentinel lymph node biopsy plus axillary dissection,Positive,2+,Positive,Lumpectomy,YES,null,null,1+,Infiltrating Lobular Carcinoma,8022/3,2+,Tumor resection,Negative,null,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),True,M0,T1c,YES,NO,NO,YES,LumB,null,null,null,Stage I,FEMALE,null
